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Abstract
ADP-ribosylation factors (Arfs) are ubiquitously expressed small molecular weight 
GTPases whose known functions in mammalian cells are as key regulators o f vesicle 
biogenesis and modulators o f  the actin cytoskeleton in the Golgi and plasma membrane 
systems. Previous studies have paid particular attention to the class I Arfl and the class III 
Arf6 , while there is virtually no information on the cellular functions o f the class II Arf 
isoforms, Arf4 and Arf5. While the different Arf isoforms have the same activities in a 
number o f in vitro and in vivo assays, several observations point to specific functions for 
the class II members. These include the identification o f an Arf5-specific guanine 
nucleotide exchange factor, GBFl, and the identification o f Arfophilin, a putative effector 
protein o f unknown function that shows specificity for class II and III iso forms.
Here a yeast two-hybrid screen has been performed to identify novel GTP-dependent AurfS 
binding proteins. This yielded two previously identified Arf-interacting proteins, Arfaptin 
2/PORl and Arfophilin, but also two novel ones, HCR and an Arfophilin homologue that 
we have named Arfophilin-2. In the yeast two-hybrid system, Arfophilin-2, like 
Arfophilin-1, appeared to specifically interact with the GTP-bound conformations o f class 
II and III Arfs and did not interact with class I isoforms. HCR displayed unique specificity 
for Arf5, but was not analysed further.
A full-length Arfophilin-2 open reading frame (ORF) was cloned from testis cDNAs, 
although there is evidence o f 5 ’ alternative splicing. Northern blotting revealed that 
Arfophilin-2 mRNA is highly expressed in testis but also at low levels in many other 
tissues, while Arfophilin-1 is predominantly expressed in testis, kidney and skeletal 
muscle. Arfophilin-2-specific polyclonal antibodies were raised against the C-terminal 
domain and used to analyse the native protein. They recognised a single band with an 
apparent molecular weight o f 83 kDa in HeLa and HEK 293 cells, as well as in a human 
testis homogenate. Moreover, these bands had the same electrophoretic mobility as the 
protein product produced from the cloned ORF. Using immunofluorescence microscopy, 
endogenous Arfophilin-2 was found to reside primarily in a brefeldin A-sensitive, cation- 
independent mannose-6-phosphate receptor-positive, trans~Go\g\ network (TGN) 
compartment. Some staining was also observed at the centrosome, where it partially 
colocalised with y-tubulin, and at the plasma membrane in structures resembling focal 
contacts or actin-rich protrusions. Overexpression o f green fluorescent protein (GFP) fused 
to the C-terminal Arf-binding domain o f Arfophilin 2, or indeed to full-length Arfophilin
IV
2, resulted in a tight pericentrosomal localisation in HeLa, HEK 293 and CHO cells. 
Strikingly, transferrin receptors (TfRs) and R ab ll, a marker for the perinuclear recycling 
endosomes, were also redistributed to the same location while early endosomal and 
Golgi/TGN markers were unaffected. Trafficking o f  TfRs through the compartment did not 
seem to be compromised, as evidenced by pulse-chase experiments using fluorescent 
transferrin in transiently transfected HeLa cells. The pericentrosomal localisation o f the 
GFP-Arfophilin 2/TfR/Rabll compartment was sensitive to microtubule disruption using 
nocodazole, which caused the compartment to disperse into punctate structures throughout 
the cytoplasm. Conversely, Brefeldin A treatment was without discernible effect.
Amino acid sequence analysis revealed that the Arfophilins are homologous to Nuclear 
Fallout (Nuf) in their C-termini. N uf is a cell-cycle regulated protein that plays a critical 
role in Drosophila melanogaster cellularisation where it is believed to facilitate the loading 
o f vesicles onto microtubules at the centrosome for subsequent transport to the periphery. 
GFP-Nuf constructs were engineered and expressed in HeLa cells to see whether a similar 
phenotype would arise. Strikingly, the same clustering o f TfRs and R abll was observed, 
again without noticeably compromising the ability o f fluorescent transferrin to traffic 
through the compartment. These data suggest that N uf and Arfophilins are functionally 
homologous.
In summary, this work has uncovered a novel putative Arf effector protein and has 
provided the first functional analysis o f the mammalian Arfophilins. The results suggest 
they may be important in regulating the spatial distribution o f the endosomal recycling 
compartment, and by analogy with the N uf protein, they may be involved in regulating 
membrane trafficking during cytokinesis.
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PI(3)P phosphatidylinositol (3) phosphate
PI(3,4,5)P3 phosphatidylinositol (3,4,5) triphosphate
PI(4,5)P2 phosphatidylinositol (4,5) bisphosphate
PLD phospholipase D
PMSF phenylmethanesulphonyl fluoride
PORI partner o f Rac 1
QDO quadruple drop-out
RACE rapid amplification o f cDNA ends
RE recycling endosome
RNA ribonucleic acid
RNase A ribonuclease A
rpm revolutions per minute
SAT suppressor o f Arf-ts
XVII
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis
SNARE soluble NSF attachment protein receptor
SNX sorting nexin
TDO triple dropout
TEMED A ,A ,A ’,A-tetramethylenediamine
TfR transferrin receptor
TGN trans-GoXgi network
ts temperature senstive
UAS upstream activating sequence
UTR untranslated region
VTC vesicular tubular cluster
v/v volume/volume ratio
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Chapter 1
General Introduction
1.1 An overview of membrane trafficking
Membrane trafficking is a major field o f study in cell biology. Eukaryotic cells have 
developed highly sophisticated mechanisms for the internalisation and uptake o f  various 
nutrients and substances as well as for both constitutive and regulated modes o f secretion. 
These mechanisms have fascinated cell biologists for the last quarter o f a century and will 
undoubtedly continue to do so for many years to come. The endocytic system allows for 
the uptake o f material from the extracellular milieu, while the secretory membrane system 
allows cells to direct newly synthesised proteins, carbohydrates and lipids to the cell 
surface, all o f which are necessary for cell homeostasis and growth. The two systems are 
intricately linked and use similar mechanisms and logic. They consist o f distinct 
membrane-bound organelles, including the endoplasmic reticulum (ER), the Golgi 
complex and the plasma membrane as well as intermediate tubulo-vesicular compartments 
such as the trans~Go\%\ network (TGN) and the endosomal system (Fig. 1.1.1). These all 
have different biochemical compositions and serve different functions. Membrane traffic 
occurs dynamically within these systems in a highly controlled manner along organised, 
directional routes and mechanisms exist to ensure that the biochemical heterogeneity 
between subcompartments is maintained. Much o f our understanding o f general membrane 
trafficking events have come from powerful genetic studies, particularly in the budding 
yeast Saccharomyces cerevisiae and also from ingenious “cell free” systems where 
individual trafficking events can be monitored in isolation. In general, membrane 
trafficking occurs via vesicular transport whereby proteins and lipids are sorted and 
packaged into membranous vesicles that bud from donor membranes. These are then 
carried along cytoskeletal tracks to an appropriate acceptor compartment to which they 
dock and then subsequently fuse (Fig. 1.1.2). As well as being an interesting subject o f  
research, the importance o f studying these aspects o f cell biology is highlighted by the fact 
that defects in membrane trafficking pathways give rise to many pathological disorders in 
humans (reviewed in Olkkonen and Ikonen, 2000; Aridor and Hannan, 2000).
1.1.1 The secretory pathway
Classical morphological analysis o f fixed cells has provided the basis for our knowledge o f  
the architecture o f the secretory pathway (Palade, 1975), and much has since been learned 
through the use o f powerful genetic and biochemical approaches (Rothman and Wieland, 
1996; Schekman and Orel, 1996). The ER represents the start o f  the secretory pathway 
(Fig. 1.1.3), and it is the largest intracellular compartment consisting o f many
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Fig. 1.1.1 Intracellular membrane trafficking.
A diagrammatic overview of membrane trafficking pathways in a typical 
eukaryotic cell. The biosynthetic/secretory pathway (indicated by red 
arrows) transports newly synthesised proteins from the endoplasmic 
reticulum, through the Golgi apparatus and to the cell surface. 
Internalised molecules enter the endocytic pathway (indicated by white 
arrows) and are sorted in the early endosomes from where they may be 
recycled back to the cell surface or transported to the late endosomes 
and lysosomes for degradation. The secretory and endocytic systems 
exchange material at the level of the Golgi apparatus and endosomes. 
Reproduced from Olkkonen & Ikonen, 2000.
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Fig. 1.1.2 Principles of vesicular transport.
In general terms, vesicular transport involves a number of steps including 
the formation of vesicles at a donor membrane. This is facilitated by 
cytosolic coat-protein complexes and is coupled to cargo- 
selection/sorting. The newly formed vesicles move along cytoskeletal 
tracks consisting of microtubules or actin filaments, attached to motor 
proteins. They are then tethered to an appropriate acceptor 
compartment, where they subsequently fuse with the membrane bilayer 
thus delivering their contents. Reproduced from Olkkonen & Ikonen, 
2000 .
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interconnecting membrane tubules and cistemae. Nascent polypeptides destined for the 
secretory pathway are recognised by the signal recognition particle and co-translationally 
translocated via the Sec61 translocon into the ER lumen (High, 1995). The correct folding 
of the newly synthesised protein is facilitated by the actions o f lumenal chaperones such as 
BiP, calnexin and calreticulin (Ellgaard and Helenius, 2001). In this respect, the ER plays 
an important role as a quality control centre as only correctly folded proteins are able to 
progress into the secretory pathway (Ellgaard and Helenius, 2001). Proteins destined for 
this route are then sorted away from ER resident proteins at discrete ER exit sites: highly 
organised membrane domains that direct membrane flow out o f the ER into an ER-Golgi- 
intermediate compartment. This transport step is under the control o f  the small GTPase 
Sari, which recruits and assembles cytosolic COPn coat protein complexes (Barlowe et 
ah, 1994, see below). This then leads either to the continual budding o f vesicles that can 
then proceed to and fuse with pre-Golgi intermediates (Bannykh et al., 1996), or the 
tubulation o f the ER that then becomes a pre-Golgi intermediate (Clermont et al., 1994; 
Krijnse-Locker et ah, 1994). It has generally been assumed that all secretory proteins leave 
the ER together and that sorting only occurs at later stages. Recent evidence, however, 
shows that this is not strictly the case since glycosylphosphatidylinositol (GPI)-linked 
proteins leave the ER in separate vesicles from non-GPI-liked proteins suggesting that 
there is some sorting at the level o f  the ER (Muniz et ah, 2001). Nevertheless, pre-Golgi 
intermediates, also known as vesicular tubular clusters (VTCs), deliver secretory and 
membrane proteins to the cis face o f the Golgi complex, the next major station along the 
secretory pathway.
The Golgi apparatus is where proteins and lipids are modified and sorted and where many 
decisions are made for onward travel to the plasma membrane or retention in the ER/Golgi 
system. Transport occurs sequentially through a characteristic stack o f 3-5 Golgi cistemae, 
from cis, through medial, to trans, during which time secretory cargo undergoes a 
maturation process. For example, glycoproteins have their oligosaccharides trimmed and 
rebuilt, proteins may become sulphated or phosphorylated and appropriate proteolytic 
cleavages may be performed (Helenius and Aebi, 2001; Varki, 1998; Steiner et ah, 1984). 
There has been some debate as to whether transport through the Golgi involves static 
cistemae between which vesicles shuttle in both directions, or whether it entails the 
movement and maturation o f the cistemae themselves as they progress from the cis to the 
trans Golgi, or indeed a combination o f both (reviewed in Pelham and Rothman, 2000). In 
any case, cargo proceeds to the TGN where it is sorted and packaged into distinct vesicles 
for delivery to the endosomal system, the plasma membrane or for the formation o f
6secretory granules in cells that undergo regulated secretion. A diagrammatic overview o f  
the secretory pathway is given in Figure 1.1.3.
Fig. 1.1.3 The secretory  pathway.
A diagrammatic overview of the secretory pathway is shown. It begins at 
the endoplasmic reticulum (ER), progresses through a pre-Golgi 
intermediate compartment consisting of vesicular tubular structures 
(VTCs) before entering the c/s-Golgi network (CGN). From here proteins 
are directed through the Golgi stack from the c/s to the trans face, either 
by cisternal maturation or by vesicular transport, and are delivered to the 
trans-Go\g\ network (TGN). Cargo can then be routed directly to plasma 
membrane (PM) in constitutive secretion pathways (A), or be directed 
into a specialised compartment in cells that undergo regulated 
exocytosis (B), or traffic into the endosomal system (0). In the early 
secretory pathway, anterograde transport from the ER is mediated by 
COPi! coated vesicles (black circles) whereas retrograde Golgi-ER 
vesicles are COPI coated (blue circles).
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1.1.2 The endosomal pathway
While the secretory pathway directs newly synthesised proteins and lipids out towards the 
cell surface, nutrients, membrane and other components are continually being internalised 
in the opposite direction. This occurs primarily by the process o f  endocytosis, but also by 
other mechanisms such as pinocytosis. Endocytosis can itself be divided into clathrin- 
dependent and clathrin-independent mechanisms, such as that occurring via caveolae 
(Mellman, 1996). The former is by far the best understood at the molecular level and it is 
the route taken by recycling receptors such as the transferrin receptor. Ligand-bound 
signalling receptors are also rapidly internalised by clathrin-mediated endocytosis to 
prevent the prolonged stimulation o f signal transduction cascades.
The endosomal system coordinates protein transport from both the biosynthetic secretory 
pathway and the endocytic pathway (Gruenberg and Maxfreld, 1995; Mellman, 1996). It 
encompasses multiple sub-compartments including early or sorting endosomes, recycling 
endosomes, and late endosomes (see Fig. 1.1.4). All o f these compartments have distinct 
biochemical compositions (Sheff et al., 1999), can sometimes be distinguished 
morphologically (Sonnichsen et al., 2000) and serve different functions (Mellman, 1996). 
On the other hand, the precise boundaries are still somewhat unclear and are variable 
between cell types. Within the endosomal system, many decisions are made in the sorting 
of proteins, such as the internalised receptors and their ligands, to determine whether they 
are to be delivered to the lysosomes, the Golgi complex or recycled back to the plasma 
membrane. The situation is further complicated in polarised cells where there is both an 
apical and a basolateral plasma membrane domain, each having separate recycling systems 
that, for example, need to differentiate between recycling and transcytosing molecules 
(Mellman, 1996).
1.1.2.1 The transferrin receptor
The archetypal marker protein o f the endosomal system is the transferrin receptor (TfR). 
This has been an excellent tool for studying the endocytic pathway because its ligand, 
holotransferrin, can be easily labelled and monitored. The TfR is an 80 kDa integral 
membrane protein involved in cellular uptake o f iron required for the maintenance o f cell 
homeostasis (see Ponka and Lok, 1999). TfRs are internalised via clathrin-coated pits 
before entering the sorting endosomes that are located in the peripheral regions o f the cell. 
Here the acidic environment (pH -6 .0 ) causes them to release their iron cargo and many o f  
the receptors are then rapidly recycled back to the cell surface for another round o f
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Fig. 1.1.4 The endosom al system .
The different subcompartments of the endosomal system are shown, including 
the early/sorting endosomes (EE), recycling endosomes (RE) and late 
endosomes (LE). The frans-Golgi network (TGN), plasma membrane (PM) and 
lysosomes (L) are also shown. Recycling receptors such as the transferrin 
receptor (TfR, in green) are internalised via clathrin coated vesicles and enter 
the EE. The acidic environment causes ligand dissociation and many 
receptors are then rapidly recycled back to the PM. Some, however, progress 
into a separate peri-centriolar compartment (RE) before being returned to the 
PM. Proteins to be degraded are delivered from the EE to the LE and then to 
the lysosomes. Different subdomains of the TfR-positive endosomal system 
contain specific Rab family GTPases that do not significantly overlap, as 
shown. Well-characterised transport routes are denoted by arrows. 
Microtubules, which form the cytoskeletal network to which many of the 
organelles are anchored, are shown with their minus ends emanating from the 
microtubule-organising centre (MTOC).
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internalisation (Dautry-Varsat, 1986). This occurs with a half-time o f  two to three minutes 
(Schmid et a l, 1988; Mayor et a l, 1993). In addition to the rapidly recycling pool, a 
substantial number o f TfRs traffic further into the cell to a distinct compartment, the peri- 
centriolar recycling endosomes (see below). From here, TfRs recycle back to the plasma 
membrane but this is markedly slower than the recycling from the sorting endosomes with 
a half-time o f five to ten minutes (Schmid et a l, 1988; Hopkins, 1983; Daro et a l, 1996). 
In migrating fibroblasts, this slower transport route through the recycling endosomes has 
been shown to direct TfRs to the leading lamellae at the plasma membrane, suggesting that 
exit from the compartment is directed to discrete sites at the cell surface (Hopkins et a l, 
1994). Up to 75% o f the total TfR population is found intracellularly and a large proportion 
o f this is in these peri-centriolar recycling endosomes (van der Sluijs et a l, 1992b). Other 
internalised molecules such as the epidermal growth factor (EOF) receptor or low density 
lipoprotein (LDL) do not follow the same route and are retained in the sorting endosomes 
before being delivered to late endosomes and lysosomes via endosomal carrier vesicles 
(reviewed in Luzio et a l, 2000). Lysosomes are even more acidic than the early endosomes 
(pH -5 .0 ) and contain hydrolytic enzymes for the degradation o f unwanted 
macromolecules (Rouille et a l, 2000).
1.1.2.2 The peri-centriolar recycling endosom es
These are tubulo-vesicular structures adjacent to the microtubule organising centre that are 
tethered to the microtubule cytoskeleton (Cole and Lippincott-Schwartz, 1995). The 
microtubule cytoskeleton is not, however, required for their recycling function, at least in 
terms o f the TfR, since it persists in the absence o f microtubules (Daro et a l, 1996; Jin and 
Snider, 1993; Sakai et a l, 1991). They are biochemically and functionally distinct from the 
early sorting endosomes in a number o f ways. Firstly, they lack proteins that are destined 
for the late endosomes and lysosomes, such as the EGF receptor and LDL mentioned 
above. Early studies revealed that they are also slightly less acidic than the early 
endosomes with a pH o f - 6 .5-6 .8 (Yamashiro et a l, 1984; Yamashiro and Maxfield, 
1984). It was also noted that while the VAMP-related v-SNARE involved in TfR 
recycling, cellubrevin, was found in both compartments, the early endosomes alone 
contained Rab4 (Daro et a l, 1996). At the same time, it was reported that the expression o f  
Rab 11 mutants selectively perturbed the trafficking o f the TfR through the peri-centriolar 
endosomes (Ullrich et a l, 1996), where Rab 11 had previously been shown to reside in 
addition to the TGN and secretory vesicles (Urbe et a l, 1993). More recent studies have 
shown that the two distinct populations can be partially resolved by density gradient 
centrifugation o f polarised MDCK cells (Sheff et a l, 1999), and different pharmacological
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sensitivities have been observed for the two compartments. Only the Rab4-positive 
structures become tubulated upon brefeldin A treatment (Daro et al., 1996), and only the 
Rab 11 “positive, peri-centriolar recycling compartment selectively retains fluorescent 
transferrin following treatment with the G protein activator AIF4 (Sheff et al., 1999). The 
latter recycling compartment is also unique in that it selectively retains TfRs that have been 
artificially oligomerised by using multivalent, chemically cross-linked transferrin as a 
ligand (Marsh et al., 1995). A TGN marker protein, TGN38, has been shown to traffic 
through the recycling compartment on its journey from the plasma membrane to the TGN 
(Ghosh et ah, 1998) and this is a route distinct from that followed by other proteins such as 
the cation-independent mannose-6-phosphate receptor (CI-MPR) and furin that traffic via 
the late endosomes (Mallet and Maxfield, 1999). Similarly, the insulin-regulated amino- 
peptidase (IRAP) cytoplasmic tail fused to the lumenal domain o f the TfR passes through 
the compartment in CHO cells and in 3T3-L1 adipocytes (Johnson et ah, 1998; Subtil et 
a l, 2000). While the TfR has been well established as a marker protein for the recycling 
endosomal compartment, it was recently demonstrated that there is a subpopulation o f peri- 
centriolar endosomes that is cellubrevin-p0sitive but TfR-negative, indicating that 
heterogeneity exists (Teter et a l, 1998). These two subpopulations have different pH 
values, different sensitivities to ion transport inhibitors and undoubtedly have different 
functions (Teter et a l, 1998), although these have not yet been elucidated.
Information as to the identities and/or functions o f specific regulators o f the peri-centriolar 
recycling endosomes is sparse. Rab 11 is a clear candidate that has been implicated in 
regulating exit from the compartment (see below), but its precise role is unknown. 
Similarly, Rab 17 appears to be a polarised cell-specific regulator since it localises to the 
compartment in mammary epithelial cells, and the expression o f a dominant negative 
mutant inhibits transcytosis but not basolateral recycling (Hunziker and Peters, 1998; 
Lutcke et a l, 1993; Zacchi et a l, 1998). The t-SNARE syntaxin 13 is another protein that 
localises to the peri-centriolar recycling endosomes in neurons (Prekeris et a l, 1999) and 
in non-polarised cells (Prekeris et a l, 1998), where it is enriched on Rab 11 
immunoadsorbed endosomes (Trischler et a l, 1999).
Recent studies, however, have implicated two additional proteins involved in regulating 
the distribution and function o f the recycling compartment: RME-1 (Grant et a l, 2001; Lin 
et a l, 2001) and myosin Vb (Lapierre et a l, 2001). RME-1 was identified in a C. elegans 
screen for mutants defective in receptor mediated endocytosis, hence the name. It belongs 
to a family o f  Eps 15-homology (EH)-domain containing proteins, and these generally have 
a role in endocytosis often via interactions with clathrin accessory proteins (Santolini et a l.
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1999). RME-1 also has coiled-coil domains and a P-loop that is predicted to bind 
nucleotides. In C  elegans, RME-1 is found associated with intracellular membranes and 
these become enlarged and filled with endocytosed markers in worms harbouring 
mutations in the P-loop or near the EH domain, suggesting a block in recycling (Grant et 
al., 2001). In mammalian CHO cells, where the recycling compartment is better 
characterised, expression o f  analogous dominant-negative mutants o f murine RME-1 
(mRmel) altered the morphology o f  the TfR-positive pericentriolar endosomes and slowed 
Tf transferrin recycling, again suggestive o f a role in regulating exit from the compartment 
(Lin et al., 2001). Myosin Vb has been implicated in recycling endosomal function based 
on studies using a GFP construct fused to the tail domain o f the protein, which acts as a 
dominant-negative mutant since it lacks the motor/actin-binding domain. Expression o f  
this construct in mammalian cells caused TfR- and Rab 11-positive endosomes to 
accumulate around the centrosome in a microtubule-dependent manner (Lapierre et ah, 
2001). Moreover, internalised fluorescent transferrin could readily access this compartment 
but could not be chased out by unlabelled transferrin, indicating a block in recycling 
(Lapierre et al., 2001). The proposed regulators o f the endosomal recycling compartment 
are depicted in Fig. 1.1.5.
1.1.2.3 Rab proteins as m arkers for endosom al subcom partm ents
The idea o f distinct subdomains o f  the TfR pathway being delineated by distinct Rab 
GTPases has recently been substantiated in an elegant study by Sdnnischen et a l ,  (2000). 
They co-expressed Rab 4, Rab5 and Rab 11 fused to different fluorescent proteins and 
monitored their distributions relative to each other and to the TfR using confocal 
microscopy. Using this approach they found that each o f these GTPases do indeed mark 
distinct, although partially overlapping, subdomains o f the pathway. Rab5 marks the very 
early endosomes and partially overlaps with Rab4 that is found on slightly later structures. 
Rab4 in turn partially overlaps with Rab 11 in the perinuclear region but no overlap at all 
exists between Rab5 and Rab 11 (Sonnichsen et ah, 2000; see Fig. 1.1.4). Interestingly, in 
this study the different proteins were sometimes seen on the same continuous membrane 
without significant mixing, indicating a high degree o f spatial organisation at the 
membrane. Immunoadsorption o f endosomes using antibodies to Rab5 and Rab 11 has also 
demonstrated that these two GTPases are segregated (Trischler et ah, 1999). Other studies 
have shown Rab7 (Bucci et al., 2000) and Rab9 (Lombardi et al., 1993; Riederer et al.,
1994) to be specific markers for late endosomes and lysosomes, which are devoid o f TfRs.
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Fig. 1.1.5 Regulators of the recycling endosomal compartment.
The pericentriolar recycling endosomes (RE) are tethererd to the microtubule 
cytoskeleton by cytoplasmic dynein, in the vicinity of the microtubule 
organising centre (MTOC). Recycling markers of the compartment include the 
v-SNARE cellubrevin and the transferrin receptor (TfR), although these two 
molecules are segregated to some extent, suggesting heterogeneity within the 
compartment. The small GTPase Rabll is a good specific marker and it 
appears to regulate the exit of cargo from the compartment. Rab17 is a 
polarised cell-specific marker that may also regulate membrane traffic out of 
the recycling endosomes. The t-SNARE syntaxin 13 has also been localised to 
the compartment. Myosin Vb and RME-1 have recently been implicated in 
regulating the distribution and function of the RE. See text for more detail.
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Rab5 is the best studied mammalian Rab protein and it is well known for its role in 
controlling homotypic early endosome fusion (Gorvel et ah, 1991; reviewed in Woodman, 
2000), but it also has additional functions in endocytosis (Bucci et ah, 1992; McLauchlan 
et ah, 1998) and in the regulation o f early endosome motility (Nielsen et ah, 1999). It has a 
large set o f  effectors including RabaptinS, phosphatidyinositol 3-kinase and early 
endosomal auto antigen 1 (EEAl), and its activation gives rise to a positive feed-forward 
loop recruiting many components, both directly and indirectly, to discrete membrane sites 
(reviewed in Zerial and McBride, 2001). Rab4 has been less well studied but it also seems 
to regulate aspects o f early endosomal traffic, particularly in recycling receptors to the cell 
surface (van der Sluijs et ah, 1992b), possibly via its novel downstream effector Rabip4 
(Cormont et ah, 2001).
Conversely, R abll has been localised to the TGN, secretory vesicles and the peri­
centriolar recycling endosomes in some cell types (Urbe et ah, 1993). Confocal and 
electron microscopic analyses also found R abll colocalised with the TfR in the peri­
centriolar recycling compartment o f  Chinese hamster ovary (CHO) and baby hamster 
kidney (BHK) cells (Ullrich et ah, 1996). Furthermore, expression o f constitutively active 
mutants o f  R abll resulted in an accumulation o f internalised transferrin in the recycling 
compartment while a dominant negative mutant dispersed the compartment (Ullrich et ah,
1996). Two downstream R abll effectors have since been purified: Rab 11 BP/Rabphilin-11 
(Mammoto et ah, 1999; Zeng et ah, 1999) and Rip 11 (Prekeris et ah, 2000). In cells 
cultured on fibronectin, Rab 11 BP/Rabphilin-11 co localised with R abll on micro tubules 
oriented towards lamellipodia, and expression o f a dominant negative Rabphilin-11 mutant 
lacking the Rabl 1 binding domain decreased the accumulation o f fluorescent transferrin in 
the recycling endosomes and also inhibited cell motility (Mammoto et ah, 1999). More 
recently, Rabphilin-11 has been shown to directly bind to the mammalian counterpart o f 
Secl3p, a constituent o f COPII vesicles, and in a manner that is enhanced by Rabll-GTP  
(Mammoto et ah, 2000). Rabphilin-11 might, therefore, serve to link newly formed 
vesicles with the R abll machinery, although COPII vesicles are generally believed to form 
only on the ER. Rip 11 was found to be enriched in polarised epithelial cells where it 
localised to apical recycling endosomes and from where it appeared to regulate trafficking 
to the apical plasma membrane (Prekeris et ah, 2000).
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1.1.3 The trans-Golgi network
The trans-Golgi network (TGN) is the final station o f the Golgi complex and it plays a 
very important role in determining the fate o f the newly synthesised proteins that reach it. 
Despite its close proximity to the rest o f the Golgi complex, the TGN can be separated 
both structurally and functionally by treatment with brefeldin A, suggesting that it is a 
distinct organelle (Ladinsky and Howell, 1992). From the TGN, proteins may be 
constitutively directed to the plasma membrane, or be directed to the endosomal/lysosomal 
system or, in cells that undergo regulated secretion, they may be packaged into immature 
secretory granules which then mature as they progress towards the plasma membrane 
(Griffiths and Simons, 1986). Many TGN residents such as TGN38 also recycle to and 
firom the plasma membrane (Luzio et al., 1990; Ladinsky and Howell, 1992).
1.1.4 Vesicle biogenesis
Membrane transport between subcellular compartments relies on a series o f vesicle 
budding, translocation and fusion events. Furthermore, sorting mechanisms are required to 
ensure that only the appropriate cargo molecules are packaged into vesicles for transport. 
In general, vesicle biogenesis involves the recruitment o f proteinaceous coat complexes, 
membrane invagination to produce a bud and finally the pinching o ff or scission o f the 
newly formed coated vesicle. There are two main types o f coats that are known: COPs and 
clathrin coats and both types actively participate in the membrane deformation required to 
produce the vesicle.
1.1.4.1 COP-coated vesicles
COPs are subdivided into multi-subunit COPI (coatomer) and COPII coats which are 
recruited to Golgi and ER membranes, respectively (reviewed in Barlowe, 2000). They are 
unrelated in terms o f their protein composition but there are mechanistic parallels. The key 
trigger for the assembly o f the coat complexes comes from GTPases o f the Arf family 
(refer to section 1.3). GTP loading o f  Arf, in the case o f  COPI, or Sari in the case o f  
COPII, initiates the recruitment o f the pre-assembled cytosolic coat complexes to the 
membrane (Palmer et al., 1993; Barlowe et al., 1994; reviewed in Springer et al., 1999). 
This is sufficient to drive polymerisation o f the coats in vitro and the subsequent formation 
o f vesicles, provided that the membranes are o f the correct phospholipid compostion 
(Matsuoka et al., 1998b). This process plays an active role in cargo selection since the 
coats directly interact with cargo molecules such as transmembrane proteins with
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cytoplasmic KKXX motifs or p24 proteins (Cosson and Letoumeur, 1994; Kuehn et al., 
1998; Springer and Schekman, 1998). Moreover, COPs are sufficient to ensure the 
inclusion o f important components such as v-SNAREs which are later required for fusion 
o f the vesicle with acceptor membranes (Matsuoka et al., 1998a). The non-hydrolysable 
GTP analogue, GTPyS, allows vésiculation to occur in reconstituted in vitro systems 
indicating that the energy o f coat polymerisation drives budding rather than GTP 
hydrolysis, and the GTPases appear to act as catalysts to the process (Rothman and 
Wieland, 1996). GTP hydrolysis catalysed by GTPase activating proteins is, however, 
required for disassembly o f the coat and to allow for further rounds o f budding (Tanigawa 
et al., 1993; Rothman and Wieland, 1996). On the other hand, while GTPyS and GTPase- 
defective Arfl allow for the formation o f COPI-coated vesicles, specific enrichment o f 
such vesicles with the medial/trans Golgi marker a l  ,2-mannosidase II in an in vitro 
system is only observed when GTP hydrolysis occurs, suggesting that this plays an active 
part in sorting (Lanoix et al., 1999).
Although COPI is best characterised at the Golgi complex, it has been found to localise to 
endosomal compartments using immunoblotting o f purified fractions (Whitney et al., 1995; 
Aniento et al., 1996). In support o f  this, a mutant CHO cell line with a temperature 
sensitive defect in e-COP has an endosomal defect, where LDL receptors are rapidly 
degraded, in addition to defects in the ER/Golgi system (Guo et al., 1994). Further studies 
using the same cell line demonstrated that, at the restrictive temperature, transferrin 
recycling and bulk-phase uptake are markedly diminished (Daro et al., 1997). In addition, 
these cells can no longer be infected with viruses such as the vesicular stomatitis virus that 
require delivery to acidic endosomes before they can enter the cytosol (Daro et al., 1997). 
COPI association with endosomal membranes has been shown to be dependent on the 
acidic pH o f the endosomal lumen and both membrane association and pH-sensing 
depends on Arfl-GTP (Gu and Gruenberg, 2000). The role(s) o f  the endosomal COPs is 
not clear although they may be involved in the biogenesis o f  multi-vesicular bodies that 
mediate transport from early to late endosomes (Gu and Gruenberg, 1999; Gu and 
Gruenberg, 2000).
1.1.4.2 Clathrin-coated vesicles and clathrin adap to rs
Clathrin plays a major role in vesicle biogenesis at the trans-Go\g\ network and plasma 
membrane. It is a hexameric complex consisting o f heavy and light chains arranged to 
form three appendages emanating fi*om a central hub to produce a triskelion (for a 
comprehensive review on clathrin see Kirchhausen, 2000). Clathrin triskelia assemble into
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polyhedral cages and these constitute the clathrin coats on vesicles. Clathrin does not 
directly contact membrane components but interacts indirectly via clathrin adaptor 
complexes (APs). Four such AP complexes have been identified in mammalian cells: AP- 
1, AP-2, AP-3 and AP-4 (see Fig. 1.1.6; Robinson & Bonifacino, 2001). GGA proteins can 
also act as clathrin adaptors but these will be considered in the next section. The APs are 
heterotetrameric complexes comprising two large subunits (y/a/5/s, (3) and two small 
subunits (p, o). The first identified and best characterised are AP-1 and AP-2 which 
mediate clathrin-coated vesicle (CCV) biogenesis at the TGN and plasma membrane, 
respectively (Robinson and Pearse, 1986; Able et ah, 1988). The p subunits are important 
in recognising sorting motifs in the cytoplasmic tails o f  receptors that are to be included 
into CCVs (Ohno et ah, 1995). Following adaptor binding, clathrin is recruited from the 
cytosol and assembly o f the clathrin lattice ensues (Kirchhausen, 2000). In the case o f AP- 
1 (Stamnes and Rothman, 1993; Traub et ah, 1993; Austin et ah, 2000) and AP-3 (Ooi et 
ah, 1998), recruitment o f  the adaptor is dependent on a direct interaction with Arf, again 
underlining the central importance o f this family o f  GTPases in vesicle formation. No such 
Arf involvement has been documented for the formation o f AP-2 dependent endocytic 
CCVs but there is a wide array o f known accessory proteins, both primary and secondary, 
including amphiphysins, Eps 15, API 80/CALM, synaptojanin, synaptotagmins, stonins, 
intersectins, endophilins. It is beyond the scope o f this introduction to describe these here, 
but they have been adequately reviewed elsewhere (Jarousse and Kelly, 2001; Brodsky et 
ah, 2001). Despite the complex picture obtained for AP-2 mediated CCV formation, it is 
not known whether similar regulatory mechanisms are at work with the other APs.
AP-3 localises around the TGN and peripheral endosomes in mammalian cells (Simpson et 
ah, 1996; Dell'Angelica et ah, 1997; Simpson et ah, 1997) and mutations in AP-3 subunits 
give rise to Hermansky-Pudlak syndrome (Dell'Angelica et ah, 1999b). This is 
characterised by defects in lysosomes and related organelles implicating AP-3 in 
trafficking to these compartments. However, there appears to be conflicting data as to 
whether AP-3 vesicles are actually clathrin-coated. On the one hand, a direct in vitro 
interaction with clathrin has been reported (Dell'Angelica et ah, 1998) as has co- 
immunoprecipitation (Liu et ah, 2001), and AP-3 can instigate clathrin assembly onto 
synthetic liposomes in a reaction that only requires AP-3, clathrin and Arf-GTP (Drake et 
ah, 2000). Conversely, AP-3 does not co-purify with clathrin-coated vesicles (Simpson et 
ah, 1996), and AP-3-dependent transport o f yeast alkaline phosphatase to the vacuole 
occurs in cells lacking clathrin function (Vowels and Payne, 1998).
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The fourth adaptor complex AP-4 is absent from yeast, worm and fly genomes, but the 
protein appears to reside around the TGN in mammalian cells where it colocalises with 
TGN38 and furin (Dell'Angelica et al., 1999a; Hirst et ah, 1999). Membrane association 
appears to be Arf-regulated since brefeldin A treatment causes its dissociation, but it seems 
to function independently o f clathrin (Hirst et ah, 1999) and its cellular role is unknown.
Once endocytic CCVs have been formed, members o f the dynamin family o f enzymes play 
an important role in directing their scission from the membrane. Dynamins are large (100 
kDa) GTPases that were originally implicated in endocytosis by studies o f  the Drosophila 
shibire temperature-sensitive mutant (Kosaka and Ikeda, 1983 a; Kosaka and Ikeda, 
1983b). Dynamin can self-assemble into rings and tubules in vitro (Carr and Hinshaw, 
1997; Hinshaw and Schmid, 1995) and its GTPase activity is associated with a 
conformational change (Marks et ah, 2001). The mode o f action o f dynamin has been 
highly contentious, particularly with respect to the role o f  the GTPase activity, and several 
models have been proposed (reviewed in Sever et ah, 2000). Although best known for its 
role at the plasma membrane, it is becoming clear that dynamins also function in vesicle 
scission at other intracellular locations (see McNiven et ah, 2000). For example, dynamin 
is implicated in vesicle scission from the TGN (Jones et ah, 1998 and references therein) 
and from late endosomes (Nicoziani et ah, 2000).
Once the vesicles have been formed, the clathrin coats are shed to allow the vesicle to dock 
and fuse with the acceptor compartment, and also to allow the recycling o f the coat 
components for the formation o f additional vesicles. This uncoating step appears to require 
the ATP-dependent chaperone hsc70 and auxilin (reviewed in Lemmon, 2001), and the 
inositol-5- phosphatase synaptojanin (Cremona et ah, 1999).
Although primarily characterised at the plasma membrane and TGN, clathrin-coated 
vesicles have been localised to endosomal membranes by electron microscopy (Stoorvogel 
et ah, 1996). With diameters o f  60 nm as opposed to 100 nm, these were found to be 
smaller than known CCVs and they lacked a- and y-adaptin characteristic o f AP-1 and AP- 
2, but their functions are currently unknown (Stoorvogel et ah, 1996). A  recent study has 
also implicated clathrin function in the regulation o f early endosome distribution. Bennett 
et ah, (2001) found that the induced expression o f clathrin hub, which acts as a dominant- 
negative mutant, in stably transfected HeLa cells resulted in a clustering o f  the EEAl- 
positive early endosomes around the centrosome. However, this did not seem to affect the 
kinetics o f  TfR trafficking suggesting that clathrin’s role in the endosomal compartment is 
distinct from that at the plasma membrane or TGN.
I »
Aww w
AP-1 AP-2
V
Clathrin
dependent
B
AP-3 AP-4V_________   VY
Clathrin
independent?
Piasma
membrane
AP-2
COPI? ( Endosomes 
APs? ^ ----- -------
< A
Lysosomes^
AP-1 GGAs
TGN
AP-3
AP-4?
Fig. 1.1.6 Adaptor Proteins.
A) Diagrammatic representations of the four heterotetrameric adaptor 
complexes AP-1, AP-2, AP-3 and AP-4 are shown. They each have two large 
subunits (y,a, 5,8 and (3 ) and two small p and a  subunits. The large subunits 
have appendages or ear" domains. While AP-1 and AP-2 are well established 
clathrin adaptors, it is not clear whether AP-3 and AP-4 function with clathrin.
B) Intracellular trafficking steps mediated by the adaptors. AP-1 mediates the 
formation of clathrin-coated vesicles destined for the endosomes and plasma 
membrane at the frans-Golgi network (TGN). AP-2 mediates endocytic 
clathrin-coated vesicle formation at the plasma membrane. AP-3 regulates 
vesicular traffic from the TGN to the lysosomes. AP-4 localises to the TGN 
region but its function is unclear. GGAs are also clathrin adaptors involved in 
TGN to endosome traffic. See text for details.
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1,1.5 Mannose~6~phosphate receptors and GGAs at the TGN,
Mannose 6-phosphate receptors (MPRs) are transmembrane proteins that are essential for 
the targeting and delivery o f  soluble lysosomal hydrolases from the TGN to lysosomes. 
These enzymes are required for the degradation o f internalised and endogenous 
macromolecules. There are two distinct MPRs with overlapping functions: a large 300 kDa 
cation-independent MPR (CI-MPR) and a smaller 46 kDa cation-dependent MPR (CD- 
MPR) (reviewed in Le Borgne and Ho flack, 1998). They are actively sorted away from 
secretory proteins in the TGN, by a mechanism that depends on the MPR cytoplasmic tails 
(Le Borgne and Hoflack, 1997; Dell'Angelica and Payne, 2001). Cargo-bound MPRs bud 
from the TGN in clathrin-coated vesicles and deliver the hydrolases to endosomes, where 
the acidic pH causes dissociation o f  their ligands. The enzymes then progress into mature 
lysosomes while the receptors are retrieved back to the TGN.
Until recently, the prevailing view was that MPR trafficking out o f  the TGN was mediated 
by the AP-1 clathrin adaptor complex (Le Borgne and Hoflack, 1998). This was based 
largely on the fact that AP-1 is concentrated at this organelle, binds MPR tails in vitro and 
because overexpressed MPRs assemble into AP-1 positive clathrin-coated buds and 
vesicles in the TGN region (Le Borgne and Hoflack, 1998). However, the recent discovery 
(Hirst et al., 2000; Dell'Angelica et al., 2000; Boman et al., 2000; Takatsu et al., 2001) and 
fervent study o f GGA proteins (Golgi localised, gamma-adaptin ear homology domain 
containing, ^ f  binding proteins) have challenged this (reviewed in Black and Pelham, 
2001).
GGAs are evolutionarily conserved, multi-domain proteins encoded by two yeast genes 
and three human genes. They are characterised by a GAT domain (GGA and TOMl [target 
of myb 1]), a VHS domain (Vps27p/Hrs/STAM domain), a hinge region, and a GAE 
domain (gamma-adaptin ear domain). The GAT domains have been shown to confer Arf 
binding and Golgi localisation (Boman et al., 2000), the GAE and hinge domains bind y- 
synergin and clathrin, respectively (Takatsu et al., 2001; Puertollano et al., 2001b), while 
the VHS domains directly interact with the acidic-cluster-dileucine motifs o f the MPRs 
(Zhu et al., 2001; Puertollano et al., 2001a; Takatsu et al., 2001). These latter findings are 
particularly important since the acidic dileucine motif was known to be important in TGN 
to endosome MPR trafficking (Chen et al., 1997), and yet it did not interact with AP-1 
suggesting that an alternative mechanism was involved. It now seems highly likely that the 
GGAs, and not AP-1, are responsible for this trafficking step, and this is substantiated by 
the fact that dominant negative GGA mutants block MPR exit from the TGN (Puertollano
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et al., 2001a). GGAs have also been shown to interact with the cytoplasmic tail o f  sortilin 
(Nielsen et al., 2001), a protein that follows a similar trafficking itinerary to the MPRs, and 
in yeast double GGA knockouts have defects in the trafficking o f  carboxypeptidase Y and 
the sortilin homologue VpslOp to the vacuole, the equivalent to the mammalian lysosome 
(Dell'Angelica et ah, 2000; Hirst et al., 2000). Furthermore, such yeast strains are also 
defective in the signal-dependent trafficking o f the syntaxin Pepl2p, which is normally 
sorted from the Golgi to the late endosomes (Black and Pelham, 2000). Elegant studies by 
Juan Bonifacino and colleagues have further established direct binding o f the GGAs to 
clathrin, and provided further insight into the role o f Arf GTPases in these events 
(Puertollano et al., 2001b). In an incredibly short time, the GGAs have thus emerged as 
major players in clathrin-mediated TGN to endosomal membrane transport and a current 
working model for their action at the TGN is shown in Fig. 1.1.7.
Fig. 1.1.7 The proposed function of GGA proteins as clathrin 
adaptors.
GGA GAT domains interact with GTP-bound ARF GTPases that become 
membrane-associated upon activation. GGA VHS (Vps27/Hrs/STAM 
homology) domains can then interact with acidic clusters of the cytosolic 
tails of transmembrane proteins such as the cation-independent mannose-6- 
phosphate receptor (MPR) or sortilin. The hinge region of the GGAs can 
directly associate with clathrin (red triskelion) thereby recruiting it for the 
formation of clathrin coated vesicles. The GAE (gamma adaptin ear 
homology) domain is also known to bind y-synergin.
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1.1.6 Intracellular protein sorting mechanisms
Sorting signals are important mechanisms in determining the localisation and fate o f  
proteins, and are important in the maintenance o f heterogeneity between different 
organelles. A number o f signals have been described and they are often intrinsic signals 
conferred by specific amino acid residues but can also be moieties appended post- 
translationally.
One o f  the best characterised sorting mechanisms concerns the specific retrieval o f  lumenal 
ER resident proteins that have ‘escaped’ into later compartments such as the VTCs or cis- 
Golgi. Such proteins teiminate in the KDEL (HDEL in yeast) amino acid sequence and this 
binds to the KDEL receptor, ERD2, allowing efficient retrieval to the ER (Munro and 
Pelham, 1987; Lewis and Pelham, 1992; Semenza et al., 1990). Similarly, ER resident 
transmembrane proteins typically have KKXX/ RRXX motifs (where X is any amino acid) 
and these interact with COPI coats allowing for their specific retrieval (Cosson and 
Letoumeur, 1994),
Sorting signals are also present in the cytoplasmic tails o f cargo molecules in the 
TGN/endosomal systems. These are involved in binding to the adaptor proteins mentioned 
earlier, thus enabling cargo receptors to be concentrated into clathrin-coated pits. They fall 
into two main classes: tyrosine-based and dileucine-based sorting motifs. The tyrosine- 
based motifs, which mostly conform to the amino acid sequence Y X X 0 (where X is any 
amino acid and 0  is is an amino acid with a bulky hydrophobic side chain), are the best 
characterised (reviewed in Kirchhausen et al., 1997; Bonifacino and Dell'Angelica, 1999) 
and are present in proteins such as TGN38 (a YQRL motif) and the transferrin receptor (a 
YTRF motif). They can direct endosomal and lysosomal targeting, internalisation from the 
plasma membrane, and sorting at the TGN (Kirchhausen et al., 1997). Y X X 0 motifs have 
been shown to bind conserved regions o f the p subunits o f adaptor complexes using yeast 
two-hybrid and biochemical approaches (Ohno et al., 1995; Ohno et al., 1996; Boll et al., 
1996; Ohno et al., 1998). However, the motifs often show preferences for particular p 
chains. For example, the signal in the TGN38 tail is better recognised by p i than p3, 
whereas the opposite is true for the signal in the lysosomal glycoprotein, LAMP-1 (Ohno 
et al., 1996; Ohno et al., 1998). It also seems likely that the affinity o f  the interactions with 
the adaptors is modulated by other factors since AP-2 binds more strongly to tyrosine- 
based motifs when present in clathrin coated pits and also in the presence o f  
phosphatidylinositol-3 phosphates (Rapoport et al., 1997). Similarly, phosphorylation o f
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AP-2 may directly regulate the interaction with sorting signals (Fingerhut et ah, 2001; 
Olusanya et al., 2001).
Dileucine-based motifs are also found in the cytoplasmic tails o f  membrane proteins such 
as the MPRs (Chen et al., 1993) and the melanosomal protein tyrosinase (Calvo et al., 
1999; Honing et al., 1998). However, it is less clear which adaptor subunits are required 
for the interactions. The dileucine motif o f the CD3y chain can bind to p-adaptin subunit o f  
AP-1 (Rapoport et al., 1998), while the p i and p2 chains can interact with the MHC 
invariant chain (Rodionov and Bakke, 1998; Hofmann et al., 1999).
It has recently become apparent that ubiquitination can act as a sorting signal. Ubiquitin is 
a 76 amino acid polypeptide that becomes conjugated to lysine residues in target proteins 
via the concerted action o f three enzymes: a ubiquitin-activating enzyme (E l), a ubiquitin- 
conjugating-enzyme (E2), and a ubiquitin ligase (E3). While polyubiquitination is well 
known to target proteins for degradation via the 26S proteasome, a role for 
monoubiquitination has recently been uncovered in endocytosis (see Hicke, 2001). It also 
seems to positively regulate traffic from the late endosome to the yeast vacuole via the 
ESCRT-1 complex which acts in sensing the ubiquitin moiety (Katzmann et al., 2001).
In addition to protein sorting, lipid based sorting also occurs. This was elegantly 
demonstrated in a recent study using lipid analogues differing only in the length and 
saturation o f their hydrophobic tails (Mukherjee et al., 1999). These analogues were shown 
to partition into different endocytic compartments indicating that sorting can occur in a 
manner dependent on the membrane composition. The fact that Shiga toxin B fragment 
follows a specific trafficking itinerary (Mallard et al., 1998) and is a cytosolic protein that 
binds to the glycolipid globotriaosylceramide (Lingwood, 1993), is again suggestive o f  
lipid-based sorting.
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1 A J  Membrane fusion
Once vesicles have budded from donor organelles, they need to travel to, and subsequently 
fuse with, the correct acceptor membranes. Membrane fusion is an energetically 
unfavourable event that requires energy in the form o f ATP. Our knowledge o f the 
molecular basis for membrane fusion has increased massively over the last decade or so 
due to intensive research from many laboratories. Much o f  the work has come from 
studying neuronal synaptic vesicle exocytosis but the processes are so highly conserved 
that the principles are applicable to most, if  not all, eukaryotic membrane fusion events. 
They occur via a highly ordered mechanism that has multiple co-ordinated steps including 
vesicle docking/tethering, priming and finally fusion. Fusion is mediated by soluble NSF 
attachment protein receptors (SNAREs, where NSF stands for W-ethyl-maleimide-sensitive 
fusion protein). There are over 30 members o f the mammalian SNARE family found in 
different subcellular compartments. The SNARE hypothesis, proposed in 1993 by 
Rothman and co-workers, postulated that for each membrane transport pathway there 
exists a distinct pair o f SNARE proteins, one on the vesicle, termed a v-SNARE, and the 
other on the target membrane termed a t-SNARE (Sollner et al., 1993). It was originally 
proposed that specific v-SNARE/t-SNARE pairing conferred the specificity o f membrane 
fusion. While it no longer seems quite so simple, since many SNARE interactions are 
promiscuous (Yang et al., 1999) and Rab GTPases may be more important in determining 
vesicular transport specificity (reviewed in Zerial and McBride, 2001; see below), 
SNAREs are unquestionably central to the fusion process.
SNARE proteins all contain conserved heptad repeats that form coiled-coil structures. 
They have been grouped into members o f the VAMP (vesicle-associated membrane 
protein), syntaxin and SNAP-25 (synaptosome-associated protein o f 25 kDa) families 
based on the neuronal isoforms first identified. One member from each o f these families 
assembles into a ternary SNARE ‘core complex’ that is extremely stable being resistant to 
SDS and temperatures up to 90 °C. The crystal structure o f the neuronal SNARE core 
complex has been solved revealing a four-helical bundle comprising one syntaxin, one 
VAMP and two SNAP-25 coils (Sutton et al., 1998), as depicted in Fig. 1.1.8. These are 
arranged in a parallel fashion, such that the formation o f the complex brings the two 
membranes into close apposition and this is believed by many to provide the force required 
to drive membrane fusion. A  number o f other regulatory molecules are known. For 
example Seel proteins such as n-Secl/M uncl8 are peripheral chaperone proteins that bind 
tightly to syntaxin family members and are important regulators o f  SNARE complex
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Fig. 1.1.8 Model for SNARE complex formation.
Schematic showing the assembly of the archetypal neuronal SNARE complex 
during vesicle/plasma membrane fusion (a). VAMP (blue) on the incoming 
vesicle interacts with syntaxin (red) and SNAP-25 (green) at the plasma 
membrane to form a four-helical bundle that then zips' together pulling the 
two membranes together thus allowing membrane fusion to occur, (b) The 
left hand panel shows the arrangement of the four helices in the core 
complex, with with cross-sectional views of the indicated positions given on 
the right. Q-SNAREs have glutamine residues in the central layer of the 
complex, while R-SNAREs have arginine residues. Reproduced from Chen & 
Scheller, 2001.
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Fig. 1.1.9 Model of membrane fusion
Syntaxin in the plasma membrane is bound to n-Sec1/Munc18. Upon n-Sec1 
dissociation, possibly under the control of a Rab GTPase, syntaxin changes 
from a closed to an open conformation allowing assembly of the ternary 
syntaxinA/AMP/SNAP-25 SNARE complex (for simplicity,only one coil is 
shown for SNAP-25). The coiled coil structures ‘zip’ together in a parallel 
fashion that is triggered by Ca2+, resulting in membrane fusion. NSF and a- 
SNAP are then recruited from the cytosol and cause the complex to 
dissociate upon ATP hydrolysis. The components are then free to be recycled 
and used in a further round of membrane fusion. Reproduced from Chen & 
Scheller, 2001.
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assembly (Hata et al., 1993; Pevsner et a l, 1994). There has been genetic and biochemical 
evidence in support o f  both positive and negative roles for Seel proteins in membrane 
fusion and their precise roles have not yet been fully elucidated. One attractive model is 
that they act as regulated inhibitors o f  SNARE complex assembly by binding to and 
sequestering syntaxins in a closed, fusion-incompetent conformation until an appropriate 
signal is received, upon which they dissociate leaving the syntaxins in an open, fusion- 
competent conformation (Yang et a l, 2000; Dulubova et a l, 1999).
A few refinements to the SNARE hypothesis have been made in recent years. Firstly, the 
ATPase NSF (A-ethyl-maleimide-sensitive fusion protein) was originally thought to act 
early on in the fusion process, but it now seems that it is required at a later stage when the 
SNARE complex is dissassembled (Mayer et a l, 1996). In a further refinement to avoid 
ambiguity arising from homotypic fusion events, SNAREs have been reclassified as R- 
SNAREs (arginine-containing SNAREs) and Q-SNAREs (glutamine-containing SNAREs) 
based on the identity o f highly conserved residues present in the central ionic interaction 
layer (Fasshauer et a l, 1998). A  schematic o f the current model for membrane fusion is 
given in Fig. 1.1.9.
1.1.8 Rab proteins as regulators of membrane traffic
Rab proteins make up the largest subfamily o f the Ras superfamily o f small molecular 
weight GTPases, with over 40 human members identified to date. They are key regulators 
o f vesicular membrane traffic, with individual Rabs localised to specific subcellular 
compartments (see Fig 1.1.10) and governing discrete endocytic and exocytic transport 
steps (reviewed in Zerial and McBride, 2001). Rabs are doubly geranylgeranylated at their 
C-termini and this is necessary for membrane association and function (Newman et a l, 
1992; Farnsworth et a l, 1994). While the majority o f Rabs are membrane associated, they 
are also found in the cytosol bound to Rab GDIs (GDP dissociation inhibitors) that 
sequester them in the GDP-bound inactive state (Sasaki et a l, 1990; Ullrich et a l, 1993). 
Rab GDI is then displaced by a GDI-displacement factor (GDF) (Dirac-Svejstrup et a l,
1997), allowing membrane association and nucleotide exchange to ensue. It was originally 
believed that Rab association with transport vesicles and recycling via GDI extraction were 
o f fundamental importance. However, this was brought into question by the finding that 
the yeast Rab Yptl constitutively anchored to the target membrane with transmembrane 
anchor is still fully functional and cannot be extracted from the membrane by GDI (Ossig 
et a l, 1995).
29
Endocytosis Exocytosis
RabSA
endo
A
R»b4A,B RabSA
Recyclingtndoeom e
 ( • / )  RibSA.BV , (  R ebia R a b 7 y \  I Rib20 ^  |y /R #b22
■) ( Rab3A Rab38Rab8
K Rflba
SecretoryvealdM
Rab6
Rab8
erena-Oolginetwork
•pperalus
Lyaoaoma
RmbtA. B R»b2
Endoplaamic reticulum
Fig. 1.1.10 Subcellular distributions of Rab proteins.
Rab proteins are localised in discrete subcelluar localisations as 
indicated. Reproduced from Takai et al., 2001
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Rabs appear to function in a number o f different ways. Firstly, they are believed to 
contribute substantially to the specificity and fidelity o f membrane fusion events. As 
discussed in the previous section, SNARE interactions can occur promiscuously and at 
multiple transport steps and are therefore unlikely to confer the specificity o f vesicle 
targeting. The loss o f the Saccharomyces cerevisiae Rab, Yptlp, can be suppressed by the 
overexpression o f SNAREs involved in ER to Golgi transport indicating genetic 
interactions (Lian et al., 1994). Yptlp has also been shown to activate the t-SNARE Sed5p 
by promoting the dissociation o f the regulatory Slylp, thus allowing v-/t-SNARE pairing 
(Lupashin and Waters, 1997). They are believed to recruit factors required for the tethering 
or docking o f vesicles at the target membrane prior to fusion (see Waters and Hughson,
2000). For example, the yeast Rab Sec4p tethers exocytic vesicles to the plasma membrane 
via a direct interaction with the sec6/sec8 exocyst complex (Guo et al., 1999b). This is an 
octameric complex present in both yeast (Terbush et al., 1996; Guo et al., 1999a) and 
mammals (Hsu et al., 1996). It is believed to function in the targeting o f vesicles to the 
plasma membrane in yeast (Terbush et al., 1996) where it is positioned at secretion ‘hot­
spots’ (Finger and Novick, 1998).
In addition, Rab5 regulates the tethering o f early endosomes prior to their homotypic 
fusion through interactions with the early endosomal auto antigen (EEAl) (Christoforidis 
et al., 1999a; Callaghan et al., 1999). Rab5 is the best studied family member and it 
interacts with a very large set o f effector molecules including Rabaptin 5 (Stenmark et al.,
1995), EEAl (Simonsen et al., 1998) and PI 3-kinases (Christoforidis et al., 1999b). These 
appear to cluster and function in a feed-forward mechanism whereby Rab5 is sustained in 
its active conformation. For example, Rabaptin 5 is complexed with Rabex5 which is itself 
a GEF for Rab5 (Horiuchi et al., 1997). The Rab5-induced activation o f  PI 3-kinase also 
increases EEAl recruitment via PI(3)P/ FYVE domain interactions. This has given rise to 
the notion o f  complex “Rab domains” involving multiple effectors and signalling 
molecules that could be general features in Rab signalling (Zerial and McBride, 2001).
In addition to these vesicle-tethering roles, Rabs are involved in vesicle motility. Rab5 
again has been shown to affect the association and motility o f  endosomes on microtubules 
(Nielsen et al., 1999) and a direct interaction o f Rab6 with a kinesin family member has 
also been reported (Echard et al., 1998). Furthermore, associations with actin based motor 
proteins as evidenced by interactions between Rab27a and myosin Va in melanosome 
motility (Wu et al., 2001), point to regulation o f traffic on both microtubule and 
microfilament tracks.
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Yet a third potential role for Rabs in membrane transport is in the budding o f vesicles. For 
example, Rabl has been implicated in vesicle budding from the ER (Nuoffer et a l, 1994), 
and Rab9 appears to regulate lysosome biogenesis (Riederer et a l, 1994). Rab9 has also 
been shown to positively regulate the association o f the TIP47 adaptor with mannose-6- 
phosphate receptors, thereby facilitating their retrieval from the endosomes to the TON 
(Carroll et a l, 2001). A  role for Rab5 in vesicle formation is also apparent since its 
overexpression has been shown to increase the rate o f endocytosis (Bucci et a l, 1992), and 
Rab5 complexed with GDI is required for ligand sequestration into deeply invaginated 
clathrin-coated pits in an in vitro assay system (McLauchlan et a l, 1998).
1.1.9 Lipid metaboiism in membrane trafficking
So far I have concentrated on the role o f proteins in membrane trafficking events. 
However, regulation by lipid-based molecules is o f  equal importance. Phosphoinositides in 
particular have emerged as central players in membrane traffic (reviewed in Simonsen et 
a l, 2001). The membrane phospholipid phosphatidylinositol (PI) can be phosphorylated by 
a number o f lipid kinases on the 3-, 4- and 5- positions o f the inositol ring, giving rise to 
numerous different phosphoinositides. These have emerged as major second messengers in 
signal transduction and membrane trafficking pathways and their synthesis and turnover 
within cells is tightly regulated both temporally and spatially. One pivotal class o f enzymes 
are the PI 3-kinases that produce PI(3)P and PI(3,4,5)P]. Their importance in membrane 
trafficking is exemplified by the ability o f the PI 3-kinase inhibitor wortmannin to inhibit a 
number o f events such as TfR recycling (Spiro et a l, 1996; Martys et a l, 1996), fluid- 
phase endocytosis (Li et a l, 1995; Clague et a l, 1995) and insulin-stimulated GLUT4 
translocation (Cheatham et a l, 1994; Haruta et a l, 1995). Direct evidence for a role for this 
class o f  enzyme in membrane trafficking also came from the discovery that Vps34p, a 
yeast PI 3-kinase, regulated the transport o f carboxypeptidase Y from the Golgi to the 
vacuole (Schu et a l, 1993).
PI (3) P binds directly to FYVE-domain containing proteins and participates in their 
membrane recruitment (Kutateladze et a l, 1999 and references therein). FVYE domains 
are conserved modules found in numerous trafficking proteins including EEAl, the Rab5 
effector involved in early endosome fusion (Stenmark et a l, 1996); Hrs, another 
endosomal protein that plays a role in clathrin recruitment (Raiborg et a l, 2001); and 
Rabip4, a Rab4 effector also implicated in endosomal function (Cormont et a l, 2001).
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The pleckstrin homology (PH) domain is another protein module regulated by 
phosphoinositides. It is an important feature common to many proteins including the 
cytohesin and centaurin families o f Arf GTPase guanine nucleotide exchange factors 
(GEFs) and GTPase activating proteins (GAPs), respectively (see sections 1.3.2 and 1.3.3). 
The Arf GEFs ARNO cytohesin-1 and GRPl, translocate to the plasma membrane via PH 
domain interactions with PI(3,4,5)P] produced by PI 3-kinase (Venkateswarlu et al., 
1998a; Venkateswarlu et ah, 1998b; Venkateswarlu et al., 1999). Furthermore, PI(3 ,4 ,5)P3 
or PI(4 ,5)P2 is required for the nucleotide exchange activity o f ARNO and GRPl on Arf 
(Santy et al., 1999; Klarlund et al., 1998). This gives rise to multiple feedback loops since, 
for example, PI(4)P 5-kinases are Arf effectors (Honda et ah, 1999; and see section 1.3.4 
for more details). Dynamin also has a PH domain that binds PI(4 ,5)P2 (Zheng et al., 1996) 
and this is required for its role in endocytosis (Lee et al., 1999; Vallis et ah, 1999),
A further recently described PI(3) P-interacting protein domain is the Phox homology or 
PX-domain (Cheever et ah, 2001; Xu et ah, 2001; Kanai et ah, 2001; Ellson et ah, 2001). 
This was first identified in the p40^ '^ '^  ^ and p47^ °^  ^ subunits o f  NADPH oxidase (Ponting,
1996), but is found in numerous proteins involved in vesicle trafficking such as 
phospholipase D and sorting nexins. The yeast t-SNARE Vam7 has a PX-domain that is 
required for trafficking to the yeast vacuole (Cheever et ah, 2001). Mammalian sorting 
nexins (SNXs) are a large family o f proteins that are believed to be regulators o f early 
endosomes. For example, overexpression o f SNX15 in COS7 cells affects membrane 
trafficking in the entire endosomal system leading to defects in transferrin endocytosis and 
TGN38 and furin recycling (Barr et al., 2000).
In addition to regulating specific proteins, lipid-modifying enzymes can affect the 
properties o f  membrane bilayers themselves by generating phospholipid asymmetries that 
may promote membrane curvature in favour o f vesicle budding and fusion events. For 
example, acidic phospholipids, such as phosphatidic acid (PA), may be important during 
vesicle formation as they promote membrane curvature. Phospholipase D generates PA 
from phosphatidylcholine (reviewed in Liscovitch et ah, 2000). Since it is activated by Arf 
GTPases, it may couple membrane invagination with Arf-mediated vesicle coat 
recruitment although this is controversial (see section 1.3.4). Similarly, endophilin I, which 
localises to the neck o f nascent clathrin-coated synaptic vesicles via interactions with 
dynamin, transfers arachidonic acid to lysophosphatidic acid in a step that is required for 
scission (Schmidt et ah, 1999; see also Ban' and Shorter, 2000).
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Many proteins involved in clathrin-coated pit formation, such as AP-2, A PI80 and 
synaptotagmins, have been found to interact with phosphoinositides, and in particular 
PI(4 ,5)P2, and this may aid their recruitment to the bilayer (reviewed in Cremona and De 
Camilli, 2001). The inositol-5-phosphatase synaptojanin also plays a critical role in 
endocytosis. Analysis o f neurons from synaptojanin knockout mice revealed an increased 
number o f clathrin-coated vesicles and increased PI(4 ,5)p2 (Cremona et ah, 1999). Since 
AP-2 binding to CCVs requires PI(4 ,5)P2 (Beck and Keen, 1991), synaptojanin may 
participate in the uncoating o f CCVs by decreasing the affinity o f  the adaptor for the 
membrane.
A genetic screen designed to identify components that interface with A if  function in yeast 
discovered a role for a protein called Drs2p in regulating membrane traffic out o f the Golgi 
complex (Chen et ah, 1999). It seems to be involved in CCV formation at the TGN 
potentially through aminophospholipid translocase activity that would give rise to 
membrane lipid asymmetry (Chen et ah, 1999).
1.1.10 Green fluorescent protein as a tool for the study of 
membrane trafficking
The use o f green fluorescent protein (GFP), originally cloned from the jellyfish Aequorea 
victoria, and its derivatives represents a major technical advance in cell biology, and one 
that deserves mentioning here (reviewed in Lippincott-Schwartz et ah, 2000; Lippincott- 
Schwartz et ah, 2001). It is an auto-fluorescent molecule that can be fused to other proteins 
through the use o f  molecular biological techniques, and has therefore enabled researchers 
to analyse specific proteins in live cells in real time by fluorescence microscopy. Its use 
has enlightened us to many aspects o f  membrane trafficking. For example, the analysis o f  
the COPII component Secl3-GFP has revealed that ER exit sites are extremely long-lived 
and static structures (Stephens et ah, 2000), Similarly, by fusing domains such as 
pleckstrin homology domains to GFP, transient changes in phosphoinositide generation 
can be visually monitored.
1.1.11 Defects in membrane trafficking pathways and human 
disorders
There are many human disorders that result from defects in membrane trafficking 
pathways. For example, non-insulin dependent Diabetes mellitus (NIDDM), which has
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officially been declared an epidemic by the World Health Organisation, is characterised by 
defects in the trafficking o f  the insulin regulated glucose transporter GLUT4. In healthy 
muscle and adipose tissues, insulin induces a rapid translocation o f  GLUT4 containing 
vesicles from intracellular sites to the plasma membrane with a concomitant increase in 
glucose transport (Rea and James, 1997). However, in NIDDM patients GLUT4 
translocation is defective resulting in elevated blood glucose levels. The precise molecular 
basis for this dysfunction is not known but it is likely to involve both insulin signalling and 
membrane trafficking defects. In addition there are many rare single gene defects that give 
rise to syndromes such as Hermansky-Pudlak syndrome (mutation o f (33A subunit o f the 
AP-3 adaptor) or Griscelli disease (mutation o f Rab27) in which membrane trafficking is 
affected (see Aridor and Hannan, 2000 for a full list).
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1.2 The role of the cytoskeleton in membrane trafficking
The architecture and structure o f the cell is maintained by a complex and dynamic 
cytoskeleton that serves as a scaffold for the spatial distribution o f  organelles and 
signalling complexes, as well as providing the mechanical force required for cell 
locomotion and cell division. Major elements o f the cytoskeleton can be divided into 
microtubules, microfilaments (actin filaments) and intermediate filaments and these are 
continually being nucleated and disassembled in a highly orchestrated manner. Membrane 
trafficking and the cytoskeleton have in the past been regarded as two quite separate fields 
o f study. However, it is becoming increasingly clear that these two major branches o f  cell 
biology are intricately linked and such distinctions may no longer be feasible. In particular, 
many membrane trafficking events use the cytoskeletal networks as ‘tracks’ along which 
vesicles and organelles are carried by molecular motor proteins (Allan and Schroer, 1999). 
It is generally believed that long distance travel is mediated by microtubule based 
mechanisms while the actin cytoskeleton facilitates movement over short distances.
1.2.1 The actin cytoskeleton
The actin cytoskeleton consists o f microfilaments that are produced by the polymerisation 
o f actin monomers to form dynamic networks that are thought to drive the protrusion o f the 
plasma membrane during such processes as cell spreading, locomotion and phagocytosis. 
Furthermore, microfilaments are attached to focal adhesion complexes that mediate 
cellular interactions with the extracellular matrix, thus providing a structural framework for 
anchored cells. Studies using actin depolymerising drugs, such as cytochalasin D, have 
revealed defects in numerous trafficking steps although complete inhibition is rarely seen 
(see Apodaca, 2001). The actin cytoskeleton appears to facititate membrane trafficking 
through two mechanisms: one by the use o f myosin motor proteins tethered to membrane 
structures, and the other using the de novo nucléation o f actin filaments as a propulsive 
force.
Myosins are motor proteins that directly interact with actin filaments and use ATP to move 
along them in a unidirectional manner. There are 18 different classes o f myosin identified 
to date (Berg et al., 2001) and they regulate many important processes such as muscle 
contraction, cell motility, cytokinesis and three classes o f  unconventional mysosins, 
namely myosins I, V and VI, have been implicated in membrane traffic (reviewed in 
Tux worth and Titus, 2000). They all have a highly conserved motor or head domain that
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confers the catalytic ATPase activity and actin binding properties, followed by a neck 
region o f variable length. Then there are C-terminal tail regions that are highly divergent 
between classes and that are believed to influence aspects such as sub cellular localisation 
and cargo binding. Several lines o f evidence directly implicate myosins in trafficking 
events. Firstly, the yeast class I myosin Myo5p is required for endocytosis (Geli and 
Riezman, 1996). Recent work has also uncovered a role for the mammalian myosin VI in 
endocytosis since it associates with AP-2 positive clathrin-coated vesicles and inhibits TfR 
internalisation when its tail is overexpressed in polarised cells (Buss et al., 2001). This is 
the only known myosin that moves towards the minus ends o f actin filaments thus allowing 
it to travel into the cell from the cell periphery (Wells et al., 1999). In addition, myosin I 
localises to endosomes and lysosomes, and its overexpression inhibits the transfer o f fluid- 
phase markers between these two organelles (Raposo et al., 1999). The mouse coat colour 
mutation dilute encodes myosin Va, indicating its requirement in melanosome transport 
(Marks and Seabra, 2001 and references therein). Myosin Vb appears to regulate both the 
distribution and the function o f recycling endosomes, since overexpression o f its tail region 
as a green fluorescent protein chimera causes them to cluster around the centrosome and 
retain cycling transferrin receptors (Lapierre et al., 2001). Myosin II, the conventional 
myosin normally associated with muscle contraction and cytokinesis, also appears to have 
a role in membrane trafficking since it transiently associates with the TGN where it may 
regulate the budding o f a subpopulation o f vesicles (reviewed in Stow et al., 1998).
The major factor involved in the nucléation o f actin filament assembly is believed to be the 
Arp2/3 complex: a highly conserved seven-subunit complex at the heart o f which are two 
actin-related proteins Arp2 and Arp3 (Welch, 1999). While the complex appears to be 
essential for actin assembly, it exhibits only weak activity alone but is potently stimulated 
by members o f  the Wiskott-Aldrich syndrome protein (WASP) family (Welch, 1999). 
WASP is found in an autoinhibited conformation (Kim et al., 2000), and becomes activated 
by phosphatidylinositol (4,5) bisphosphate and GTP-bound Cdc42 (Rohatgi et al., 1999), a 
Rho family GTPase that has long been associated with actin remodelling and filopodia 
formation (Hall, 1998). Some pathogenic microorganisms exploit these mechanisms to 
invade and move inside host cells. For example. Listeria monocytogenes has an ActA  
protein on its outer membrane that potently stimulates Arp2/3-mediated actin 
polymerisation, resulting in actin ‘comet tails’ that physically propel it through the host 
cytoplasm (Welch et al., 1997). It is now becoming clear that similar mechanisms exist for 
propelling membrane-bound vesicles (reviewed in Taunton, 2001). For example, actin 
comet tails have been observed on endosomes and lysosomes following protein kinase C 
activation in an in vitro Xenopus egg extract system (Taunton et al., 2000). Newly formed
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pinosomes are also propelled away from their sites o f formation by actin polymerisation in 
mast cells (Merrifield et ah, 1999) and in fibroblasts expressing constitutively active Arf6 
(Schafer et al., 2000). They have also been implicated in the movement o f TGN-derived 
vesicles containing haemagglutinin protein in cells infected with influenza virus (Rozelle 
et al., 2000). Given that this protein is exclusively sorted into lipid raft-enriched vesicles 
and the fact that cholesterol depletion with methyl p-cyclodextrin abrogated actin 
polymerisation, it seems likely that lipid rafts are important in these events (Rozelle et al., 
2000).
1.2.2 The microtubule cytoskeleton
Unlike actin filaments, micro tubules seem to be nucleated primarily from one central 
location in the cell: the microtubule organising centre (MTOC), which corresponds to the 
spindle pole body in yeast or the centrosome in metazoans. Here a  and p tubulin 
heterodimers are assembled in a process that requires y tubulin (Jeng and Steams, 1999). 
Studies with microtubule-dismpting dmgs such as nocodazole have revealed an important 
role for this cytoskeletal network in the positioning and movement o f cellular organelles 
(for example, see Thyberg and Moskalewski, 1985). Microtubule-based motors provide the 
mechanism for this important mode o f  membrane transport. These motors also move in a 
unidirectional manner and either belong to the kinesin family which move towards the plus 
ends o f microtubules (i.e. away from the MTOC), or the dynein family that move in the 
opposite direction (see Fig. 1.2.1; reviewed in Hirokawa, 1998). There are potentially 
hundreds o f different variants in eukaryotic cells and each consists o f two heavy chains and 
two light chains, giving rise to rod-like stmctures with two globular heads that bind 
micro tubules, a stalk, and a more divergent tail made up from the light chains (Hirokawa,
1998). These tails are likely to be involved in cargo recognition and binding, although 
information as to the identity o f  motor receptors is sparse. A  recent study has, however, 
identified a direct interaction between the kinesin KIF13A and the p-adaptin subunit o f the 
AP-1 adaptor complex providing the first real evidence linking vesicle formation to vesicle 
transport machinery (Nakagawa et a l, 2000). Studies into the regulation o f  kinesin activity 
have uncovered an autoinhibitory regulatory mechanism, whereby the C-terminal domain 
interacts with the motor domain sequestering it in an inactive conformation (Stock et a l, 
1999; Coy et a l, 1999). Upon cargo binding to the C-terminal tail, this autoinhibition is 
relieved, a conformational change occurs and the motor domain becomes active (reviewed 
in Woehlke and Schliwa, 2000). Dynein function in membrane traffic appears to be 
different; since it relies on an auxilliary complex called the dynactin complex to link it to
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its cargo (reviewed in Karki and Holzbaur, 1999). The dynactin complex consists o f  ten 
subunits including dynamitin, actin-related protein 1 (Arpl) and p i w h i c h  binds the 
dynein intermediate chain (Karki and Holzbaur, 1995). Disruption o f the dynactin complex 
by overexpression o f dynamitin causes endosomes and lysosomes to redistribute to the cell 
periphery (Burkhardt et al., 1997), or to stop moving completely (Valetti et al., 1999). The 
Arpl filament o f  dynactin resembles the short actin filaments associated with spectrin in 
erythrocytes (Schafer et al., 1994). Spectrin is also found as a meshwork around many 
intracellular membranes, and it is recruited to membranes by Arf and PH-domain 
dependent interactions with phospholipids (Godi et al., 1998; reviewed in De Matteis and 
Morrow, 2000). It has now been directly shown that dynein/dynactin can indeed associate 
with and move liposomes containing acidic phospholipids via interactions with spectrin 
(Muresan et al., 2001). Since Arf is well-known to activate lipid kinases and phopholipase 
D, giving rise to acid phospholipid generation, (see section 1.3.4) and the fact that it 
recruits spectrin (Godi et al., 1998), could present an appealing model linking vesicle 
biogenesis to motor recruitment.
In addition to the motor protein complexes themselves, other microtubule-associated 
proteins (MAPs) may influence membrane transport, by interfering with motor binding or 
movement along the micro tubule. For example, overexpression o f the neuronal MAP Tau 
causes a redistribution o f organelles towards the cell centre, suggesting that it blocks plus- 
end directed travel (Ebneth et al., 1998). These MAPs are themselves regulated by other 
proteins, such as mapmodulin which competes for microtubule binding thus promoting 
motor recruitment/motility (Itin et al., 1999). A  recent study provided evidence that the y- 
adaptin subunit o f AP-1 directly interacts with MAPs, since the two could be co- 
immunoprecipitated from rat brain cytosol and AP-1 could associate with microtubules in 
vitro in the presence o f purified MAPs (Orzech et ah, 2001). This may be another 
mechanism whereby nascent vesicles contact the cytoskeleton.
Functional interactions between the actin and microtubule cytoskeletons are apparent. For 
example, it has been demonstrated that myosin V can directly interact with kinesin in yeast 
two-hybrid and co-immunoprecipitation experiments (Huang et ah, 1999). This provides a 
potential mechanism for vesicles to switch between actin and microtubule tracks. Also 
intriguing is the finding that myosin V and dynein share a light chain subunit that allows 
them to dimerise and may enable them to bind the same cargo receptor (Benashski et ah,
1997). In addition, a number o f  dual microtubule and micro filament associated proteins 
(MMAPs) have been identified providing evidence that the two networks are physically
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Fig. 1.2.1 The cytoskeleton and m em brane traffic.
A diagrammatic overview of how the cytoskeleton participates in the 
movement of vesicles. Membrane-bound vesicles/organelles may be 
transported along microtubules (MTs) by dynein/dynactin (towards the minus 
ends) or kinesin (towards the plus ends). Cytoplasmic linker proteins (CLIPs) 
such as CLIP-170 tether vesicles near the plus ends of MTs, and microtubule 
associated proteins (MAPs) can block motor protein motility. Movement along 
actin filaments also occurs, by virtue of myosin motor proteins. De novo actin 
polymerisation (actin ‘comet tails’) at the surface of vesicles can also provide a 
propulsive force. Myosins and kinesins have been shown to directly interact 
(white arrow) potentially allowing vesicles to switch between MT and actin 
tracks.
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linked (Sisson et al., 2000). Similarly, a homologue o f  CLIP-170, which is believed to link 
endocytic vesicles to microtubules (Pierre et al., 1992), interacts with an unconventional 
myosin in Drosophila (Lantz and Miller, 1998).
1.2.3 Membrane traffic during mitosis
Mitosis, or M phase o f the cell cycle, is the process by which a cell divides to produce two 
daughter cells each containing exact copies o f the parental chromosomal DNA. In addition 
to nuclear components, other organelles need to be partitioned and packaged into each 
daughter cell to ensure that the full complement o f cellular processes can be carried out. 
Mitosis can be subdivided into a number o f well characterised stages including prophase, 
metaphase, anaphase, telophase and finally cytokinesis. These pass through a number o f  
checkpoint mechanisms and coincide with dramatic morphological changes that are well 
described in any textbook. The cytoskeleton plays a very important role during mitosis, not 
least in the formation o f the microtubule based spindle, but also in the acto-myosin 
contractile mechanism that is required for cytokinesis (see Glotzer, 2001).
However, numerous changes in membrane dynamics are apparent during mitosis. Much 
work has been performed investigating the Golgi complex in this respect (reviewed in 
Lowe et al., 1998a; Roth, 1999; Rossanese and Glick, 2001). During the transition from 
interphase to mitosis, the Golgi apparatus fragments and vesiculates to become scattered 
throughout the cell (Lucocq and Warren, 1987). This disassembly is believed to involve 
the continued budding o f vesicles that have lost the ability to fuse (see Lowe et al., 1998a 
and references therein). Endocytosis is also shut down (Warren et al., 1984; Pypaert et al.,
1991), and endosome-endosome fusion stops (Tuomikoski et al., 1989; Thomas et al.,
1992). Endosomes and lysosomes have been less well studied during the cell cycle but they 
have been reported to cluster around the microtubule organising centre either during 
mitosis (Zeligs and Wollman, 1979; Tamaki and Yamashina, 1991; Kaplan et al., 1992; 
Tooze and Hollinshead, 1992), or 30 minutes after cytokinesis (Bergeland et al., 2001). 
Many o f these events seem to be initiated by mitotic phosphorylation events. For example, 
Rab4 and Rab5 are phosphorylated in vitro by cdc2 (Bailly et al., 1991), a kinase which 
has been shown to inhibit endosome fusion (Tuomikoski et al., 1989). Indeed Rab4 
phosphorylation during mitosis prevents its association with endosomal membranes (Ayad 
et al., 1997; van der Sluijs et al., 1992a). Golgi fragmentation and reassembly is also 
regulated by cdc2 kinase phosphorylation o f the Golgi matrix protein GM130 (Lowe et al., 
1998b). Similarly there are cell cycle-regulated motor proteins implicated in membrane 
traffic. For example, two have been identified that mediate brefeldin A-induced membrane
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tubulation (see section 1.3.2.3) (Robertson and Allan, 2000), and their motor activities 
and/or microtubule binding is inhibited in metaphase, a stage o f  the cell cycle when BFA 
no longer induces tubulation (Robertson and Allan, 2000). Cdc2 kinase has also been 
shown to phosphorylate the light intermediate chain o f  cytoplasmic dynein during mitosis, 
a modification that inhibits dynein-mediated membrane transport (Dell et al., 2000).
There is now a good body o f evidence indicating that cytokinesis requires the delivery and 
insertion o f intracellular membrane to the site o f abscission (O'Halloran, 2000; Glotzer, 
2001). For example, t-SNAREs o f the syntaxin family are required for cytokinesis in 
diverse organisms including Arabidopsis thaliana, Caenorhabditis elegans and Drosophila 
melanogaster (Burgess et al., 1997; Lauber et al., 1997; Jantsch-Plunger and Glotzer, 
1999; Conner and Wessel, 1999). Similarly, the Golgi-associated coiled-coil protein Lava 
Lamp is required for furrow ingression during cellularisaion o f the Drosophila embryo, a 
process mechanistically akin to cytokinesis (Sisson et al., 2000). Consistent with a role for 
Golgi-derived membrane in these processes, BFA treatment also inhibits cellularisation 
(Sisson et al., 2000)and cytokinesis in the early C.elegans embryo (Skop et al., 2001). 
Clathrin is another membrane trafficking protein implicated in cytokinesis since clathrin- 
null Dictyostelium  fail to divide due to problems associated with furrow ingression 
(Niswonger and O'Halloran, 1997; Gerald et al., 2001).
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1.3 The ADP-ribosylation factor family of GTPases
The Ras superfamily o f  small molecular weight GTPases is subdivided into the Arf, Ras, 
Rab, Rho and Ran sub-families. These are all GTP-binding proteins o f approximately 21 
kDa that regulate many diverse cellular processes affecting cell morphology, intracellular 
trafficking, proliferation, differentiation and apoptosis. One o f  their hallmarks is that they 
act as binary switches cycling between inactive GDP-bound and active GTP-bound forms, 
the latter having a different structure allowing interactions with downstream effector 
molecules. The mammalian ADP-ribosylation factor (Arf) family consists o f six Arf 
isoforms, more than ten Arf-like (Arl) isoforms (Clark et al., 1993a), Arf domain protein 
(A RD l) and Sari is also a more distantly related member. In yeast there are three Arfs, 
three Arls, SARI and CIN4.
1.3.1 ADP-ribosylation factors
ADP-ribosylation factors (Arf) were originally purified and identified as cofactors for 
cholera toxin-catalysed ADP-ribosylation o f  Gg, the heterotrimeric G protein that 
stimulates adenylyl cyclase (Kahn and Gilman, 1984; Kahn and Gilman, 1986). There are 
six mammalian isoforms that share >60% sequence identity and these have been sub­
divided into three classes based on primary amino acid sequence, size, gene structure and 
phylogenetic analysis. The main differences between the classes are evident in the extreme 
N- and C-termini (see Fig. 1.3.1 for an amino acid sequence alignment). Arfs 1-3 constitute 
the class I enzymes, Arfs 4 and 5 make up class II while Arf6 is the most divergent and 
hence the sole member o f class III (see Fig. 1.3.1). There are three Arf proteins in the yeast 
Saccharomyces cerevisiae. Yeast Arfl and Arf2 share 96% identity, are most similar to the 
mammalian class I isoforms and are functionally redundant. They are required for protein 
secretion (Steams et al., 1990b), spomlation (Rudge et al., 1998), respiration and mitotic 
growth (Zhang et al., 1998a). Double knockout o f these is lethal, while the deletion o f  
either gene alone has no severe phenotype (Steams et al., 1990b). Arf2 deletion exhibits a 
wild-type phenotype, while the removal o f  the Arfl gene has been reported to confer 
slower growth and increased sensitivity to fluoride (Steams et al., 1990c; Kahn et al.,
1995), but this is probably attributable to the fact that Arfl is expressed at 10 fold higher 
levels than Arf2 (Steams et al., 1990b). Yeast Arf3, which exhibits 54% identity with yeast 
Arfl and about 60% with mammalian Arf6, is not required for viability and most likely 
corresponds to a class III isoform (Lee et al., 1994b). Yeast cells do not possess a class II- 
like isoform, whereas metazoans such as Caenorhabditis elegans and Drosophila
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Fig. 1.3.1 Sequence alignment of mammalian Arf proteins
The amino acid sequences of human Arfs 1,3,4,5 & 6 are shown 
together with murine Arf2 (no human Arf2 has yet been discovered). Arfs 
1, 2 & 3 are known as class I Arfs, Arfs 4 & 5 make up class II and Arf6, 
which is the smallest and most divergent, is the sole member of class III.
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melanogaster have at least one orthologue from each class (Lee et ah, 1994a). Arfs are 
well conserved between species and this is exemplified by the finding that isoforms from 
many species including Drosophila (Murtagh et ah, 1993) and Giardia (Lee et ah, 1992) 
can restore vegetative growth to arfVarfl' mutants. There also appears to be a high degree 
o f redundancy or overlapping function between classes since, for example, this rescue can 
be achieved by any o f the 6 mammalian Arfs.
Arfs have an N-terminal extension o f  about 17 amino acids that is not found in Ras. This 
folds into an amphipathic helix and is buried in a hydrophobic pocket at the surface o f  the 
core domain o f  Arfl-GDP (Amor et ah, 1994; Greasley et ah, 1995). Also unlike Ras, Arfs 
are myristoylated at their N-termini on the position 2 glycine and this is essential for 
function since a mutation o f the glycine to alanine behaves as a null allele in yeast (Kahn et 
ah, 1995) and produces an inactive protein in mammalian cells (D'Souza-Schorey and 
Stahl, 1995). The myristoyl moiety contributes to membrane insertion (Amor et ah, 1994), 
as do hydrophobic residues within the N-terminal alpha helix, which only become exposed 
in the GTP-bound state (Antonny et ah, 1997). Arfl has a greater affinity for GDP than for 
GTPyS in the absence o f phospholipids, and this is reversed upon addition o f  
phospholipids. Since this is the case for myristoylated but not non-myristoylated A rfl, it 
implies that the lipid modification acts as a phospholipid switch ensuring activation only 
when in the correct environment at the membrane (Randazzo et ah, 1995).
The Arf switch regions are the major sites o f interaction with regulators and effectors, but 
these have almost identical amino acid sequences between isoforms. The structures o f  both 
Arfl (Amor et ah, 1994; Greasley et ah, 1995) and Arf6 (Menetrey et ah, 2000; Pasqualato 
et ah, 2001) bound to GTP and GDP (or their analogues) have recently been solved (see 
Fig. 1.3.2). Interestingly, this has revealed that the GTP-bound conformations are more 
similar than the GDP-bound conformations suggesting that the switch regions probably 
only confer specific interactions in the inactive state (Pasqualato et ah, 2001). This 
suggests that active Arfs may elicit specific functions more on the basis o f their cellular 
context than on unique structural determinants.
1.3.2 Arf guanine nucieotide exchange factors
As with all Ras-like proteins, the Arf GTPase cycle is regulated by other accessory 
proteins. Among these are guanine nucleotide exchange factors (GEFs) that serve to 
activate the Arfs by catalysing the exchange o f GDP for GTP. These all contain a
4b
characteristic 200 amino acid See? domain first identified in yeast Sec7p (Achstetter et al., 
1988) that acts as the minimum catalytic domain. A role for these Sec 7-re lated proteins in
Arfl Arf6
Fig. 1.3.2 Structures of Arfl and Arf6.
Shown are the crystal structures of both Arf 1 and ArG in both the GDP-bound 
(in purple) and the GTP-bound (in dark blue) conformations. The switch I and 
II regions are in dark shades and other switch elements are in light shades. 
The dotted lines represent flexible regions. Note that the GTP-bound 
conformations appear more similar while the GDP-bound conformations 
appear most different. Reproduced from Pasqualato et a!., 2001.
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Arf function has been demonstrated genetically by the finding that human Arf4 expression 
rescues mutant Sec7 phenotype in Saccharomyces cerevisiae (Deitz et al., 1996). 
Biochemical analysis o f the Sec7 domain itself has revealed that is has a groove containing 
mainly exposed hydrophobic residues that binds to the switch I and II regions o f Arfl 
(Beraud-Dufour et al., 1998; Betz et al., 1998; Cherfils et al., 1998; Goldberg, 1998; 
Mossessova et al., 1998). As this happens, a critical Sec7 domain glutamate residue 
probably destabilises GDP by displacing Mg^ "^  allowing rapid nucleotide exchange to 
ensue (Beraud-Dufour et al., 1998). The net result is a dramatic conformational change in 
which the myristoylated N-terminus o f Arfl becomes exposed as it binds to GTP.
1.3.2.1 High m olecular weight GEFs
Arf GEFs can be broadly separated into two groups: high molecular weight GEFs and low  
molecular weight GEFs (see Fig. 1.3.3). The former ineludes yeast Geal/2 (Peyroche et al., 
1996; Peyroche et al., 2001), Sec7p (Achstetter et al., 1988) and mammalian GBFl 
(Claude et al., 1999)and BIG 1/2 (Yamaji et al., 2000). With the exception o f GBFl, these 
are all sensitive to the fungal metabolite brefeldin A (BFA; see below) and function 
primarily in the ER/Golgi system. These large GEFs are cytosolic proteins that are able to 
associate with membranes. However, it is not presently known how they achieve this.
In yeast, Sec7p was first identified by Novick and Schekman in a screen for mutants 
defective in secretion (Novick et al., 1980). GEAI and GEA2 are 50% homologous and 
exhibit functional redundancy since deletion o f either gene alone has no detectable 
phenotype, while a double knockout strain is not viable (Peyroche et al., 1996). SEC7 is 
also necessary for viability (Achstetter et al., 1988) indicating that Sec7p and Gealp/Gea2p 
have distinct functions.
Mammalian BIGl and BIG2 are two closely related Arf GEFs that colocalise in HeLa cells 
in punctate cytosolic and peri-nuclear/Golgi regions. Furthermore, they co-purify in a large 
-700  kDa complex (Yamaji et al., 2000). In vitro, they exhibit GEF activity towards class I 
and II Arfs, but not Arf6 (Morinaga et al., 1999; Togawa et al., 1999).
Claude et al. (1999) used expression cloning to select cDNAs whose overexpressed 
pro duets would allow Brefeldin A-sensitive 293 cells to grow in the presence o f  BFA. For 
this they used a cDNA library from a BFA-resistant CHO cell line and identified GBFl, 
which they discovered was a BFA-resistant Sec7-domain containing Arf GEF (Claude et 
al., 1999). It is a 205 kDa protein that is localised to the Golgi region where it colocalises
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with the coatomer subunit p-COP. Intriguingly, GBFl does not exhibit exchange activity 
towards the class I Arfs but is the only GEF to show specificity towards Arf5, suggestive 
o f a specific ArfS pathway (Claude et ah, 1999),
1.3.2.2 Low m olecular weight GEFs
In contrast to the larger GEFs, the low molecular weight GEFs are BFA-resistant, contain 
coiled coil and pleckstrin homology (PH) domains, and seem to function more in the 
endosomal/ plasma membrane systems. They are also absent from the S. cerevisiae 
genome suggesting that they perform functions unique to higher eukaryotes. They include 
cytohesins, ARNO (Arf nucleotide binding site opener), GRP1/ARN03 and EFA6. While 
most o f these appear to have in vitro GEF activity towards all Arf isoforms, EFA6 is 
unique in that it is specific for Arf6 (Franco et al., 1999). ARNO, cytohesin-1 and GRPl 
seem to prefer the class I Arfs as in vitro substrates (Macia et ah, 2001; Klarlund et ah,
1998), but they may be important regulators o f Arf6 in vivo. For example, transient 
expression o f GFP-ARNO in HeLa cells augments the ability o f  epidermal growth factor 
(EGF) to induce Arf6 redistribution, while Arfl and Arf5 are unaffected (Venkateswarlu 
and Cullen, 2000). Similarly, overexpression o f GRPl in mammalian cells resulted in a 
greater increase in Arfb-GTP than Arfl-GTP, as determined by direct analysis o f  
nucleotides associated with Arfs immunoprecipitated from ^^P-orthophosphate-labelled 
cells (Langille et ah, 1999). On the other hand others have reported that ARNO and 
ARN03/GRP1 overexpression fragments the Golgi and inhibits secretion without affecting 
the endocytic pathway (Franco et ah, 1998; Monier et ah, 1998), suggesting effects on Arfs 
other than Arf6. Similarly, chimeric proteins consisting o f  the N-terminal coiled-coil 
domains o f ARNO, ARN03 and GRPl fused to GFP are efficiently targeted to the Golgi 
apparatus (Lee and Pohajdak, 2000). Thus, the in vivo isoform specificity o f  these GEFs is 
questionable.
EFA6 localises to the plasma membrane and, when overexpressed, it induces actin-based 
membrane ruffles that can be inhibited by co-expression o f dominant negative mutants o f  
Arf6 and Racl (Franco et ah, 1999). Overexpression also specifically induces a 
redistribution o f transferrin receptors to the plasma membrane (Franco et ah, 1999), in a 
manner reminiscent o f expression o f the Arf6Q67L mutant (D'Souza-Schorey et ah, 1995). 
EFA6 also contains proline-rich domains that may mediate protein-protein interactions 
with as yet unidentified binding partners.
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Fig. 1.3.3 Arf Guanine nucleotide exchange factors (GEFs).
Shown are the known human (Hs) and budding yeast (Sc) guanine nucleotide 
exchange factors for Arfs. They all contain a characteristic Sec7 domain that 
is necessary and sufficient for enzymatic activity. In addition, the small 
mammalian GEFs have pleckstrin homology (PH) domains and coiled-coil 
(CC) regions. EFA6 also has proline rich sequences. The Arf isoform 
specificities are shown where known. All of the large GEFs except GBF1 are 
brefeldin A-sensitive, while the exchange activities of the smaller GEFs and 
GBF1 are resistant to the drug. Adapted from Donaldson & Jackson, 2000.
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The PH domains o f the small Arf GEFs promote GEF activity and mediate associations 
with specific membrane sites in response to the generation o f phosphoinositides (for 
reviews see Jackson and Casanova, 2000; Jackson et al., 2000). PH domain-dependent 
translocation to the plasma membrane, in response to elevated levels o f PI(3,4,5)P3, has 
been observed for ARNO (Venkateswarlu et a l, 1998b) and cytohesin-1 (Venkateswarlu et 
al., 1999). Indeed in this respect, the GFP-ARNO-PH domain is a useful in vivo tool for 
monitoring PI(3,4,5)Ps generation and hence PI3 kinase activation. The PH domain o f  
EFA6 is slightly different in that it recognises PI(4,5)P% as well as PI(3,4,5)P3 which may 
explain why it is more constitutively membrane associated (Jackson and Casanova, 2000).
1.3.2.3 Brefeldin A
Brefeldin A  (BFA) is a small hydrophobic molecule produced by toxic fungi that is a 
potent inhibitor o f  protein secretion (Klausner et al., 1992). It does this by interfering with 
GDP/GTP exchange on Arf (Donaldson et al., 1992; Helms and Rothman, 1992). Recent 
structural studies have shown that BFA stabilises an abortive Sec7 domain/Arf-GDP 
complex by preventing the switch regions o f Arfl-GDP from reorganising and contacting 
the Sec7 domain catalytic ‘glutamic finger’ (Peyroche et a l, 1999; Robineau et a l, 2000). 
BFA treatment causes Golgi resident proteins to redistribute into the ER (Lippincott- 
Schwartz et a l, 1989). It can also induce membrane tubulation in endosomes, lysosomes 
and the TGN (Lippincott-Schwartz et a l, 1991), and appears to affect vesicle budding in 
late secretory steps (Simon et a l, 1996; Wood et a l, 1991). Indeed many proteins 
peripherally associated with the Golgi disassociate upon BFA treatment (Kooy et a l, 1992; 
Podos et a l, 1994; Misumi et a l, 1997) and it is not clear whether this is due to a direct 
requirement for Arf in Golgi localisation or whether it is an indirect consequence o f  
alterations in Golgi structure and function. In addition, BFA probably has other non-Arf- 
mediated effects, such as via the 50 kDa protein Brefeldin A-ADP-ribosylated substrate 
(BARS50) (Silletta et a l, 1997), or via Aril which also appears to be BFA-sensitive (Van 
Valkenburgh et a l, 2001). Caution should therefore be used when ascribing an Arf 
function based on BFA inhibition. Similarly, since some Arf GEFs such as GBFl, EFA6 
and ARNO are BFA-resistant, Arf functions cannot be ruled out based on the lack o f BFA  
inhibition.
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1.3.3 Arf GTPase activating proteins
In order for Arf signals to be switched off, the bound GTP nucleotide needs to be 
hydrolysed to GDP. In contrast to many other Ras superfamily GTPases, purified Arfs 
have virtually undetectable intrinsic GTPase activity so they rely exclusively on other 
proteins termed GTPase activating proteins (GAPs) to catalyse this reaction (reviewed in 
Donaldson & Jackson, 2000). The Arf GAP family is rapidly expanding with many new 
members having been identified in the last few years and this has become quite an intense 
area o f  research. The family includes the yeast proteins G csl and Glo3 and mammalian 
ARFGAPl, centaurin a , ASAPl and PAP, Gitl and Git2 (also known as Catl and Cat2) 
and Pkl (see Fig. 1.3.4). They all contain a characteristic GAP domain o f about 70 amino 
acid residues that contains a zinc finger motif, CxxCx(16-17)CxxC (where C is cysteine 
and X represents any amino acid), that is critical for GAP activity (Cukierman et al., 1995). 
There is also a conserved arginine within the GAP domain, mutation o f which results in a 
100,000 fold decrease in activity (Mandiyan et al., 1999; Randazzo et al., 2000). 
Interestingly, many Arf GAPs also possess other features such as PH domains, src 
homology 3 (SH3) domains and ankyrin repeats (reviewed in Donaldson and Jackson, 
2000). They have also been shown to interact with actin-regulating and integrin-binding 
proteins, suggesting that they may function at the interface o f signalling, trafficking and 
cytoskeletal systems (Turner et al., 2001). Indeed, with the notable exception o f  
ARFGAPl, which localises to the Golgi (Cukierman et al., 1995), many mammalian GAPs 
have been found at the plasma membrane, where they might be predicted to act on Arf6. In 
addition, many have been shown to bind paxillin, an adaptor protein in integrin signalling 
(reviewed in Turner et al., 2001). Indeed overexpression o f the Arf GAPs PAPa and Git2- 
short, but not their respective GAP-inactive mutants, leads to a decrease in paxillin 
recruitment to peripheral focal adhesions (Kondo et al., 2000; Mazaki et al., 2001). This 
correlates nicely with the earlier finding that activated Arfl recruits paxillin to focal 
adhesions (Norman et al., 1998). Similarly, the A if GAP A SA Pl has been shown to alter 
the morphology o f focal adhesions and to inhibit cell spreading when overexpressed, and 
this is reversed upon expression o f a GAP domain mutant (Randazzo et al., 2000). Since 
this protein also binds Src, PI(4,5)Pz and FAK, it is likely that ASAPl co-ordinates 
multiple signalling pathways in the control o f cortical actin rearrangements, with Arf 
protein signalling being central to this (Randazzo et al., 2000). Based on these findings, 
together with its localisation and observations regarding Arf6 (see below), it seems likely 
that Arf6 is the in vivo target for A SA Pl, although in vitro it seems to prefer Arfl and Arf5 
as substrates (Brown et al., 1998). As with the GEFs, differences in phospholipid
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Fig. 1.3.4 Arf GTPase activating proteins (GAPs).
Shown are the known mammalian and budding yeast GTPase activating 
proteins for Arfs. They all contain a characteristic GAP domain (black) 
domain that contains a critical zinc finger motif. In addition, some have 
pleckstrin homology (PH) domains (vertical stripes), Src homology 3 (SH3) 
domains (horizontal stripes) and ankyrin repeats (AR; grey boxes). The Arf 
specificities and subcellular localisations are indicated. ND: not determined. 
Reproduced from Donaldson & Jackson, 2000.
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dependencies exist between GAPs, implying that specific ones operate downstream o f  
distinct signals. For example, ARFGAPl and ARFGAP2 activities are stimulated by 
varying degrees by PI(4,5)P2 (Randazzo, 1997b), while the GIT family GAPs are 
stimulated by PI(3,4,5)Ps suggesting that they function downstream o f PI3 kinase (Vitale et 
al., 2000b).
The crystal structure o f the GAP domain o f ARFGAPl complexed with Arfl-GDP has 
been published (Goldberg, 1999). This revealed that the GAP domain made contacts with 
Arfl at sites distant from the GTP binding pocket, implying that other molecules or 
effectors might participate in the GTP hydrolysis reaction. Indeed this does seem to be the 
case since coatomer greatly enhances the GAP activity o f ARFGAPl in vitro (Goldberg,
1999), while GGAs appear to delay the reaction in vivo (Puertollano et al., 2001b). It is 
likely that many Arf GAPs function as Arf effectors in addition to regulating the GTPase 
cycle. Consistent with this notion, it was found that the yeast homologue o f ARFGAPs, 
Gcsl was found to act as a suppressor o f the loss o f  Arf function along with three other 
SAT proteins (Suppressors o f  ^ f  ts) (Zhang et al., 1998a).
1.3.4 Functions and effectors of Arf proteins
1.3.4.1 Vesicle coat proteins
Elucidating the functions o f  Arf proteins has been a remarkably intense area o f research. 
Most attention has been on the class I isoforms, and Arfl in particular, although the class 
III isoform Arf6 has also attracted much interest. By contrast, virtually nothing is known 
about the function o f the class II Arfs, Arf4 and Arf5. As previously mentioned, Arfl was 
found to be a component o f the coatomer protein coat found on vesicles produced from 
isolated Golgi membranes and was subsequently found to be required for the formation o f  
these vesicles, termed COPI vesicles (Palmer et al., 1993; Rothman and Wieland, 1996). In 
vivo evidence for a role for Arfl in coatomer function came from yeast genetic studies 
whereby arfl A null mutations combined with mutations in coatomer subunits resulted in 
synthetic growth defects while the same arfl A null combined with other sec mutations did 
not (Steams et al., 1990c; Gaynor et al., 1998). In vitro biochemical assays have also 
shown that Arfl and coatomer subunits are the only cytosolic components required for the 
formation o f COPI-coated vesicles from Golgi membranes (Orci et al., 1993). Similarly, 
Arfl lacking the first 17 residues has been shown to directly bind the coatomer complex in 
vitro (Goldberg, 1999) and specifically p-COP and s-COP in the yeast two-hybrid system 
(Eugster et al., 2000).
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Since the initial studies on COPI, Arfs have been implicated in clathrin coated vesicle 
formation mediated by AP-1 (Stamnes and Rothman, 1993; Traub et al., 1993; West et al., 
1997; Zhu et al., 1999), and AP-3 adaptor protein complexes (Goi et al., 1998). The 
binding o f  AP-1 to Golgi membranes in vitro is dependent on Arfl loaded with GTPyS 
(Stamnes and Rothman, 1993; Traub et al., 1993), and direct GTP-dependent interactions 
between Arfl and AP-1 have been documented (Austin et al., 2000). Recent studies have 
also shown them to be important in the assembly o f clathrin-coated vesicles mediated by 
GGA proteins, the novel class o f clathrin adaptors (Boman et al., 2000; Puertollano et al., 
2001b; reviewed in Robinson and Bonifacino, 2001). Furthermore, a screen in 
Saccharomyces cerevisiae for mutations exhibiting synthetic lethality with an Arfl A allele 
identified a mutation in the clathrin heavy chain gene, providing in vivo genetic evidence 
o f Arf function in clathrin coat assembly (Chen and Graham, 1998).
1.3.4.2 Phospholipase  D
In addition to the cofactor activity in the ADP-ribosylation o f Gg, Arfs are all potent 
activators o f phospholipase D (PLD) (Brown et al., 1993; Cockcroft et al., 1994). This 
finding raised the possibility o f an alternative model for the role o f Arf in membrane 
budding and fission. PLD catalyses the conversion o f phosphatidylcholine to phosphatidic 
acid (reviewed in Liscovitch et al., 2000), the latter increasing membrane fluidity and 
having the propensity to promote membrane curvature. An in vitro assay whereby ethanol 
was used to competitively inhibit PLD activity revealed that COPI-coated vesicle 
formation on Golgi membranes could be inhibited in the presence o f Arf, and that bacterial 
PLD could stimulate coatomer binding in the absence o f Arf (Ktistakis et al., 1996). This 
led to the proposal that PLD activation mediated the action o f Arfs on vesicle formation 
(Ktistakis et al., 1996). However, this now seems implausible for a number o f  reasons. 
Firstly, there is no Arf-regulated PLD activity in yeast (Rudge et al., 1998) and yet Arf 
mutants exhibit the same phenotypes in both yeast and mammalian cells. Secondly, Arf 
mutants defective in PLD activation can still recruit coatomer and produce profound 
morphological effects on the Golgi complex (Kuai et al., 2000). Thirdly, PLD inhibition 
using neomycin has no effect on Arf-dependent AP-1 recruitment to the TGN, although it 
does block AP-2 recruitment to the plasma membrane and endosomes (West et al., 1997). 
So, while PLD activation may explain some Arf effects, it certainly cannot account for all 
o f them and the precise relationship between Arfs and PLD remains elusive.
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Fig. 1.3.5 The Arf cycle during vesicle biogenesis.
Cytosolic, inactive Arf-GDP is recruited to membrane sites during the 
nucleotide exchange catalysed by Sec7-domain containing guanine 
nucleotide exchange proteins (GEPs). Arf-GTP binds to cytosolic coat 
proteins that assemble and polymerise at the membrane where they also 
interact with specific cargo receptors. The energy of polymerisation is 
sufficient to deform the membrane and drive the budding process. 
GTPase activating proteins (GAPs) trigger the GTP hydrolysis on Arf, 
reverting it to the inactive GDP-bound conformation. GTP hydrolysis 
contributes to the uncoating of the newly formed vesicle. Reproduced 
from Takai et al., 2001.
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1.3.4.3 Phosphatidylinositol 4-phosphate 5-kinases
Another class o f recently identified Arf effectors are phosphatidylinositol 4-phosphate 5- 
kinases (PI(4)P 5-kinases). These enzymes produce the lipid second messenger PI(4,5)P2 
by phosphorylating the 5-position o f PI(4)P and at least three isoforms are known; a , p and 
Y (Ishihara et al., 1996; Ishihara et al., 1998). PI(4,5)P2 is crucial for many cellular 
processes (for reviews see Toker, 1998; Martin, 2001). These include the regulation o f the 
actin cytoskeleton through interactions with actin-binding proteins (Janmey and Stossel, 
1987; Fukami et al., 1992) and by stimulating actin polymerisation, for example via the 
activation o f N-WASP (Ma et al., 1998; Miki et al., 1996). It is also a key modulator o f  
endocytosis since it interacts with ENTH (epsin N-terminal homology) domains present in 
many proteins o f the endocytic machinery, and the AP-2 adaptor requires PI(4,5)P2 to bind 
to the plasma membrane (Beck and Keen, 1991). Importantly, PI(4,5)P] is also directly 
involved in Arf GTPase cycles since it stimulates some o f the guanine nucleotide exchange 
factors (Terui et al., 1994) and GTPase-activating proteins (Kam et al., 2000; Randazzo, 
1997b; Randazzo and Kahn, 1994), as well as directly interacting with Arf itself 
(Randazzo, 1997a). By assaying recombinant mouse PI(4)P 5-kinase a  activity in the 
presence o f  bovine brain cytosol sequentially fractionated by column chromatography, 
Honda et al. (1999) purified Arfl and Arf3 as the most abundant upstream activators o f the 
enzyme. This is a particularly interesting finding because PI(4)P 5-kinase activity is also 
dependent on phosphatidic acid (see Honda et al., 1999 and references therein), the product 
o f PLD enzymes, which are themselves activated by Arfs (Cockcroft et al., 1994; Brown et 
al., 1993). Subsequent experiments showed that in transfected HeLa cells, PI(4)P 5-kinase 
colocalised with HA-tagged Arf6 but not Arfl or Arf5, and that Arf6 recruited the lipid 
kinase to plasma membrane suggesting that it is the in vivo activator. Another study using 
an in vitro system consisting o f liposomes, PI(4)P 5-kinase, ARNO, Arfl and guanine 
nucleotides showed that the stimulation by Arf is direct and not via PLD (Jones et al.,
2000). However, epitope tagged PI(4)P 5-kinase and PLD isofonns can be co- 
immunoprecipitated from cells co-expressing them, and PLD2 activity is enhanced by the 
expression o f PI(4)P 5-kinase (Divecha et al., 2000). So it seems likely that there is a 
complex relationship between Arfs, PLDs and PI(4)P 5-kinases involving multiple positive 
and negative feedback mechanisms.
1.3.4.4 Spectrin and actin assem bly
Spectrin and ankyrin assembly onto Golgi membranes is stimulated by GTPyS in an Arf- 
dependent manner as evidenced by immunodepletion and add-back experiments using an
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in vitro assay (Godi et al., 1998). Furthermore, this is dependent on Arf-stimulated 
PI(4,5)P2 generation which interacts with spectrin PH domains (Godi et al., 1998). Spectrin 
is best known for its role in maintaining the structural integrity o f  the erythrocyte cortical 
cytoskeleton, and its role at the Golgi could be analogous. Arf-regulated Golgi spectrin 
might actively participate in vesicular transport. This is supported by the finding that 
disruption o f the spectrin cytoskeleton by expression o f the Golgi targeting domains o f  
spectrin inhibits the transport o f the Na/K-ATPase and vesicular stomatitis virus-G protein 
from the ER to the Golgi (Devarajan et al., 1997). Spectrin can also directly bind the ARPl 
component o f the dynactin complex and may therefore be a link between membranes and 
dynein microtubule motor proteins (HoUeran et al., 1996). Arf has also been shown to 
assemble at least two distinct pools o f actin onto Golgi membranes in a GTP-dependent 
manner (Fucini et al., 2000). One pool was found to be sensitive to salt extraction and 
cytochalasin D treatment, while the other was insensitive to both (Fucini et al., 2000). 
Furthermore, the sensitive pool co-fractionated with COPI-coated vesicles and these were 
more readily removed from Golgi membranes by high salt following cytochalasin D 
treatment, suggesting that Arf-dependent actin plays a role in linking COPI-vesicles to the 
Golgi (Fucini et ah, 2000).
1.3.4.5 Arfaptins
Among the first proteins found to be direct binding partners o f activated Arfs were 
Arfaptins 1 and 2 (Kanoh et ah, 1997). They were identified in a yeast two-hybrid screen 
using a “GTP-locked” Arf3Q71L mutant as bait and both interacted specifically with GTP- 
bound Arfs in in vitro assays. These share 60% identity and a truncated form o f Arfaptin 2 
lacking the first 38 amino acids had been previously identified as a Racl-GTP interacting 
protein called PORI (van Aelst et ah, 1996). PORI has been shown to coordinate 
rearrangements o f the cortical actin cytoskeletal mediated by Arf6 and Racl (D'Souza- 
Schorey et ah, 1997). However, it binds much more tightly to class I Arfs than to Arf6 and 
may, therefore, function downstream o f these isoforms as well (Kanoh et ah, 1997; Shin 
and Exton, 2001; Tarricone et ah, 2001). Arfaptin 1 has been less well studied but appears 
to localise to the Golgi in immunofluorescence experiments and associates with 
intracellular membranes in the presence o f Arf and GTPyS (Kanoh et ah, 1997). Arfaptin 1 
has also been reported to inhibit Arf-mediated PLD activity in vitro (Tsai et ah, 1998) and 
in cells overexpressing the protein where a modest inhibition o f  ER/Golgi transport was 
also documented (Williger et ah, 1999). However, its precise cellular function is yet to be 
determined.
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1.3.4.6 Mitotic kinesin-like protein
Mitotic kinesin like protein (MKLPl) was also recently identified as a putative Arf effector 
(Boman et al., 1999). The C-terminal tail domain was recovered from a yeast two-hybrid 
screen using Arf3Q71L as bait, although it was later found that all six Arf isoforms 
interacted equally well. The mysristoylated N-terminal alpha-helix o f Arf3 was not 
required for the interaction since a mutant lacking the first 13 amino acids still interacted in 
the two-hybid system (Boman et al., 1999). In vitro biochemical assays were also 
performed to confirm the validity and GTP-dependence o f  the interactions. MKLPl is best 
known for its role during cytokinesis, where it appears to be a core component o f the 
central spindle (reviewed in Glotzer, 2001). It has an amino terminal kinesin motor domain 
and exhibits plus-end directed motility (Nislow et al., 1992), and it can cross-link 
microtubules in anti-parallel bundles via two microtubule binding sites (Nislow et al.,
1992). Mutants o f the Drosophila and C. elegans homologues, pavarotti and ZEN-4, 
respectively, show spindle and cytokinetic defects (Adams et al., 1998; Powers et al., 1998; 
Raich et al., 1998). The protein is found in the nucleus in interphase cells, at the spindle 
poles during metaphase, and concentrates at the midbody and on the midzone microtubules 
during anaphase (Nislow et a l, 1992; Sellitto and Kuriyama, 1988). Moreover, MKLPl 
has also been shown to co-immunoprecipitate with Polo kinase (Lee et a l, 1995), a cell- 
cycle regulated kinase required for cytokinesis (Carmena et a l, 1998; Nigg, 1998). The 
significance o f  the Arf/MKLPl interaction is currently unknown, but it may be an event 
that occurs transiently at a specific stage o f the cell cycle.
1.3.4.7 Arfophilin
Arfophilin is another putative Arf effector identified by the yeast two-hybrid system (Shin 
et a l, 1999). Importantly, it was found to specifically interact with the GTP-bound form o f  
Arf5, and did not interact with class I Arf isoforms. Subsequent experiments by the same 
investigators have recently revealed that Arfophilin also interacts with Arf6 in glutathione 
S-transferase (GST) pulldown experiments, although possibly via a distinct binding site 
(Shin et a l, 2001). As with PICKl and MKLPl, the physiological relevance o f the 
interactions with Arf remain to be elucidated.
1.3.4.8 PICK1
PICKl (protein interacting with C kinase 1) is another protein implicated as an immediate 
downstream Arf effector (Takeya et a l, 2000). This is a PDZ-domain containing protein
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that was originally identified by virtue o f its interaction with protein kinase Ca in the yeast 
two-hybrid system (Staudinger et al., 1995). Interestingly, it contains a region homologous 
to the Arfaptins, but this does not bind Arfs as might be predicted (Takeya et al., 2000). 
However, the PDZ domain does appear to bind the C-termini o f  activated (Q71L mutants) 
class I, but not class II or III, mammalian Arfs, again in the yeast two-hybrid system 
(Takeya et al., 2000). PICKl has been shown to localise to a perinuclear region 
(Staudinger et al., 1995), but again the significance or validity o f the putative interaction 
with Arfs is unknown.
1.3.4.9 Modulation of the GTPase cycle by effector interactions
It has become apparent that Arf/effector interactions play direct roles in regulating the Arf 
GTPase cycle. In the case o f Arf3 binding to Arfaptin 2, GGAl and MKLPl, these 
interactions appear to increase the affinity for GTP in vitro (Zhu et ak, 2000). This would, 
therefore, be predieted to prolong the interactions and any downstream events in vivo. 
Another report showed that the interaction o f GGAs with Arfl-GTP inhibits GTP 
hydrolysis catalysed by ArfGAPl, and this would increase the duration o f the interaction 
even more (Puertollano et al., 2001b). On the other hand, coatomer binding to Arfl 
appears to enhance the GAP activity o f ArfGAPl 1000-fold (Goldberg, 1999). So it seems 
that there is another level o f complexity in the control o f Arf function that is dependent on 
specific interactions with specific effectors. Indeed, it is conceivable that subtle differenees 
could exist between different Arf isoforms interacting with the same effectors, and that 
these could potentially result in distinct cellular effects.
7.3.5 Arf6 -  the odd one out?
Although Arf6 behaves essentially the same as all the other isoforms in in vitro assays such 
as the cholera toxin-stimulated ADP-ribosylation o f Gg, or PLD activation, it is clearly 
different from the other five isoforms in that it does not localise to the Golgi complex. It 
localises to the plasma membrane in the GTP-bound state but there has been some debate 
as to whether it dissociates in the GDP-bound conformation like the other isoforms, and 
also whether it localises to intracellular endosomal locations. Initial immunoblot analysis 
o f subcellular fractions suggested it localised uniquely to the plasma membrane 
irrespective o f nucleotide status (Cavenagh et al., 1996). Other groups have, however, 
identified a cytosolic pool (Gaschet and Hsu, 1999; Yang et al., 1998), and the discrepancy 
is hard to reconcile. Ultrastructural and confocal microscopic investigations have revealed 
that mutants defective in GTP-hydrolysis and GTP-binding localise to the plasma
Fig. 1.3,6 Cellular functions of ARF GTPases.
A diagrammatic overview of the known functions and effectors of ARF 
GTPases. ARFs are activated by Sec7 domain-containing exchange 
factors that are often sensitive to brefeidin A (BFA) inhibition, and are 
inactivated by proteins containing ARF GAP domains. Downstream 
cellular events can be broadly divided into lipid metabolism, coat 
recruitment and cytoskeletal regulation, although there are no clear 
boundaries between these as they are all inter-related.
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membrane and recycling endosomes, respectively in cultured cells (D'Souza-Schorey et al., 
1995; D ’Souza-Schorey et al., 1998; Peters et al., 1995). Thus, it seems likely that Arf6- 
GDP is located in the endosomal compartment and then translocates to the plasma 
membrane upon GTP binding.
In terms o f function, Arf6 has been implicated in the control o f regulated exocytosis in 
chromaffin cells since it is associated with purified chromaffin granules and calcium- 
stimulated catecholamine exocytosis can be attenuated using a synthetic myristoylated 
peptide corresponding to the N-terminus o f Arf6 but not with an analogous Arfl peptide 
(Galas et ah, 1997). A similar approach uncovered a potential role for Arf6 in regulated 
exocytosis in permeabilised 3T3-L1 adipocytes, since the same synthetic peptide could 
inhibit insulin-stimulated GLUT4 translocation (Millar et al., 1999). Another study in the 
same cell type using a virally-expressed Arf6D125N mutant (predicted to be an XTPase) 
as a dominant negative, saw no effect on GLUT4 trafficking although the basal and 
insulin-stimulated secretion o f adipsin was apparently defective (Yang and Mueckler,
1999). Further studies in the same cell type reported inhibitory effects o f the expression o f  
the “GDP-locked” Arf6T27N mutant on endothelin-stimulated but not insulin-stimulated 
GLUT4 translocation (Bose et al., 2001). A role for Arf6 in endocytosis in CHO cells has 
also been proposed based on findings that Arf6 mutants could perturb the endocytosis and 
recycling o f transferrin (D'Souza-Schorey et al., 1995). In polarised MDCK cells, Arf6 
localises exclusively to the apical plasma membrane where both Arf6Q67L and Arf6T27N 
mutants stimulate clathrin-mediated endocytosis (Altschuler et al., 1999). Exactly how  
Arf6 regulates endocytosis/exocytosis is not known but it is likely to involve modulation o f  
the cortical actin cytoskeleton through mechanisms that could involve phospholipase D 
activation and PI(4,5)P2 generation.
Donaldson and colleagues have shown that aluminium fluoride treatment o f cells 
overexpressing wild type Arf6 induces actin-rich protrusions o f the plasma membrane 
(Radhakrishna et al., 1996) and that expression o f Arf6T27N inhibits Rac-mediated 
membrane ruffling (Radhakrishna et al., 1999). More recently, these investigators have 
made a chimeric Arf protein consisting o f the N-terminal half o f  Arfl fused to the C- 
terminal half o f Arf6. This chimera behaved like Arf6 in terms o f  subcelluar localisation 
and endosome to plasma membrane cycling in HeLa cells and did not affect Rac-induced 
membrane ruffling (A1 Awar et al., 2000). However, it did inhibit the formation o f actin- 
containing protrusions, suggesting that effects on membrane trafficking/Rac function and 
protrusion formation are functionally distinct (A1 Awar et al., 2000).
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Arf6 also appears to be involved in the desensitisation o f  G protein-coupled receptors such 
as the (32-adrenoceptor and the choriogonadotropin receptor since the process is inhibited 
by an Arf6 peptide (Mukherjee et al., 2000) and the GAP Gitl (Premont et al., 1998), 
while it is enhanced by overexpression o f the GEF ARNO (Mukherjee et al., 2000). 
Receptor internalisation has long been known to involve (3-arrestins that serve as adaptors 
between ligand-bound receptors and the clathrin endocytic machinery, and more recent 
evidence has shown that (3-arrestin associates with ARNO and, following agonist 
stimulation, also with Arf6-GDP thereby facilitating guanine nucleotide exchange (Claing 
et ah, 2001).
1.3.6 Other members of the A rf family
In addition to the Arfs, there are at least 3 yeast and 10 mammalian Arf-like proteins called 
Arls (Tamkun et ah, 1991; Clark et ah, 1993b; Schurmann et al., 1994; Zhang et al., 1995; 
Lowe et ah, 1996) and a much larger protein called A RDl that contains an 18 kDa Arf 
domain as well as an Arf GAP domain (Vitale et ah, 1996). The Arls are also 
myristoylated GTP-binding proteins o f approximately 20 kDa that are 40%-60% identical 
to each other or to other Arfs, but very little is known about their functions. The fact that 
mutation o f the only Drosphila ARL is embryonically lethal, and cannot be rescued by 
upregulation o f ARF  genes, suggests separate but equally essential functions for the Arls 
(Tamkun et ah, 1991), Unlike the Arfs, Arls have not been purified by an activity (e.g. 
cholera toxin ADP ribosylation o f Gs, PLD activation) but they do exhibit some 
similarities. For example, overexpression in mammalian cells o f a mutant Aril defective in 
GTP hydrolysis (ArllQTlL) leads to a similar phenotype as that for ArflQTlL, whereby 
Golgi morphology is disrupted in a manner reminiscent o f  BFA treatment (Van 
Valkenburgh et ah, 2001). Yeast two-hybrid assays have also shown that ARLl-GTP can 
interact with some putative ARF effectors, such as Arfaptin 2/PORl and MKLPl. Arl2 has 
been shown to be involved in micro tubule nucléation at the centrosome by regulating the 
interaction o f native tubulin with cofactor D (Bhamidipati et ah, 2000).
The A RDl protein has been described by Moss, Vaughan and colleagues (Vitale et ah,
1996). It seems to have both Golgi and lysosomal targeting sequences conferred by the 
ARF domain and the GAP domain, respectively, but its function is unclear (Vitale et ah, 
2000a).
Other GTP-binding proteins that belong to the Arf family include the yeast proteins SARI 
and CIN4 although they only share 25%-35% identity with the ARFs and have clearly
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distinct activities. SARI was originally identified as a multicopy suppressor o f a 
temperature-sensitive mutant o f  the SEC12 gene that had been genetically identified as 
necessary for ER to Golgi transport in yeast (Nakano et al., 1988). There is only one SARI 
gene in yeast, while two Sari proteins (Saria and Sarlb) have been found in mammals 
(Kuge et al., 1994). Secl2p was found to be a guanine nucleotide exchange factor for 
Sarlp (Barlowe and Schekman, 1993) and the Sari GTPase cycle is now known to 
regulate the formation o f COPII-coated vesicles (Barlowe, 2000). Cin4 was identified in a 
genetic screen for mutants defective in micro tubule function (Hoyt et al., 1990; Steams et 
al., 1990a) and it is most homologous to mammalian Arl2, also implicated in similar 
pathways.
7,3.7 Cross-ta/k between A rf and Rho family GTPases
Several lines o f evidence suggest that Arf and Rho family GTPases act in concerted ways, 
and these should be considered when assessing Arf functions. They have been particularly 
pertinent in findings relating to Arf6- and Rac-induced cytoskeletal rearrangements. 
Firstly, Arfs and Racl both bind Arfaptin-2/PORl (Kanoh et al., 1997; D'Souza-Schorey et 
al., 1997; Tarricone et al., 2001; Shin and Exton, 2001), and overexpression o f a PORI 
deletion mutant blocks Arf6-mediated cytoskeletal rearrangements (D'Souza-Schorey et 
al., 1997). Similarly, expression o f dominant-negative mutants o f  Rac or Arf6 can abolish 
the cytoskeletal remodelling observed upon overexpression o f EFA6, the Arf6 GEF 
(Franco et al., 1999). Thirdly, dominant-negative Arf6 expression can prevent Racl- 
mediated membrane mffling (Radhakrishna et al., 1999; Zhang et al., 1998b). Further 
evidence for a connection comes from the finding that the Arf GAP, PKL, links paxillin to 
PAK and PIX, which are components o f Rac/Cdc42 pathways (Turner et al., 1999). Much 
o f this cross-talk may be at the level o f phosphoinositide signalling. Phosphatidylinositol 
4-phosphate 5-kinase has been shown to directly interact with Rac-GTP (Tolias et ak, 
1995), to be activated by the Rho effector Rho-kinase (Oude Weemink et ak, 2000), and to 
be an Arf6 effector that translocates to membrane mffles and produces PI(4,5)P2 
synergistically with Arf6 and phosphatidic acid (Honda et ak, 1999). Phosphatidic acid is 
itself produced by phospholipase D in response to both Rho and Arf proteins (Frohman and 
Morris, 1996). PI(4,5)P2 itself regulates Arf activation via the recruitment o f  PH-domain 
containing GEFs and GAPs and also promotes the activation o f  Rho family members. In 
addition, PI(4,5)P2 is required for other aspects o f Rho family signalling such as the 
activation o f  N-WASP during Cdc42-stimulated actin polymerisation (Ma et ak, 1998; 
Miki et ak, 1996). Since a role for Arf6 in endocytosis has been demonstrated (D'Souza-
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Schorey et al., 1995), this could be part o f a mechanism coupling vesicle formation with 
actin rearrangements to facilitate vesicle trafficking. Also o f  interest is the finding that the 
tail o f Cdc42 directly interacts with the y-COP subunit o f  coatomer (Wu et al., 2000), 
whose assembly onto Golgi membranes is regulated by Arf (see section 1.1.4.1).
1.3,8 Aims of this study
An overwhelming body o f evidence supports the central role o f  Arf proteins in the control 
o f membrane traffic. However, there are still large gaps in our understanding o f their 
precise cellular functions, and more recent developments regarding the actin cytoskeleton 
and ARFGAP signalling hint at how complex the situation really is. Particularly sparse is 
information as to the identities and/or functions o f immediate downstream effectors, 
especially when compared to other small GTPases like Rab5.
What o f the class II Arf isoforms: do they have specific eftectors/functions, and if  so, what 
are they? Previous work in the lab had shown that the addition o f  a myristoylated synthetic 
peptide corresponding to the unique N-terminus o f  Arf5 to permeabilised 3T3 LI 
adipocytes inhibited insulin-stimulated translocation o f the endosomal markers GLUTl 
and the transferrin receptor to the plasma membrane (Millar et al., 1999). Analogous Arfl 
or Arf6 peptides or a non-myristoylated peptide could not mimic this effect suggesting the 
existence o f an Arf5-specific pathway (Millar et al., 1999). These findings inspired the 
work presented here and led us to try to identify novel Arf5 effector proteins. The 
preliminary aim was, therefore, to use the yeast two-hybrid system to identify novel class 
II Arf-interacting proteins, and this represents the focus o f the first results chapter. Chapter 
3. This strategy successfully identified two novel putative binding proteins and one o f  
these, named Arfophilin-2, became the main focus o f the two subsequent chapters. Chapter 
4 deals with the initial characterisation o f Arfophilin-2, including the cloning o f  the cDNA, 
the analysis o f its expression in different tissues, and its subcellular distribution and 
pharmacological sensitivity in cultured cells. The aim o f Chapter 5 was then to gain insight 
into the cellular function o f Arfophilin-2, by examining the effects o f overexpression or 
truncation o f the protein, and by trying to establish the relationship between Arfophilin-2 
and the Arfs themselves.
Chapter 2
Materials & Methods
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2.1 Materials
All materials used in this study were o f a high quality and were obtained from the 
following suppliers:
Am ersham  Pharm acia Biotech, Little Chalfont, Buckingham shire, UK
Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG antibody 
Horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG antibody 
ECL Western blotting detection reagents 
Glutathione sepharose 4B 
Activated CH sepharose
Anachem  Ltd., Luton, Bedfordshire, UK
30% acrylamide/bisacrylamide
Bio-Rad Laboratories Ltd, Hemel Hem pstead, Hertfordshire, UK
N, N, N', N'-tetramethylethylenediamine (TEMED)
Boehringer Mannheim, Germany
Isopropyl-thio-B-D-galactopyranoside (IPTG)
Tris
Brefeidin A
Protease inhibitor cocktail tablets: complete™ and complete-mini™
EXPAND™ High-Fidelity PGR kit
Clontech, Palo Alto, CA, USA
Human testis Matchmaker™ II library in pACT2 
Human brain Matchmaker™ II library in p GAD 10 
Human multiple tissue Northen blots (MTNI and MTNII)
ExpressHyb hybridisation buffer 
Human testis Marathon-Ready^^ cDNAs 
Human testis Protein Medley™ lysate
Dako, Ely, Cam bridgeshire, UK
Horseradish peroxidase (HRP)-conjugated donkey anti-sheep IgG antibody
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Difco Laboratories, Detroit, USA
Yeast nitrogen base (without amino acids)
Bacto-agar (for yeast work)
Fisher Scientific Ltd., Loughborough, Leicestershire, UK
Ammonium persulphate 
Calcium chloride (CaCl2)
Diaminoethanetetra-acetic acid, Disodium salt (EDTA)
Disodium hydrogen orthophosphate (Na2HP04 )
D-Glucose
Glycerol
Glycine
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES)
Hydrochloric acid (HCl)
Isopropanol
Magnesium sulfate (MgS04 )
Methanol
Potassium chloride (KCl)
Potassium dihydrogen orthophosphate (KH2PO4)
Sodium dodecyl sulphate (SDS)
Sodium chloride (NaCl)
Sodium dihydrogen orthophosphate dihydrate (NaH2P04 )
Sodium hydrogen carbonate (NaHCOa)
Sucrose
Trichloroacetic acid 
Tri-Sodium citrate (NaaCôHsO?)
Invitrogen, Groningen, The Netherlands
pCRII-TOPO™ TA cloning kit
Bibby-Sterilin, Staffordshire, UK
IWAKI cell culture plastic ware: 6 well plates, 75 cm  ^ flasks, 10 cm dishes 
Graduated disposable pipettes
Kodak Ltd, Hemel Hem pstead, Hertfordshire, UK
X-Omat S film
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Life Technologies, Paisley, Scotland, UK
Dulbecco’s modified Eagle’s medium (without sodium pyruvate, with 4500mg/L 
glucose) (DMEM)
Modified Eagle’s medium (MEM)
Hams F I2 medium 
Opti-MEM
Foetal bovine serum (FBS)
lOOOOU/ml penicillin, lOOOOU/ml streptomycin
Trypsin/EDTA solution
Non essential amino acids
Lipofectamine reagent
1 kb DNA ladder
Agarose
Merck Ltd (BDH), Lutterworth, Leicestershire, UK
Magnesium chloride (MgCE)
Tween 20
Zinc cloride (ZnClz)
Molecular Probes, Oregon, USA
Alexa"^^^-conjugated donkey anti-mouse IgG secondary antibody 
Alexa^^^^-conjugated donkey anti-rabbit IgG secondary antibody 
Alexa^ "^^ - conjugated donkey anti-sheep IgG secondary antibody 
Texas-Red™-Transferrin
MWG-Biotech, Germany
All oligonucleotide primers
NEN Dupont (UK) Ltd, S tevenage, Hertfordshire, UK
[a-^^P]-dCTP
New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK
Prestained protein marker, broad range (6-175kDa)
Oxoid Ltd, Hampshire, UK
Bacteriological agar 
Yeast extract
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Tryptone
Pierce, Rockford, Illinois, USA
Slide-a-lyzer™ dialsysis cassettes
Prem ier B rands UK, Knighton Adbaston, Staffordshire, UK
Marvel powdered milk
Prom ega, Southam pton, UK
All restriction enzymes (except Dpn 1)
Pfu polymerase
Taq polymerase
Nuclease-free water
Calf intestinal alkaline phosphatase
Deoxynucleotide triphosphates (dNTPs)
Qiagen, Crawley, W est Sussex , UK
TMQIAprep spin miniprep kit 
QIAprep™ maxiprep kit 
Nickel NTA-agarose
Schleicher & Schuell, Dassel, Germany
Nitrocellulose membrane (pore size:0,45pM)
Shandon, Pittsburgh, PA, USA
Immu-mount^'^ mounting medium
Stratagene, La Jolla, CA, USA
Supercompetent XLI-blue Escherichia coli
Pfu Turbo™ polymerase (for Quikchange mutagenesis)
Dpn 1 restriction enzyme (for Quikchange mutagenesis)
W hatman International Ltd, M aidstone, UK
Whatman No. 1 filter paper 
Whatman N o,3 filter paper 
Whatman 3mm filter paper
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Unless otherwise indicated, all remaining chemicals were supplied by Sigma Chemical 
Company Ltd, Poole, Dorset, UK.
Primary antibodies
Monoclonal anti transferrin receptor antibody was from Zymed Laboratories, Cambridge, 
UK. Monoclonal anti haemagluttinin antibody, anti Rab5, R ab ll, Rho, Rac, EEAl were all 
from Santa Cruz Biotechnology, Santa Cruz, California. Monoclonal anti Na/K ATPase 
was from Upstate Biotech, New York. Anti clathrin was from Transduction Laboratories, 
San Diego, CA, USA. Anti y tubulin, a  tubulin, and (3 COP were all from Sigma. 
Polyclonal anti GRASP55 and GRASP65 antibodies were a gift from Francis Barr (Max- 
Plank-Institute, Martinsreid, Germany). Margaret Robinson (University o f Cambridge, 
UK) generously provided polyclonal antibodies to GGAl, RM El, AP-3Ô and y adaptin. 
Anti cellubrevin was a kind gift from David James, University o f Queensland, Australia. 
Anti Arf6 was a gift from Julie Donaldson, NIH, Bethesda, USA. Anti-sortillin was from 
Nick Morris (University o f  Newcastle, UK). Antibodies to the CI-MPR and the CD-MPR 
were gifts from G. E. Lienhard (Dartmouth Medical School) and A. Hille-Rehfeld 
(Universitat Gottingen, Germany), respectively. Anti-syntaxin 6 polyclonal antibodies 
were produced in house by Kumudu Perera, against a recombinant His-tagged protein.
Escherichia coli s tra ins
DH5a  
XLl-blue 
TOP 10 
JM109
BL21 DE3 (pLys)S 
KC8
Saccharomyces cerevisiae strain for two-hybrid work
PJ69-2A was the only strain used in this study (James et ak, 1996). It has the following 
genotype:
MATa, trpl-901, leu2-3,112, ura3-52, his3-200, gal4A, galSOA, L YS::G A L 1uas~G A L 1tata~  
HIS3, G A L 2 u a s-G A L 2 ta ta -A D E 2
70
General so lu tions
DNA loading buffer 40% (w/v) sucrose, 0.25% bromophenol blue
GST-tag buffer 100 mM HEPES, 200 mM KCl, pH 7.0
His-tag buffer 100 mM HEPES, 200 mM KCl, 5 mM imidazole, pH 8.0
Immunofluorescence buffer PBS plus 0.2% fish skin gelatin and 0.1 % donkey or goat
(IF) serum [a different species to that in which the secondary
antibodies were raised in]; freshly made and filtered through 
a Nalgene 0.2 pm vacuum type filter
Luria Broth (LB) 10% (w/v) tryptone, 5% (w/v) yeast extract, 10% (w/v) NaCl
Lysis buffer 25 mM HEPES, pH 7.5; 50 mM NaCl; 5 mM EDTA; 10%
(v/v) glycerol; 1% (v/v) Triton X-100
Phosphate buffered saline 136mM NaCl, lOmM NaH2P0 4 , 2.5mM KCl, 1.8mM
(PBS) KH2PO4, pH 7.4
SDS-PAGE electrode buffer 25mM Tris, 190mM glycine, 0.1% (w/v) SDS
SDS-PAGE sample buffer 93mM Tris-Cl pH6.8, ImM sodium EDTA, 10% (w/v)
glycerol, 2% (w/v) SDS, 0.002% (w/v) bromophenol blue, 
20mM dithiothrietol
TAB 40 mM Tris-Acetate, 1 mM EDTA
TBST 20 mM Tris-HCl, pH 7.4; 150 mM NaCl; 0.08% (v/v)
Tween-20
Transfer buffer 25 mM NaH2P0 4 , pH 6.5
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2.2 Methods
General methods are given in this chapter, while more specific procedures or methods that 
are unique to a given chapter are presented in those chapters.
2.2.7 Molecular Biology
2.2.1.1 Amplification of DNA by Polym erase Chain Reaction (PGR)
All polymerase chain reactions (PCRs) were performed in thin walled PGR tubes in a 
Techne Pro gene thermocycler. Amplification o f DNA from purified plasmid DNA was
performed using Pfu polymerase enzyme (Promega), while PGR from cDNAs was
performed using an EXPAND high-fidelity kit (Roche).
Reactions were set up on ice typically as follows:
1 Ox polymerase buffer (with MgClz) 5 pi
nuclease-free water to 50 pi
forward primer (4 pmol/ pi) 2.5 pi
reverse primer (4 pmol/ pi) 2.5 pi
dNTPs (10 mM each dCTP, dGTP, dATP, dTTP) 1 pi
template DNA (50-100 ng) 0.5 pi
polymerase 1 pi
The tubes were then briefly vortexed and pulsed in a microfuge, before thermal cycling 
was initiated. Typical cycling conditions were as follows:
X 25 <
94°G 2 min
94°G 15 sec
55°G 30 sec
68°G 2 min/kb (Pfu) or 1 min/kb (Expand)
68°G 5 min
4°G Hold
The 55°G annealing temperature was sometimes decreased as low as 50 °C if  initial 
attempts failed due to low primer melting temperatures. Following PGR cycling, half o f the
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reaction mixture was analysed by agarose gel electrophoresis (see below). All 
oligonucleotide primers were highly purified salt free (HPSF) grade (MWG-Biotech) and 
stocks were made at 100 pmol/pl in TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). 
These were then diluted to 4 pmol/pl in nuclease-free water when required.
2.2.1.2 Purification of PCR products
If a second round o f PCR was to be performed, for example using nested primers, the first 
round PCR reaction was purified using a Qiagen PCR purification kit, according to the 
manufacturer’s instructions and using the buffers supplied. Briefly, 25 pi o f the reaction 
was mixed with 125 pi buffer PB and placed in a QIAspin column. This was then 
centrifuged in a micro fuge at full speed for 1 min. The column was then washed in 750 pi 
buffer PE containing ethanol, and the column was spun and the flow-through was 
discarded. The column was then spun again to ensure the complete removal o f the buffer 
and then placed in a sterile 1.5 ml microcentrifuge tube. 50 pi o f  buffer EB, warmed to 
40°C, was then pipetted into the centre o f the column and incubated for 1 min. The DNA  
was then collected in the microcentrifuge tube by centrifugation for 1 min. 5 pi o f this 
would then be used as a template for a further round o f PCR.
2.2.1.3 A garose gel electrophoresis
For standard small 1% agarose gels, agarose was dissolved by boiling in 50 ml TAE buffer 
in a microwave oven. This was then allowed to cool to about 50-60°C before 1 pi o f  
ethidium bromide (10 mg/ml) was added. This was mixed thoroughly and poured into a 
horizontal electrophoresis gel cartridge was an appropriate comb inserted. This was 
allowed to set at room temperature before being transferred to the electrophoresis tank 
containing TAE buffer. The comb was gently removed, samples in DNA loading buffer 
(30% (v/v) glycerol, 0.25% bromophenol blue) were applied to the wells, adjacent to a lane 
containing 0.5-0.75 pg 1 kb DNA ladder. Electrophoresis was carried out at 70 volts for 
45-60 min or until the dye front had migrated sufficiently far to have allowed the 
resolution o f the relevant DNA fragments. The gels were then visualised using an 
ultraviolet transilluminator and photographs were taken using a Mitsubishi video copy 
processor, where appropriate.
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2.2.1.4 Gel extraction of DNA
A clean scalpel blade was used to excise required bands from agarose gels that were 
visualised under ultraviolet light. This was performed as quickly as possible to minimise 
DNA damage by ultraviolet irradiation. Gel slices were transferred to sterile 1.5 ml 
microcentrifuge tubes and DNA extraction was performed using a Qiagen gel purification 
kit, according to the manufacturer’s instructions and using the buffers supplied. 600 pi o f  
buffer QC was added to each gel slice and the tubes were incubated at 37°C for 10-15 
minutes or until the agarose had completely dissolved. This was facilitated by periodic 
vortexing. The solution was then applied to a QIAspin column. This was then centrifuged 
in a micro fuge at full speed for 1 min. The column was then washed in 750 pi buffer PE 
containing ethanol and the column was spun and the flow-through discarded. The column 
was spun again to ensure the complete removal o f  the buffer and was then placed in a 
sterile 1.5 ml micro centrifuge tube. 50 pi o f buffer EB, warmed to 40 °C, was then pipetted 
into the centre o f the column and incubated for 1 min. The DNA was then collected in the 
microcentrifuge tube by centrifugation for 1 min.
2.2.1.5 Adding ‘A’ base  overhangs onto Pfu-amplified products
If Pfu-amplified PCR products were to be cloned into pCRll-TOPO for sequencing, 
mutagenesis and subcloning, they first had to be treated with Taq polymerase to add 
overhanging ‘A ’ bases required for TA cloning. To do this, 5 pi o f  Taq buffer, 1 pi dNTPs 
(10 mM each dCTP, dGTP, dATP, dTTP) and 1 pi Taq polymerase were added to gel 
purified PCR products (<50 pi ). These were mixed thoroughly and incubated at 72°C for 
20 min.
2.2.1.6 TA cloning of PCR products
This was performed using the pCRll-TOPO kit (Invitrogen), according to the 
manufacturer’s instructions. As a rule, 2 pi o f purified PCR product containing 
overhanging ‘A ’ bases was added to a sterile micro centrifuge tube and mixed with 0.5 pi 
o f pCRll-TOPO vector. This was then incubated at room temperature for 5 min, before 
adding 0.5 pi o f ‘stop’ solution (supplied with the kit). Meanwhile a vial o f OneShot 
TOP 10 competent Escherichia coli cells (Invitrogen) were thawed on ice. The 3 pi 
reaction mixture was then gently added to the cells and these were incubated on ice for 30 
min. The cells were then heat-shocked for 30 sec at 42°C in a water bath, chilled on ice for
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1 min and then incubated in 250 pi SOC medium (supplied by Invitrogen) for 1 h at 37°C. 
The cells were then plated onto LB agar plates containing 50 pg/ml kanamycin and 
incubated overnight at 37°C. Colonies were then picked, cultured overnight in LB 
containing 50 pg/ml kanamycin. Small-scale DNA preparations were then carried out and 
plasmids were analysed by restriction digestion and sequencing (see below).
2.2.1.7 DNA restriction d igests
Approximately 500 ng plasmid DNA was used for diagnostic restriction digests (i.e. to 
determine the presence and/or orientation o f an insert), while 2-4 pg were used for 
subcloning. Digests were routinely performed in 20 pi volumes, with 2 pi o f an appropriate 
lOx buffer (taking into account the efficiency o f  both enzymes in double digests), 0.5-1 pi 
of each restriction endonuclease and the remaining volume made up with sterile water. 
Digests were incubated at 37°C for 2-3 h. If a cut vector was to be purified for a 
subsequent subcloning step, and especially if  the subcloning was into a single restriction 
site, the digested vector would be de-phosphorylated with calf intestinal alkaline 
phosphatase (CIP) at this point to reduce the probability o f religation in the absence o f an 
insert. To do this, 2 pi o f  CIP buffer and 1 pi CIP enzyme were added to the ligation and 
incubated for a further 10 min at 37°C. Following the addition o f  5x DNA loading buffer 
(30% (v/v) glycerol, 0.25% bromophenol blue), the digested DNA was then subjected to 
agarose gel electrophoresis as described above.
2.2.1.8 Ligations
Digested inserts and CIP-treated vectors were purified by agarose gel electrophoresis 
followed by gel extraction as described above. Ligation reactions were then set up in sterile
microcentrifuge tubes using approximately a 3:1 molar ratio o f insert:vector. These were
mixed together with 2 pi ligase buffer and 1 pi T4 ligase in a final volume o f 20 pi that 
was made up with sterile distilled water. The ligation reactions were then incubated either 
at room temperature for 2-3 h or overnight on an ice/water slurry. 5 pi o f the reaction were 
then used to transform Escherichia coli strain DH5a or XLl-blue.
2.2.1.9 Preparation of com petent Escherichia coli
10 ml sterile LB in a plastic universal tube was inoculated with E. coli from a glycerol 
stock and cultured overnight at 37°C with shaking at 300 rpm. 5 ml o f this was then
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subcultured into 100 ml LB in a sterile 500 ml flask and further grown at 37°C with 
shaking, until the optical density at 600 nm was 0.5 (typically about 3 h). The cells were 
then chilled on ice for 5 min and harvested by centrifugation in sterile 50 ml centrifuge 
tubes at 3000 rpm for 10 min in a Beckman benchtop centrifuge at 4°C. The supernatant 
was discarded and the cells were gently resuspended in a total o f  40 ml sterile-filtered 
buffer 1 (30 mM KAc, 100 mM RbCL, 10 mM CaCl], 50 mM MnClz, 15% (v/v) glycerol; 
pH 5.8) using a sterile pipette. The cells were incubated on ice for a further 5 min and were 
then spun as before. All traces o f the supernatant were removed and discarded and the cells 
were resuspended in a total o f 4 ml sterile-filtered buffer 2 (1 0  mM MOPS, pH 6.5; 75 mM 
CaC12; 10 mM RbClz and 15% (v/v) glycerol). Following a further incubation o f 15 min 
on ice, the cells were divided into 220 pi aliquots in pre-chilled sterile microcentrifuge 
tubes and stored at -80°C until required.
2.2.1.10 Iransform ation  of Escherichia coli
Competent E. coli cells that had been made by the method in section 2.2.1.9 were thawed 
on ice and 50 pi per transformation were pipetted into sterile pre-chilled 1.5 ml 
microcentrifuge tubes. For each transfoiTuation, 5 pi o f  ligation reaction or 0.5 pi (50 ng) 
o f purified plasmid DNA were added to the cells. These were gently mixed and incubated 
on ice for 15-30 min. The cells were then heat-shocked in a water bath at 42°C for exactly 
90 sec, and then chilled on ice for 1 min. 450 pi o f  LB were then added to each tube and 
these were incubated at 37°C for 45 min. The cells were then spun down for 10 sec at full 
speed in a microfuge, 350 pi o f  LB were discarded and the cells were resuspended in the 
remaining 150 pi. They were then plated onto LB agar plates containing the appropriate 
antibiotic, and grown overnight inverted at 37°C. Competent E. coli cells that had been 
obtained from commercial suppliers were transformed according to the protocols provided 
by the suppliers.
2.2.1.11 Sm all-scale DNA preparations
Bacterial colonies were picked from selective LB agar plates and transferred to 3 ml LB 
(containing 100 pg/ml ampicillin or 50 pg/ml kanamycin, as appropriate) in 16 ml plastic 
tubes (Falcon). These were then grown overnight at 37°C with shaking at 300 rpm. DNA  
purification was then performed using a Qiagen miniprep kit, according to the 
manufacturer’s instructions and using the buffers supplied. Briefly, the cells from 1.5 ml 
culture were collected by centrifugation for 5 min at full speed in microfuge. The
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supernatant was discarded and the tube refilled with culture and spun again. Cell pellets 
were then resuspended in 250 pi buffer PI (containing RNase A) by pipetting. 250 pi 
buffer P2 were then added and the tubes were mixed by inverting several times. These 
were left to incubate for 5 min at room temperature, after which time 350 pi buffer N3 
were added and again mixed by inverting several times. The tubes were then centrifuged 
for 10 min at full speed in a microfuge and the supernatants were carefully decanted into 
Qiagen miniprep spin columns and spun at full speed for 1 min in microfuge. The flow­
through was discarded and 750 pi buffer PE (with ethanol added as in the manufacturer’s 
instructions) was added. The column was spun again and the flow-through was discarded. 
The column was spun a further time to ensure the complete removal o f the buffer and it 
was then placed in a sterile 1.5 ml microcentrifuge tube. 50 pi o f buffer EB, warmed to 
40°C, was then pipetted into the centre o f the column and incubated for 1 min. The DNA  
was then collected in the microcentrifuge tube by centrifugation for 1 min.
2.2.1.12 Large-scale DNA preparations
Large-scale DNA preparations were performed using a Qiagen plasmid maxi kit, following 
the high-copy plasmid protocol and using the buffers supplied by the manufacturers. 
Briefly, bacterial cultures o f  100 ml were grown overnight in 500 ml flasks in LB 
containing the appropriate antibiotic for selection. The cells were then harvested by 
centrifugation at 3000 rpm for 10 min in 50 ml centrifuge tubes. The cells were 
resuspended in a total o f 10 buffer PI (containing RNase A) by pipetting. 10 ml buffer P2 
were then added and mixed and this was left to lyse the cells for 5 min. The reaction was 
neutralised by the addition o f 10 ml o f chilled buffer P3. The flocculent precipitate formed 
was removed by centrifugation at 3000 rpm for 30 min followed by filtration through two 
layers o f  muslin. This supernatant was then applied to a P I00 Qiagen column pre­
equilibrated with 10 ml buffer QBT and was allowed to drain under gravity. The column 
was then washed with 30 ml buffer QC (with added ethanol according to manufacturer’s 
protocol). The DNA was then eluted into a 50 ml tube by the addition o f 15 ml buffer QF.
10.5 ml isopropanol was then added and well mixed and the precipitated DNA was 
collected by centrifugation at 3000 rpm for 30 min in a benchtop centrifuge. The 
supernatant was discarded and the pellet was washed in 4 ml 70% (v/v) ethanol. This was 
then removed and the pellet air-dried prior to being resuspended in 250 pi TE (10 mM 
Tris-HCl, pH 8.0, 1 mM EDTA). The DNA concentration and purity was then assessed 
spectrophotometrically.
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2.2.1.13 Site-directed m utagenesis
This was essentially carried out according to the Quikchange method (Stratagene). Two 
oligonucleotide primers were designed with the desired mutation(s) present in the middle 
o f the sequence. These primers were the reverse and complement o f each other and were 
routinely 33 bp long. A  PCR reaction was then set up on ice as follows:
lOx Pfu-turbo buffer 5 pi
nuclease-free water to 50 pi
forward primer (4 pmol/ pi) 2.5 pi
reverse primer (4 pmol/ pi) 2.5 pi
dNTPs (10 mM each dCTP, dGTP, dATP, dTTP) 1 pi 
template DNA (50-100 ng) 0.5 pi
Pfu-turbo polymerase 1 pi
The tubes were then briefly vortexed and pulsed in a microfuge, before thermal cycling 
was initiated. Typical cycling conditions were as follows:
r
X 14 <
95°C 30 sec
95°C 15 sec
55°C 1 min
68°C 2 min/kb template
68°C 5 min
4°C Hold
Following this, 10 pi o f  the reaction was analysed by agarose gel electrophoresis to ensure 
amplification had occurred. 1 pi Dpn 1 restriction enzyme was then added to the remaining 
40 pi and the parental dam methylated DNA was digested for 2 h at 37°C. 1 pi o f  the 
digest was then used to transform XLl-blue supercompetent cells (Stratagene), according 
to the suppliers protocols. The cells were plated on LB agar plates containing appropriate 
antibiotics and grown at 37°C for about 24 h. Colonies were then picked, cultured 
overnight in selective LB media and the DNA was extracted. Recovered plasmids were 
sequenced to ensure the presence o f  the desired mutations and the absence o f undesired 
ones.
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2.2.1.14 DNA sequencing
The University o f Glasgow Molecular Biology Support Unit performed all DNA  
sequencing using Big Dyes kits (PE biosystems) and an ABI Prism 377 sequencer. This 
was performed for all constructs that were produced following PCR steps to ensure that no 
undesired mutations had been introduced.
2.2.2 Mammalian Ceil culture
2.2.2.1 Cells and culture conditions
Human embryonic kidney HEK 293 cells, human cervical carcinoma HeLa cells and 
Chinese hamster ovary (CHO) cells were generous gifts from Dr. Pam Scott (University o f  
Glasgow). HEK 293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) foetal calf serum (PCS) and L-glutamine; HeLa cells were 
cultured in minimal Eagle’s medium (MEM) supplemented with 10% (v/v) foetal calf 
serum (PCS) and non-essential amino acids; and CHO cells were grown in Hams F I2 
medium supplemented with 10% (v/v) foetal calf serum (PCS) and 1% (v/v) penicillin and 
streptomycin. These media are referred to as complete growth media. All cells were grown 
on Iwaki plasticware at 37°C in a humidified atmosphere containing 5% CO2 and the 
media were replaced every 2-3 days if  the cells did not require passaging (see below). Cells 
were cultured in 75 cm^ flasks for maintenance.
2.2.2 2 Trypsinisation and passage  of ceils
When cells had reached 80-90% confluency, the media were aspirated and the cells were 
rinsed with 3-4 ml sterile PBS warmed to 37°C. This was then aspirated and 2 ml 
trypsin/EDTA was added and evenly distributed over the entire base o f the flask. 
Following a 3 min incubation at 37°C, the cells were dislodged by gentle tapping o f the 
flask, and the cells were then separated by gentle pipetting. The cells were then transferred 
to a fresh flask containing the desired volume o f fresh complete growth media, mixed well, 
and were distributed to the appropriate culture vessels (6 well plates, 10 cm dishes, more 
flasks) as required. Cells were generally diluted 1:5 or 1:10 in this manner. For cells 
destined for confocal microscopy, glass coverslips were flamed in ethanol briefly to ensure 
sterility prior to placing them in 6 well plates ready for seeding cells.
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2.2.2 3 Freezing down and resurrecting celis
Cells trypsinised from one 75 cm  ^ flask as described above were added to 12 ml o f 
appropriate growth medium in a 16 ml sterile centrifuge tube. They were then spun at 2000 
X g for 3 min. The medium was aspirated and the cells were resuspended in 1 ml complete 
growth medium containing 10% dimethyl sulphoxide (DMSO) and transferred to a 1.8 ml 
polypropylene cryo-vials. These vials were then wrapped in multiple layers o f tissue paper 
and placed at -80°C overnight to freeze slowly before being transferred to a liquid nitrogen 
storage vat.
To resurrect cells from liquid nitrogen storage, vials were rapidly thawed by incubation at 
37°C in a water bath. Any cell clumps were dispersed by pipetting and the cells were 
transferred to a flask containing 15 ml complete growth medium that had been previously 
equilibrated in the incubator at 37°C for about 1 h. The growth media were changed the 
following day to remove the DMSO.
2.2.2.4 Ceil transfections
Cell transfections were carried out using Lipofectamine reagent (Life Technologies, Gibco, 
Paisley, UK), according to the manufacturer’s recommendations. Typically, cells were
plated the day before transfection and the transfections were performed on cells that were
between 40-60% confluent. Per 6 well plate or 10 cm dish, 7.5 pg maxiprep DNA (see 
section 2.2.1.12) were diluted in 600 pi Optimem (Life Technologies) in a sterile 50 ml 
centrifuge tube and 30 pi Lipofectamine were diluted in a separate 600 pi Optimem. The 
Lipofectamine/Optimem mixture was then added drop-wise to the DNA/Optimem mixture. 
This was then incubated for 30 min at room temperature. Meanwhile, the cells were rinsed 
in 1 ml/well or 5 m l/10 cm dish Optimem at 37°C. 4.8 ml warm Optimem was then added 
to the DNA/Lipofectamine mixture and this was dispensed onto the cells (1 ml per well or 
6 ml per 10 cm dish). The cells were then returned to the incubator for 3-6 h, after which 
time an equal volume o f complete growth medium containing a total o f 20% (v/v) PCS 
was added to give a final concentration o f 10% PCS. Cells were typically harvested or used 
18-22 h post-transfection (i.e. post the addition o f the DNA/Lipofectamine mixture).
2.2.2.5 Incubation of ceils with fluorescent transferrin  and drugs
Cells to be treated with drugs or fluorescent transferrin, were first quiesced for 2 h by 
replacing the complete growth media with serum free media. After this time, drugs such as
80
brefeldin A (20 p^g/ml for 10 min; Boehringer Mannheim), nocodazole (50 ng/ml for 1 h; 
Sigma) or wortmannin (100 ng/ml; Sigma) were added and the cells returned to the 
incubator for the appropriate time. Control experiments using the vehicle alone (methanol 
or DMSO) were conducted in parallel. Cells were then washed in ice-cold PBS and 
processed for immunofluorescence as described below in section 2.2.3.1. Similarly, Texas- 
red transferrin (1 pg/ml; Molecular Probes) was incubated with the quiesced cells for a 
specified time (5 or 30 min). The cells were then either washed extensively in cold PBS 
prior to fixation, or washed in complete growth media containing 1 mg/ml iron-saturated 
transferrin (Sigma) for a specified chase time. The cells were then fixed as described 
below.
2.2.3 immunofluorescence and con focal microscopy
2.2.3.1 Fixing cells and processing  them  for im m unofluorescence
The transfection media were aspirated and the cells were washed twice with 2 ml/well ice 
cold PBS and all traces were removed by aspiration. 2 ml methanol at -20°C were then 
added to each well and these were then incubated at -20°C for 5 min. The methanol was 
aspirated and the coverslips were washed 3 times in cold PBS and twice in IF buffer (PBS 
containing 0.2% fish skin gelatin and 0.1% donkey or goat serum [whichever species the 
secondary antibodies were raised in]; freshly made and filtered through a Nalgene 0.2 pm 
vacuum type filter). The cells were left in the second IF buffer wash for 10-15 min. 
Meanwhile primary antibody dilutions were prepared. These were generally diluted 1:100 
to 1:200 in IF buffer (except a-tubulin 1:3200; y-tubulin 1:300; actin-Cy3 conjugate 
1:1000). Coverslips were then placed cells-down onto a 100 pi drop o f antibody solution 
on parafilm. These were incubated for 1 h at room temperature, then returned to the 6 well 
plates for 5 x washes in IF buffer. Secondary antibodies were then prepared in IF buffer at 
a dilution o f 1:200 and coverslips were again incubated for 1 h cells-down onto 100 pi 
placed on parafilm. The coverslips were again washed 5 times in IF buffer and were 
mounted onto a small drop o f Immu-mount (Shandon, Pittsburgh, USA) on glass slides. 
These were then allowed to harden overnight and were kept in the dark until analysed by 
confocal microscopy.
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2.2.3 2 Confocal m icroscopy
Mounted coverslips were analysed using a 63x Zeiss oil immersion objective on a Zeiss 
Axiovert fluorescence microscope (Carl Zeiss, Germany) equipped with a Zeiss LSM4 
laser confocal imaging system. Images were captured using either (or both) o f 488 nm or 
543 nm lasers with appropriate filter sets for collection o f  GFP/Alexa'^^^/FITC signals 
(band-pass 505-520 nm) or Alexa^^" /^TRITC signals (long-pass 590 nm). Data files were 
saved in .TIF format and analysed using Photoshop 5.5 software (Adobe).
2.2.4 Biochemical Procedures
2.2.4.1 Protein a ssay s
Protein concentration was measured using the Bradford method (Bradford, 1976). 
Coomassie Brilliant Blue G-250 (35 mg) was dissolved in 50 ml o f 95% (v/v) ethanol and 
60 ml 85% (w/v) orthophosphoric acid was added. The mixture was made up to 1 L with 
distilled water, filtered through Whatman 541 grade filter paper and stored protected from 
light. For protein determinations, 1 ml o f this reagent was added to 100 pi o f sample and 
the absorbance measured at 595 nm against a reference sample which contained 1 ml o f  
reagent and 100 pi o f buffer or water as appropriate. Readings were compared to those o f a 
standard curve obtained fi'om analysing samples containing 1 to 5 pg bovine serum 
albumin (BSA).
2.2 .42 SDS-PAGE
Sodium dodecyl suphate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out 
using Bio-Rad mini-PROTEAN II gel apparatus and either 10 or 15 well combs. The 
percentage o f acrylamide in each gel ranged from 8% to 15%, according to the molecular 
weight o f the proteins o f  interest. All reagents were o f  electrophoresis grade.
A resolving gel was prepared using 30% acrylamide/bisacrylamide, 1.5 M Tris-HCl (pH 
8.8) (to a final concentration o f 375mM), 10% (w/v) SDS (to a final concentration o f  
0.1%), polymerised with 10% (w/v) ammonium persulphate (to a final concentration of  
0.1%) and TEMED (to a final concentration o f 0.019%). This gel was allowed to 
polymerise overlaid with water and leaving enough space for the wells plus about 1.5 cm 
o f stacking gel. The stacking gel was prepared using 30% acrylamide/bisacrylamide, IM 
Tris-HCl (pH 6.8) (to a final concentration o f 125mM), 10% (w/v) SDS (to a final
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concentration o f 0.1%), polymerised with 10% (w/v) ammonium persulphate (to a final 
concentration o f 0.1%) and TEMED (to a final concentration o f  0.05%). This was then 
applied on top o f the resolving gel, with a comb in place and allowed to polymerise.
Protein samples were resuspended in Ix SDS PAGE sample buffer (93mM Tris-Cl pH6.8, 
20mM dithiothreitol [added immediately before use], ImM sodium EDTA, 10% (w/v) 
glycerol, 2% (w/v) SDS, 0.002% (w/v) bromophenol blue) and were routinely boiled for 2- 
3 min in a water bath. The samples were then loaded onto the wells in the stacking gel, 
adjacent to broad-range (Mr 6-175 kDa) pre-stained molecular weight markers (New  
England Biolabs). Gels were electrophoresed in electrode buffer (25mM Tris, 190mM 
glycine and 0.1% (w/v) SDS) at 60 mA for about 1 h or until the dye front had reached the 
bottom o f the gel.
2.2.4.3 C oom assie staining of SDS-PAGE gels
Following the separation o f  proteins by SDS-Polyacrylamide Gel Electrophoresis, a 0.25% 
Coomassie blue stain solution was prepared. For this 10ml o f  glacial acetic acid was mixed 
with 90ml o f a methanoliHiO (1:1 v/v) mixture and 0.25g o f  Coomassie Brilliant Blue R 
were added. This stain was then filtered through Whatman number 1 filter paper. The gel 
was submerged in the stain for about 1 h then rinsed and destained with the same acetic 
acid, methanol:H20 mixture (without the Coomassie dye). Destaining was for at least 3 h 
with frequent changes o f  destain buffer or overnight. The gels were then placed between 
clear polythene sheets and scanned to provide digital records.
2.2.4.4 T ransfer of proteins to nitrocellulose
Proteins were separated by SDS-PAGE as described above. A  sponge pad, two sheets o f  
Whatman 3 mm filter paper and a sheet o f  nitrocellulose membrane (pore size 0.45mM), 
cut to size and previously soaked with transfer buffer (25mM NaH2P0 4 , pH 6.5) were 
placed on the black plate o f a Bio-Rad Trans Blot gel cassette holder. The gel was then 
placed on top o f the nitrocellulose membrane and any air bubbles were gently removed. 
The "sandwich" was completed with two more sheets o f  filter paper and a sponge pad as 
before. Transfer was carried out using a Bio-Rad mini or Bio-Rad trans-blot 
electrophoretic cell containing transfer buffer at a constant current o f 300 mA for 3 h or 
overnight at 60 mA. The efficiency o f transfer was then assessed by staining the 
nitrocellulose with Ponceau S solution (Sigma).
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2.2.4.S Immunoblotting
Following transfer, non-specific binding sites on the nitrocellulose membrane were 
blocked by shaking for at least 1 h in 5% (w/v) dried skimmed milk in TEST buffer 
(20mM Tris, 150mM NaCl, 0.02% Tween-20, pH 7.4). The nitro cello se membrane was 
then heat-sealed in polythene tubing together with primary antibody in 1% (w/v) dried 
skimmed milk in TEST buffer at the appropriate dilution and shaken for at least 2 h at 
room temperature. Following five washes with TEST buffer over a period o f 1 h, the 
membrane was incubated with shaking in 1% (w/v) dried skimmed milk in TEST buffer 
containing the appropriate secondary antibody, (HRP-linked IgG) at a 1:1000 dilution for 1 
h at room temperature. The membrane was then washed a further five times over a period 
o f 1 h.
The detection o f antigen/primary/secondary antibody complexes on the nitrocellulose blots 
was then performed using the enhanced chemiluminescence method (ECL, Amersham). 
Equal volumes o f Amersham "detection reagent 1" and "detection reagent 2" (typically 2 
ml o f each) were mixed and placed onto the membrane for about 1 min. The blot was then 
dabbed dry with some tissue paper and wrapped in cling film. This was then placed in a 
light tight cassette and exposed to Kodak film in a dark room for varying exposure times. 
The film was developed using an X-OMAT automatic processor.
2.2.4.G Im m unoprécipitations
Using a rubber policeman, cells were collected in ice-cold lysis buffer (25 mM HEPES, pH 
7.5; 50 mM NaCl; 5 mM EDTA; 10% (v/v) glycerol; 1% (v/v) Triton X-100 containing 
complete protease inhibitor cocktail; 250 pl/well o f a 6 well plate). They were then 
triturated several times using a pipette, transferred to 1.5 ml micro centrifuge tubes and 
incubated on ice for 15 min. The tubes were then spun at full speed for 10 min in a 
microcentrifuge chilled to 4°C. The supernatants were transferred to fresh screw-cap 
microcentrifuge tubes and the triton-insoluble pellets were discarded. Approximately 5 pg 
primary antibody/ preimmune serum were then added to 500 pi o f  lysate and the tubes 
were rotated end over end for 2 h at 4°C. Meanwhile protein AJ protein G-sepharose beads 
were washed three times in lysis buffer and a 50% slurry was made in the same buffer. 25 
pi o f  this was then added to each tube and these were rotated for a further 1 h. The tubes 
were then spun in the microfuge for 1 min and the supernatants were carefully removed 
and transferred to separate tubes. The beads were washed four times with 1 ml o f lysis 
buffer by resuspension and centrifugation. All traces o f  buffer were removed fter the final
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Spin and 50 pi high urea buffer (8 M urea; 5% (w/v) SDS; 200 mM Tris-HCl pH 6.8; 0.1 
mM EDTA; 0.5 mg/ml bromophenol blue; 10% (v/v) (3-mercaptoethanol) were added to 
the beads. These were vortexed for 15 sec, pulsed in a microfuge, boiled for 2-3 min, 
pulsed again and the supernatants were removed and the proteins were resolved by SDS- 
PAGE.
2.2.4.7 Recom binant protein production
An E. coli colony harbouring an appropriate plasmid was picked from a freshly grown 
selective LB agar plate and used to inoculate 10 ml o f LB containing appropriate 
antibiotics. This was grown overnight at 37°C with shaking at 250 rpm. The following day, 
the 10 ml culture was used to inoculate 1 L LB plus antibiotics in a 5 L flask. This was 
grown at 30°C with shaking until the optical density at 600 nm had reached about 0.5-0.6. 
IPTG was then added to a final concentration o f 0.5-1 mM and the culture was induced for 
5 h. The cells were then harvested in 250 ml tubes in a Beckman JA-14 rotor by 
centrifugation at 5000 rpm for 15 min. The cell pellets were resuspended by pipetting in 40 
ml His-tag buffer (100 mM HEPES, 200 mM KCl, 5 mM imidazole, pH 8.0) or GST-tag 
buffer (100 mM HEPES, 200 mM KCl, pH 7.0) depending on the type o f recombinant 
protein to be purified. This was transferred to a 50 ml centrifuge tube and spun at 3500 rpm 
in a benchtop centrifuge for 20 min. The supernatant was discarded and the cell pellet was 
frozen on dry ice and kept at -20°C overnight.
2.2.4.8 Recom binant protein purification
The cell pellet was thawed and resuspended in 20 ml ice-cold His-tag buffer (containing 
complete protease inhibitor cocktail and 1 mM PMSF) or GST-tag buffer (containing 
complete protease inhibitor cocktail and 1 mM PMSF) depending on the type o f  
recombinant protein to be purified. 1 ml o f  10 mg/ml lysosyme in the same buffer was then 
added and the tube was inverted several times and vortexed to ensure proper mixing. This 
was then incubated on ice for 30 min until the contents had become very viscous due to 
cell lysis. The lysate was then sonicated four times for 30 sec each using a 0.8 mm tapered 
Dawa Ultrasonics probe at 50 watts with a 30 sec pause between sonications. The lysate 
was then clarified by centrifugation for 15 min at 10,000 rpm in a Beckman JA-20 rotor at 
4°C. The lysate was then transferred to a 50 ml centrifuge tube containing 2.5 ml o f  
washed nickel NTA-agarose (for His-tagged proteins; Qiagen) or glutathione-sepharose 4B 
(for GST-fusion proteins; Pharmacia) beads. The tube was sealed with parafilm and placed
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on a roller mixer for 2 h at 4°C. Following centrifugation at 2000 rpm for 5 min in a 
benchtop centrifuge, the supernatant was removed and the beads were washed five times in 
50 ml His-tag buffer (for His-tagged proteins) or PBS (for GST-fusion proteins). The beads 
were transferred to a column consisting o f a 5 or 10 ml syringe barrel plugged with a small 
disc o f Whatman filter paper. 5 ml o f His-tag elution buffer (His-tag buffer containing 200 
mM imidazole, pH 7.0) or GST-tag elution buffer (10 mM reduced glutathione in 50 mM 
Tris, pH 8.0) were then added to the column and 1 ml fractions were collected from the 
bottom o f the column. The protein concentrations o f the fractions were determined as 
described in section 2.2.4.1 and those eontaining the most protein were pooled and 
dialysed into PBS using slide-a-lyzer dialysis cassettes (Pierce). The purity o f the protein 
was assessed by SDS-PAGE followed by Coomassie staining o f the gel (see sections 
2.2.4.2 and 2.2.4.3).
Chapter 3
A yeast two-hybrid screen for Arts effectors
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Introduction
3.1.1 ADP ribosylation factors
The ADP ribosylation factor (Arf) family o f small molecular weight GTP-binding proteins 
forms one branch o f the Ras superfamily. It is itself further subdivided into Arfs and Arf- 
like proteins called Arls. There are six known mammalian Arf isoforms (Arfl-6) 
categorised into three classes based on sequence homology and size. Class I Arfs include 
Arfs 1, 2 & 3, class II comprises Arfs 4 & 5 while Arf6, the least conserved family 
member, is the sole member o f class III. There are also a number o f  Arls so far described 
but these have been less well studied. As with all Ras-like GTPases, Arfs cycle between 
active and inactive conformations when GTP- and GDP-bound, respectively, and these 
states can be mimicked by point mutations (Fig. 3.1.1). Arfs have almost no detectable 
intrinsic GTPase activity, and hence GTP hydrolysis is catalysed by accessory GTPase 
activating proteins (GAPs) and GDP/GTP exchange is mediated by guanine nucleotide 
exchange factors (GEFs), which contain Sec7 domains (reviewed in Donaldson and 
Jackson, 2000). Upon GTP binding, conformational changes occur such that the Arf N- 
termini, which are the regions with the greatest sequence diversity, become exposed 
allowing for interactions with membranes and downstream effector molecules. 
Importantly, Arfs are myristoylated on position 2 glycine residues and these moieties are 
required for in vitro and in vivo activities. Arfs generally cycle on and o ff membranes 
depending on their nucleotide status and this is central to their function (see section 1.3).
Arf6 is the most divergent member o f the family in terms o f primary amino acid sequence. 
It also differs from the other Arfs in that in its active state, it is located at the plasma 
membrane, where it regulates endosomal recycling to the plasma membrane (D’Souza- 
Schorey et al., 1995), GLUT4 exocytosis and adipsin secretion in adipocytes (Millar et al., 
1999; Yang and Mueckler, 1999), and clathrin endocytosis (Altschuler et al., 1999). It also 
seems to be a major player in the regulation o f the cortical actin cytoskeleton (see section 
1.3.5). By contrast, Arfs 1-5 are reported to reside intracellularly in and around the Golgi 
complex. O f these isoforms, Arfl is by far the best characterised and its role in coatomer 
and clathrin coat formation is very well documented (Schekman and Orel, 1996; Brodsky 
et al., 2001). All Arf isoforms are virtually indistinguishable in a number o f assays 
including the ADP-ribosylation o f  Gs catalysed by cholera toxin, the activation o f  
phospholipase D, the recruitment o f coat complexes to Golgi membranes and the rescue o f  
lethal arfr/arf2' double mutation in Saccharomyces cerevisiae (Boman and Kahn, 1995).
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Fig. 3.1.1 The Arf GTPase cycle.
Inactive cytosolic Arfs are activated by GDP/GTP exchange catalysed by 
exchange factors containing Sec7 domains (GEFs). This causes a 
conformational change allowing interaction with downstream effector 
molecules and membrane association via an N-terminal myristoyl moiety. 
GTP hydrolysis is then catalysed by GTPase activating proteins (GAPs) 
returning the Arf to its inactive form. GTP binding is defective in T31N 
mutants (T27N for Arf6) resulting in a GDP-locked form, whereas a Q71L 
mutation (Q67L for Arf6) results in a GTPase deficient GTP-locked form.
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It had generally been accepted by many researchers that the class I and II Arfs have 
overlapping or redundant roles since, for example, Arfl and Arf5 are equally effective at 
recruiting the adaptor AP-1 to purified Golgi membranes (Liang and Komfeld, 1997). 
While this may be true for some assays, there is recent evidence to suggest that there are 
probably some class-specific functions as well. Firstly, an Arf GEF, G BFl, was cloned 
from CHO-Kl cells and shown to exhibit specificity for Arf5 in vitro, suggesting a unique 
Arf5 pathway (Claude et al., 1999). Secondly, a yeast two-hybrid screen led to the 
discovery o f  Arfophilin, a class Il/III-specific and GTP-dependent Arf interacting protein 
(Shin et al., 1999; Shin et a l, 2001). Furthermore, work fi’om this laboratory showed that 
the addition o f a myristoylated synthetic peptide corresponding to the unique N-terminus 
o f Arf5 to permeabilised 3T3 LI adipocytes inhibited insulin-stimulated GLUTl and 
transferrin receptor translocation to the plasma membrane (Millar et a l, 1999). Analogous 
Arfl or Arf6 peptides could not mimic this effect, again suggestive o f an Arf5-specific 
pathway (Millar et a l, 1999). Also consistent with the notion that class I and II Arfs are not 
completely interchangeable and perform some distinct functions is the finding that the PDZ 
domain o f PICKl specifically interacts with GTP-bound class I Arfs but not class II Arfs 
(Takeya et a l, 2000).
3.1.2 The yeast two-hybrid system
The yeast two-hybrid system was first described just over a decade ago (Fields and Song, 
1989), and it has since become a widely used tool for detecting protein-protein 
interactions. It is an exceptionally powerful technique as it can be used to screen whole 
cDNA libraries from any organism and can rapidly provide cloned cDNAs o f proteins 
interacting with a chosen protein o f interest. The GAL4 system is perhaps the most widely 
used two-hybrid system and it is based on the fact that the GAL4 yeast transcription factor 
is comprised o f  two separable domains, a DNA binding domain that recognises a specific 
upstream activating sequence (UAS) and a transcriptional activation domain that recruits 
the cellular transcription machinery. These two domains can be expressed from plasmids in 
yeast as proteins fused to putative interacting partners o f  interest, proteins X and Y. If 
proteins X and Y do interact, they bring the two GAL4 domains into sufficient proximity 
to one another to allow transcription o f any genes under the control o f  a GAL4 UAS 
promoter. Yeast reporter strains have been engineered to have auxotrophic amino acid 
biosynthesis genes under the control o f such promoters. Therefore, these yeast strains are 
only able to survive on media lacking the particular amino acids when there is an
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interaction between proteins X and Y. A simplified diagram o f  the yeast two-hybrid system 
is shown in Fig. 3.1.2.
Yeast two-hybrid screens have helped uncover many interactions and pathways involved in 
intracellular protein trafficking (reviewed in Stephens and Banting, 2000). They have been 
particularly successful when functional relevance has been built into the screening strategy. 
One such example was a sereen for proteins that interacted with the cytosolic acidic cluster 
domain o f furin. It was known that this domain was reversibly phosphorylated and that this 
was involved in the trafficking o f the protein. Therefore, a screen was performed by using 
a bait consisting o f a mutant furin domain mimicking the phosphorylated form and then 
counter-screening with a mutant corresponding to the non-phosphorylated form, and 
looking for a loss o f interaction with the latter. This strategy yielded PACS-1, which does 
indeed mediate the trafficking o f  furin in a phosphorylation-dependent manner (Wan et al., 
1998). Another well-planned screen identified TIP47 as a cargo selection device involved 
in mannose-6-phosphate receptor trafficking (Diaz and Pfeffer, 1998). Here the authors 
looked for proteins that would interact with the cytosolic tails o f  both the cation-dependent 
and -independent isoforms, which are structurally unrelated.
Systematic and large-scale yeast two-hybrid screening to identify any binary interacting 
partners has already been performed (reviewed in Uetz and Hughes, 2000) and one 
particular study using Saccharomyces cerevisiae open-reading frames identified 957 
putative interactions involving 1004 different yeast proteins (Uetz et al., 2000). While this 
is a useful strategy for rapidly producing maps o f putative protein-protein interactions, 
such an approach would fail to uncover many important interactions. One type o f  
interaction that would be missed would be that o f  Ras-like GTPases interacting with their 
effectors. Because o f the transient, GTP-dependent nature o f such interactions in vivo, they 
cannot usually be detected in the two-hybrid system using the GTPases in their wild type 
conformations. Nevertheless, when tailored to specific small G proteins, the yeast two- 
hybrid system has been instrumental in identifying their downstream effector molecules 
(see Table 3.1.1 for some examples). This has been aided by the fact that there are known 
mutations that mimic GTP and GDP bound conformations, that were originally identified 
in Ras but analogous ones are found throughout the family, including the Arfs (Kahn et al., 
1995). By definition, an effector molecule should only interact with a GTP-liganded G 
protein, so these mutations offer excellent intrinsic controls that can be incorporated into 
the screening strategy to discount potential false-positives. As these mutations can often 
have toxic effects on the yeast host, however, very low-level expression plasmids are
91
A  DNA-binding domain fusion
Reporter gene OFF
UAS
B  Activation domain fusion
Reporter gene OFF
UAS
Reconstituted active transcription factor
ON
UAS
Fig. 3.1.2 The principle of the yeast two-hybrid system.
DNA-binding domain (BD) and transcription activation domain (AD) fusion 
proteins are engineered and expressed from plasmids in a yeast reporter 
strain. A. The BD fused to protein X binds to upstream activating 
sequences (UAS) but cannot itself activate transcription. B. The AD fused 
to protein Y is similarly unable to activate transcription in the absence of a 
DNA-binding domain. C. Interaction between proteins X and Y 
reconstitutes a functional transcription factor resulting in transcription of 
reporter genes, such as HIS3 or LacZ, providing a read-out for the 
interaction. (Adapted from Stephens & Banting, 2000).
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preferable if  not essential. Another important consideration is the removal o f prénylation 
motifs, such as the C-terminal CAAX motif in Rab proteins, as these can interfere with the 
targeting o f  the fusion proteins, which must o f course enter the nucleus for the system to 
work. When properly implemented, such screens have successfully identified many 
binding partners for Rabs, Arfs/Arls, Rho family GTPases, Ran and Ras itself (see Table 
3.1.1 for some examples for the Arf, Rab and Rho families).
Arfs are ubiquitous and abundant proteins, but the current repertoire o f Arf effectors seems 
rather small. As this is especially the case for the class II Arfs, it was decided to perform a 
yeast two-hybrid screen for Arf5 effectors using the constitutively active Arf5Q71L mutant 
as bait. The specific aim o f this chapter was, therefore, to perform such a screen and 
identify putative effectors based on selective interaetions with the Q71L but not the T31N 
mutant o f Arf5. A  further aim was to assess the specificity o f any interacting proteins for 
the different Arf isoforms, again using the two-hybrid system.
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GTPase
Arf
Class I Arfs
Arf5
Arl6
Rab1
RabS
Rab4
Rab5
Rab6
Rab7
Rab8
RabQ 
Rab 11
Rho
Rho/Raci
Cdc42
Rho/Rac/Cdc42
Rac
Putative Effector
Arfaptin 1 & 2
MKLP1
GGA 1-3
PICKl
Arfophilin
Sec6ip
GM130
RabinS
Rabip4
cytoplasmic dynein light chain-1
RabaptinS
RabaptinSp
RabSip
Rabkinesin-6
Rab7-RIPL
RabSip
FIP-2
p40
Rab11BP/Rabphilin-11
Myosin Vb
rhotekin
rhophilin
citron
WASP
Cip4
SPECS
kinectin
Plexin-B
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Table 3.1.1 Putative small GTPase effectors Identified by yeast two-hybrid 
screening.
Some examples of putative effector proteins for small Ras-like GTPases of the Arf, 
Rab and Rho families that have been identified by yeast-two hybrid screening. 
While this is not an exhaustive list, it demonstrates the power of the technique in 
this particular application.
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3.2 Materials & Methods
3.2.1 Yeast media
YPD powder was purchased from Sigma and dissolved in distilled water according to the 
manufacturer’s instructions. This was sterilised by autoclaving and allowed to cool. A  
0.2% (w/v) sterile-filtered solution o f adenine hemisulphate (Sigma) was prepared and 
used to make YPAD which had a final concentration o f 0.003% adenine. For agar plates 
(containing 20 g/L agar), the sterilised media were allowed to cool to 55-60°C before the 
addition o f adenine and subsequent pouring.
Quadruple-dropout synthetic selection media consisted o f  0.67% (w/v) yeast nitrogen base 
(Difco), 2% (w/v) glucose and 0.01% (w/v) each o f alanine, arginine, asparagine, aspartic 
acid, cysteine, glutamine, glutamic acid, glycine, inositol, isoleucine, lysine, methionine, 
phenylalanine, proline, serine, threonine, tyrosine and valine and 0.001% para- 
aminobenzoic acid (all from Sigma). Leucine and histidine were added as appropriate to 
give final concentrations o f 0.002% and 0.001%, respectively. The media were sterilised 
by autoclaving and allowed to cool. If required, a 0.2% (w/v) sterile-filtered solution o f  
adenine hemisulphate (Sigma) was then added to a final concentration o f 0.003%. For agar 
plates (containing 20 g/L agar), the sterilised media were allowed to cool to 55-60°C 
before the addition o f adenine and subsequent pouring.
3.2.2 Constructing the bait piasmids
Murine Arf5Q71L and Arf5T31N cDNAs were obtained from Dr. J. Tavare (University o f  
Bristol). These were then PCR amplified using Pfu polymerase and primers 5 ' - 
GGGagatctccATGGGCCTCACGGTGTCCGCG-3 ' {Bglll ûXq in small letters, initiating codon in 
bold) and 5 ' -GGGctcgagTCAGCGCTTTGACAGCTCGTGGGA-3' {Xhol site in small letters, 
STOP codon in bold). The resulting products were TA cloned into pCRII-TOPO, 
sequenced and subcloned into the BamHI and Sail sites o f pGBT9, all according to the 
methods in chapter 2 and producing plasmids pGBT9-Arf5Q71L and pGBT9-Arf5T3 IN  
(see the appendix).
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3.2.3 Small-scale yeast transformations
Yeast reporter strain PJ69-2A (Clontech) was cultured on YPAD agar plates, with a fresh 
plate being streaked out every three weeks. A match head sized ball o f  yeast cells were 
used to inoculate a starter culture in 25 ml o f sterile YPAD medium in a 100 ml flask that 
was grown overnight at 30 °C with shaking at 200 rpm. This starter culture was then used 
to inoculate 200 ml o f  YPAD in a 1 L flask to give a starting ODeoo o f between 0.1-0.2. 
This was then further cultured at 30 "C with shaking at 200 rpm until the OD^oo reached 
0.5-0.6 (typically 3-4 h). At this point the cells were harvested by centrifugation at 2000 
rpm for 5 min at room temperature in 50 ml Falcon tubes in a Beckman bench-top 
centrifuge. The pelleted cells were resuspended and pooled in 50 ml sterile water and spun 
again. All traces o f water were removed and the cells were resuspended in 1.5 ml freshly 
prepared sterile 100 mM Li Ac in 1 x TE buffer. 100 pi o f  cells were then added to sterile
1.5 ml centrifuge tubes containing 10 pi o f salmon sperm carrier DNA (Sigma) at a 
concentration o f 10 mg/ml and also containing 1 pi o f  each plasmid to be transformed. 
These were then briefly mixed by vortexing and 0.6 ml freshly prepared sterile 5% PEG- 
3350/100 mM LiAc solution was added to each tube. After a 10 second vortex, these were 
incubated at 30 °C for 30 min with shaking at 300 rpm. 70 pi o f  DMSO were then added to 
each tube and these were mixed by inversion and then heat-shocked for 15 min at 42 °C in 
a water bath. The tubes were then placed on ice for 1 min and centrifuged for 5 seconds in 
a microcentrifuge. The supernatants were removed by aspiration and the cell pellets were 
resuspended in 0.5 ml sterile TE. 200 pi from each transformation were then plated onto 
the appropriate synthetic medium selective for the transformed plasmids (lacking leucine 
and tryptophan if  pGBT9 and pACT2 plasmids were co-transformed). After 3 or 4 days o f  
growth at 30 ®C, colonies were picked with sterile yellow pipette tips and restreaked onto 
selective media also lacking histidine (triple dropout, TDO) or histidine and adenine 
(quadruple dropout, QDO) to look for the reconstitution o f transcriptional activation and 
hence interactions.
3.2.4 Yeast two-hybrid screening
A schematic o f the two-hybrid system used in this study is given in Fig 3.2.1 The screens 
were performed essentially according to the TRAFO protocol (Agatep et al., 1998; 
Parchaliuk et al., 1999) (see also http://www.umanitoba.ca/faculties/medicine/units/ 
human_genetics/gietz/2HS.html). Since greater transformation efficiency is achieved if  
sequential transformation is performed, a bait strain containing pGBT9-Arf5Q71L was
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produced by performing a small-scale transformation, as described above, and it was 
selected for on medium lacking tryptophan. This was then cultured overnight at 30 “C with 
shaking at 200 rpm in 50 ml SC media lacking tryptophan to maintain the presence o f the 
plasmid. This was then sub-cultured into 150 ml YPAD medium to give an OD^oo o f 0.1 (5 
X 10  ^ cells/ml) and grown until the OD^oo reached 0.4 (2 x 10  ^ cells/ml). The cells were 
then harvested and washed as in section 3.2.3, and resuspended in fresh 100 mM LiAc in 
TE to give a total volume o f 4 ml. This was then divided into 6 aliquots o f 0.6 ml in 15 ml 
sterile Falcon centrifuge tubes. To these were added, and in the following order, 960 pi 
50% PEG-3350, 216 pi 1 M LiAc, 300 pi salmon sperm carrier DNA (at a concentration o f  
2.0 mg/ml, boiled for 5 min and chilled on ice for 5 min), and 204 pi o f water containing 
60, 600, or 6000 ng o f human testis or human brain cDNA libraries in pACT2 and 
pGADlO vectors, respectively (both from Clontech). These were then vigorously vortexed 
for 10 seconds and incubated at 30 ‘’C for 30 min. This was followed by a 15 min heat- 
shock at 45 “C in a water bath. During this time, the tubes were gently agitated every 1-2 
min to ensure even heat distribution. The tubes were then chilled on ice for 2 min and 
centrifuged briefly to pellet the cells. All o f the supernatant was removed and the cells 
were resuspended in 2 ml sterile water. 2 pi from each transformation were added to 100 pi 
of water and plated onto a -leu/-trp plate to monitor the transformation efficiency, while 
the remaining cells were pooled according to the library that was transformed and these 
were then each plated onto a total o f six 150 mm triple dropout selection plates lacking 
histidine as well as leucine and tryptophan. These plates were then incubated at 30 ®C for 
3-6 days and any colonies appearing during this time were picked and restreaked onto fresh 
triple and quadruple dropout plates awaiting further analysis.
3.2.5 Extraction of DNA from yeast cells
Crude DNA extractions were performed as follows on the yeast clones o f interest. A  match 
head sized ball o f cells scraped from a fresh plate were resuspended in 1 ml o f water in a
1.5 ml centrifuge tube. These were then pelleted by centrifugation at 10,000 g for 2 min 
and resuspended in 0.5 ml buffer S (10 mM K2HPO4, pH 7.2; 10 mM EDTA; 50 mM (3- 
mercaptoethanol; 50 pg/ml zymolase). Following incubation at 37 °C for 30 min, 100 pi o f  
lysis buffer (25 mM Tris-HCL, pH 7.5; 25 mM EDTA; 2.5% (w/v) SDS) were added. The 
tubes were then vortexed and incubated for a further 30 min at 65 °C. Then 166 pi o f 3 M 
potassium acetate were added to each tube and these were mixed by inversion and 
incubated on ice for 10 min. The tubes were then spun in a microcentrifuge for 10 min at
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‘prey’ plasmid
LEU2
cDNAX
Gal4 AD AmpR
‘bait’ plasmid
Gal4 BD
Arl5Q71LAmpR
TRP1
Protein X
Arf5Q71L
Reporter gene {HIS3)
GAL1 UAS Reporter strain PJ69-2A
Reporter gene {ADE2)
GAL2 UAS
Fig. 3.2.1 Schematic of the yeast two-hybrid system used in this 
study.
The yeast strain PJ69-2A has two reporter genes H/S3 and ADE2 under 
the control of a GAL4 promoter. Arf5Q71L fused to the GAL4 DNA binding 
domain (BD) is expressed from a plasmid (pGBT9) that also contains a 
TRP1 marker. Putative interacting proteins (X) are expressed as fusions to 
the GAL4 activation domain (AD) from a plasmid containing a LEU2 
selectable marker. If a protein X interacts with Arf5Q71L, the GAL4 
transcription factor is reconstituted and the yeast can grow on media 
lacking histidine and adenine.
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full-speed, the supernatants were aspirated and discarded and the pellets were washed with 
1 ml 70% ethanol. The pellets, containing a mixture o f genomic and plasmid DNA, were 
then air dried and resuspended in 40 |il distilled water.
3.2.6 Recovery of prey plasmids
As both the bait plasmid pGBT9 and the prey plasmids pACT2/pGAD10 have ampicillin 
resistance as their selectable marker for growth in Escherichia coli, it was necessary to 
recover the prey plasmids o f interest by using nutritional selection. KC8 strain o f  
Escherichia coli requires leucine to be added to growth medium, so transformants 
containing the pACT2 or pGADlO plasmids (which have a yeast LEU2 marker) should 
grow on media lacking leucine, while transformants containing the pGBT9 plasmid should 
not. 50 jLil o f  electrocompetent KC8 cells were then placed at the bottom o f pre-chilled 
sterile electroporation cuvettes (Bio-Rad) together with 1 pi extracted yeast DNA. These 
were then electroporated in a Bio-Rad Genepulser at 2.5 Mv with the capacitance set at 25. 
The cells were then gently recovered in 1 ml LB broth and incubated for 1 h at 37 ”C 
without agitation. The cells were then pelleted by centrifugation at 4000 rpm for 1 min in a 
microcentrifuge, resuspended in 50 pi o f sterile water and plated onto M9 minimal media 
agar plates lacking leucine. Colonies appearing after 24-30 h o f growth at 37 °C were 
picked and cultured overnight in 3 ml LB broth containing 100 pg/ml ampicillin. Small- 
scale DNA preparations were then performed according to the protocol in section 2.2.1.11 
and the purified plasmids were digested with B glll and EcoRI to verify that the correct 
plasmids had been rescued and also to verify the sizes o f the inserts within those plasmids.
3.2.7 Retransformation of recovered piasmids
Following the rescue o f the pACT2/pGAD 10 prey plasmids encoding the putative Arf5- 
interacting proteins, it was necessary to retransform these back into the yeast strain 
together with the bait pGBT9-Arf5Q71L plasmid to ensure that the yeast were indeed 
growing as a result o f the plasmids and not due to some mutation or anomaly. At the same 
time, the prey plasmids were also retransformed together with the pGBT9-Arf5T31N 
plasmid to check whether interactions were specific for the GTP-bound mutant and not the 
GDP-bound mutant, as would be predicted for any effector protein. All transformations 
were carried out exactly as in section 3.2.3.
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3.2.8 Immunoblot analysis of yeast proteins
Immimoblot analysis was also performed o f the yeast expressing the putative positives as 
GAL4 activation domain fusion proteins. Samples for SDS-PAGE were prepared as 
follows: match head sized balls o f cells from fresh plates were resuspended in 1 ml water 
in 1.5 ml microcentrifuge tubes. 100 pi 1.85 M NaOH containing 7.5% (v/v) p- 
mercaptoethanol were then added, and the tubes were incubated on ice for 10 min. 150 pi 
o f 55% (w/v) trichloroacetic acid were then added and the tubes were further incubated for 
10 min on ice. These were then centrifuged at full-speed for 10 min at 4”C. The 
supernatants were discarded and the precipitated proteins were resuspended in 200 pi HU 
buffer (8 M urea; 5% (w/v) SDS; 200 mM Tris-HCl pH 6.8; 0.1 mM EDTA; 0.5 mg/ml 
bromophenol blue; 10% (v/v) p-mercaptoethanol). The samples were then boiled for a few 
min and a few microlitres o f IM Tris-base were added if  the solutions turned yellow. 20 pi 
o f each sample were run on 10% or 15% SDS-PAGE gels and immunoblotted using a 
monoclonal anti-haemagglutinin (HA) antibody (Santa Cruz, F7 probe), all according to 
the protocols in section 2.2.4. This antibody recognises a HA epitope situated between the 
GAL4 activation domain and any protein fused to it encoded by the pACT2 vector.
3.2.9 Sequence anaiysis
Prey plasmids that appeared to confer GTP-dependent interactions with Arf5, were 
digested with B glll to determine the sizes o f the inserts, and subjected to automated 
sequencing. This was initially performed according to the procedure outlined in section 
2.2.1.14 using a primer designed against the GAL4 activation domain sequence 5 ' -  
TACCACTACAATGGAT-3'. Internal forward and reverse sequencing primers were then 
designed and used to sequence the whole inserts. Sequences obtained were then analysed 
in Editview and by BLAST searching against the public non-redundant and EST databases 
(at http://www.ncbi.nlm.nih.gov/blast/) .
3.2.10 Cioning and mutagenesis of other A rf proteins
Bovine ArflQ71L and ArflN126I (another dominant negative GTP-binding defective 
mutant) were amplified by PCR from pre-existing plasmids obtained from Dr. S. Cockcroft 
(University College London), using primers 5 ' -ggatccCCATGGGGAACATCTTCGCCAACC-3' 
{BamHI site in small letters) and 5' -ctcgagTCACTTCTGGTTCCGGAGCTG-3 ' {Xho I  site in 
small letters) and subcloned into the BamHI and Sail sites o f pGBT9 exactly as described
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for Arf5 in section 3.2.1. Arf6Q67L and Arf6T27N pGBT9 constructs were similarly 
generated by amplifying the ORFs from plasmids obtained from Dr. J. Donaldson (NIH, 
Bethesda), using primers 5 ' “GGGagatctccATGGGGAAGGTGCTATCCAAA-3 ' {Bgl II site in 
small letters, start codon in bold) and 5 ' -GGGctcgagTTAAGATTTGTAGTTAGAGGTTAA-3 ' 
{Xho I  site in small letters, stop codon in bold).
Arf2 was amplified by two rounds o f PCR from a murine Marathon-Ready cDNA library
(Clontech) using primers S ' -GggatccCCATGGGGAATGTCTTTGAAAAGCTGTTTAA AAGCC-3' 
{BamHI site in small letters, start codon in bold) and 5 ' -G ctcgagT C A  
CTTCTGGTTTTTGAGCTGGTTGGAGAG-3 ' {Xho I  site in Small letters, stop codon in bold). Arf3 
and Arf4 cDNAs were amplified from a human foetus Marathon-Ready library (Clontech) 
using primers 5 ' -GggatccCCATGGGCAATATCTTTGGAAACCTTCTCAAG-3' {BamHI site in 
small letters, start codon in bold) and s ' -GctcgagTCACTTCTTGTTTTTGAGCTGATTGGCCAG- 
3 ' {Xho I  site in small letters, stop codon in bold), and 5 ' -GggatccCCATG  
GGCCTCACTATCTCCTCCCTCTTCTCC-3 ' {BamHI sitc in small letters, start codon in bold) and 
5 ' -GctcgagTTAACGTTTTGAAAGCTCATTTGACAGCCAGTC-3 ' {Xho I  site in Small letters, Stop 
codon in bold), respectively. These were then TA cloned into pCRII-TOPO vector 
(Invitrogen) and subjected to QuikChange site-directed mutagenesis to produce the active/ 
inactive mutants, all according to the protocols described in Chapter 2. These were then 
sequenced and subcloned into the BamHI and Sal I  sites o f  pGBT9. The pairs o f mutagenic 
primers used to produce the indicated mutants were as follows, with changes in bold:
Arf2Q71L: 5 ' - tgggatgttggtggcctggacaaaattagacct-3  '
3 ' - ACCCTACAACCACCGGACCTGTTTTAATCTGGA-5'
Arf2T3 IN : 5 ' - gatgcagctggcaaaaacacgatcttgtacaaa- 3 '
3 ' -CTACGTCGACCGTTTTTGTGCTAGAACATGTTT-3'
Ai'f3Q71L: 5 ' - tgggatgtgggtggcctggacaagattcgaccc-3  '
3 ' -ACCCTACACCCACCGGACCTGTTCTAAGCTGGG-5'
Arf3T3 IN : 5 ' - gatgccgcaggaaagaacaccatcctatacaag- 3 '
3 ' -CTACGGCGTCCTTTCTTGTGGTAGGATATGTTC-5'
Arf4Q71L: 5 ' - t g g g a t g t t g g t g g t c t a g a t a g a a t t a g g c c t - 3 '
3 ' -ACCCTACAACCACCAGATCTATCTTAATCCGGA-5'
Arf4T3IN : 5 ' - g a t g c t g c t g g c a a g a a c a c c a t t c t g t a t a a a - 3 '
3 ' "CTACGACGACCGTTCTTGTGGTAAGACATATTT-5'
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3.2.11 Production of Arf4/Arf5 chimeras
This work was performed jointly with Sam Yarwood, and an outline o f the strategy used to 
produce the Arf4/Arf5 chimeras is given in Fig. 3.2.1, Constructs containing Arf4Q71L 
and Arf4T31N in the pCRII vector, that were obtained in section 3.2.9, were subjected to a 
further round o f  site directed mutagenesis to introduce an ztcc /  restriction site at position 
276 o f the ORFs. This required a single base substitution (T-C) at position 280, a mutation 
that would not affect the amino acid composition o f the resulting polypeptide. The primers 
used were 5 ' - cccagggtcttatttttgtggtagacagca  a c g a tcg tg aaag aattcag -3  ' and 5 ' - 
CTGAATTCTTTCACGATCGTTGCTGTCTACCACAAAAATAAG ACCCTGGG-3 ' and the presence o f the 
desired mutation and the absence o f  undesired ones were verified by automated 
sequencing. Arf5Q71L and Arf5T31N cDNAs also in pCRII had pre-existing /  sites at 
the same position and all four constructs had been TA cloned in the same orientation into 
the vector, such that the 5 ’ end o f the ORFs were nearer the T7 promoter than the SP6 
promoter. This then allowed the isolation o f Kpn I  and Acc I  digested 5 ’ ends, which could 
then be swapped and religated to produce N5-Arf4Q71L, N5-Arf4T31N, N4~Arf5Q71L 
and N4-Arf5T31N (see Fig. 3.2.1, and the appendix). These chimeric cDNAs were then 
subcloned into the BamHI and Sal I  sites o f pGBT9. All DNA manipulations were using 
the standard molecular biology procedures outlined in Chapter 2.
1 0 2
1 HumanHumanArf4 Arf 5MGLTISSLFSRLFGKKQMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNMGLTVSALFSRIFGKKQMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKN6060
HumanHumanArf 4 Arf5
ICFTVWDVGGQDRIRPLWKHYFQNTQGLIFWDSNDRERIQEVADELQKMLLVDELRDAVICFTVWDVGGQDKIRPLWRHYFQNTQGLIFWDSNDRERVQESADELQPCMLQEDELRDAV120120
HumanHumanArf4Arf5
LLLFANKQDLPNAMAISEMTDKLGLQSLRNRTWYVQATCATQGTGLYEGLDWLSNELSKRLLVFANKQDMPNAMPVSELTDKLGLQHLRSRTWYVQATCATQGTGLYDGLDWLSHELSKR180180
Arf4 Acc I
5' -CCCAGGGTCTTATTTTTGTGGT AGACAGCAAGCATCGTGAAAGAATTCAG-3 '
3 ' -GGGTCCCAGAATAAAAACACCATCJrGTCGTTCGTAGCACTTTCTTAAGTC-5'
B Kpn Ii Acc Ii pCRIIvectors
ATG Arf 4 Arf 4 TA AI
ATG ArfS Arf 5 TA A
X h o l
ATG Arf 4 Arf5 TAAi
ATG Arf 5 Arf4 TAA
Fig. 3.2.2 The construction of Arf4/Arf5 chimeras.
Panel 1: Amino acid sequence alignment of Arf4 and Arf5. The 18 non-identical 
residues are in bold and the position where the N-termini were swapped is 
underlined. Panel 2: Strategy for producing chimeras. A, oligonucleotide primers 
used to produce a silent mutation at base 276 (in bold) of the Arf4 ORF to 
introduce an A cc I  restriction site (underlined). B, Arf4(276C) and ArfS pCRII 
plasmids were then digested with Kpn I and Acc 1. C, The resulting inserts were 
then swapped and ligated to the other vector sequences to produce chimeric Arf 
cDNAs. These were then subcloned into pGBT9 using the Bgl II and Xho 1 sites 
as indicated. Although not shown, the entire procedure was performed using 
both T31N and Q71L mutants of Arf4 and Arf5. These DNA manipulations were 
performed jointly with S. Yanvood.
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3.3 Results
Arf5 constitutively active (Q71L) and dominant negative (T31N) mutants were subcloned 
into vector pGBT9 in frame with the GAL4 DNA binding domain, as described in section 
3.2.1. This vector uses a truncated ADH  promoter that gives rise to very low-level 
expression in yeast, which is necessary to reduce the toxic effects that would otherwise be 
apparent upon constitutively active Arf expression (Deitz et al., 1996). It was then 
necessary to check that the expression o f the constructs did not allow growth on media 
selective for an interaction, in the presence o f the ‘empty’ prey plasmid pACT2, since any 
growth would render the screen unworkable. This was performed in the reporter strain 
PJ69-2A which has two reporter genes under the control o f  GAL4: HIS3 and ADE2. This 
allows for two levels o f  stringency for selecting for an interaction: medium stringency by 
monitoring growth on media lacking histidine, and high stringency requiring the activation 
o f both genes. The plasmids were co-transformed as described in section 3.2.3 and no 
growth was observed on media lacking histidine showing that the constructs did not allow 
auto-activation (data not shown). Immunoblots o f yeast transformed with these plasmids 
were also performed using a monoclonal antibody against the GAL4 DNA-binding domain 
to check for expression o f the fusion constructs. This revealed bands with apparent 
molecular weights o f  approximately 40 kDa, as expected (data not shown).
At the outset, the intention was to perform large-scale screens but as it turned out, this was 
not necessary. Pilot scale screens were performed by producing a bait strain, pGBT9- 
Arf5Q71L in PJ69-2A and then transforming this with human brain and testis libraries in 
pGADlO and pACT2, respectively. This gave rise to approximately 60,000 transformants 
that were plated onto synthetic media lacking leucine, tryptophan and histidine (triple 
dropout) to select for the plasmids and any interactions. Colonies appearing within 5 days 
o f growth at 30 °C, were then picked and restreaked onto the same media, and media also 
lacking adenine (quadruple dropout) as a higher stringency selection for interactions. At 
this stage there were 3 colonies from the brain screen and 23 colonies from the testis 
screen. DNA was then recovered from the yeast and the prey plasmids were isolated as 
described in sections 3.2.5 and 3.2.6. These were then retransformed into PJ69-2A yeast 
together with pGBT9-Arf5Q71L or pGBT9-ArfST3 IN constructs and plated onto -Leu/Trp 
plates. The resulting co-transformants were then streaked onto triple and quadruple dropout 
selection media to ascertain whether the HIS3 and ADE2 reporter genes were activated. 
One plasmid from the brain library (designated clone B l)  and eight from the testis library 
(clones T3, T4, T9, T12, T14, T17 and T20) allowed growth under these conditions when
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CO-transformed with the pGBT9-Arf5Q71L construct but not with the pGBT9-Arf5T31N 
dominant negative construct (see Figs. 3.3.1-3.3.5 and Table 3.3.1). The plasmids 
conferring these specific interactions were then digested with B g lll to determine the insert 
sizes, and were sequenced using a plasmid-specific primer as described in section 3.2.8 and 
analysed by BLAST searching. The results are summarised in Table 3.3.1.
Immunoblot analyses o f the yeast expressing the different GAL4-activation domain fusion 
proteins were also performed to check for the expression and sizes o f the proteins 
produced. This revealed that T4, T14, T17 and T20 clones expressed fusion proteins o f  
approximately 100 kDa (Fig. 3.3.6), while T9 only encoded a protein o f about 35-40 kDa. 
Curiously, no fusion protein was detected in cells transformed with the T3 plasmid (Fig. 
3.3.6). The size o f the B l clone fusion protein was not determined as the pGADlO vector, 
unlike pACT2, does not encode a HA epitope.
From the testis screen, clone T3 encoded the full open-reading frame o f Arfaptin 2/PORl 
including some 5 ’ and 3’ UTR sequences. Interestingly, the 5 ’ UTR contained a 40 bp 
insert not present in the Genbank entries and also contained a single in-ffame stop codon 
near the GAL4-AD/testis cDNA fusion junction.
A third plasmid recovered from the testis screen, T12, encoded the C-terminal half o f a 
protein present in the database as two proteins o f slightly different length (accession 
numbers AB029343 and XM_041760) but whose function is unknown. It is named HCR 
for “a-helical coiled-coil rod homologue”. The gene is on chromosome 6 near the HLA 
(human leukocyte antigen) locus where many major histocompatibility complex genes are 
found, but no other information was available at the time.
Five additional clones from testis (T4, T9, T14, T17, T20) had inserts o f varying size 
ranging from 900-2000 bp but that were all identical at their 3 ’ ends, with T4 and T20 
having the longest insert and T9 the shortest. BLAST analysis against the non-redundant 
database revealed that these came from a novel gene on human chromosome 17, aided by 
the fact that the genomic region had been fully sequenced. Further analysis revealed that 
the protein encoded by this gene shared significant homology in its C-terminus with the C- 
terminal Arf-binding domain o f KIAA0665/Arfophilin (63% identity and 79% homology; 
see Fig. 3.3.7, and in greater detail in Chapter 4), although the N-termini were divergent. It 
was, therefore, decided to name this novel protein Arfophilin-2. BLAST analysis also 
revealed homology between both Arfophilins and other metazoan proteins, but this will be 
addressed in Chapter 4.
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Fig. 3.3.1 Yeast two-hybrid Interaction assay between T3 and ArfS 
Q71L and T31N mutants.
Plasmid pACT2-T3 (encoding full-length Arfaptin 2/PORI) recovered from 
the two-hybrid screen, was co-transformed into yeast strain PJ69-2A with 
pGBT9-Arf5Q71L or pGBT9-Arf5T31 N and plated onto synthetic media 
lacking leucine and tryptophan to select for the plasmids. After 3 days of 
growth at 30 °C, six independent colonies were then restreaked onto triple 
dropout medium lacking histidine (TOO; top plates) and quadruple dropout 
medium also lacking adenine (QDO; bottom plates), to select for an 
interaction with two levels of stringency. These were then grown for a 
further 3 days at 30 °C, and then scanned to produce the image above. 
Yeast co-expressing Arf5Q71L are displayed on the right, while those 
expressing Arf5T31N are on the left. This experiment was performed 
three times with similar results.
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Fig. 3.3.2 Yeast two-hybrid interaction assay between T4 and ArfS 
Q71L and T31N mutants.
Plasmid pACT2-T4 (encoding the C-terminal 556 residues of arfophilin-2) 
recovered from the two-hybrid screen, was co-transformed into yeast 
strain PJ69-2A with pGBT9-Arf5Q71L or pGBT9-Arf5T31N and plated 
onto synthetic media lacking leucine and tryptophan to select for the 
plasmids. After 3 days of growth at 30 °C, six independent colonies were 
then restreaked onto triple dropout medium lacking histidine (TOO; top 
plates) and quadruple dropout medium also lacking adenine (QDO; 
bottom plates), to select for an interaction with two levels of stringency. 
These were then grown for a further 3 days at 30 °C, and then scanned to 
produce the image above. Yeast co-expressing Arf5Q71L are displayed 
on the right, while those expressing Arf5T31N are on the left. This 
experiment was performed three times with similar results.
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Fig. 3.3.3 Yeast two-hybrid interaction assay between T9 and ArfS 
Q71L and T31N mutants.
Plasmid pACT2-T9 (encoding the C-terminal 200 residues of arfophilin-2) 
recovered from the two-hybrid screen, was co-transformed into yeast 
strain PJ69-2A with pGBT9-Arf5Q71L or pGBT9-Arf5T31N and plated 
onto synthetic media lacking leucine and tryptophan to select for the 
plasmids. After 3 days of growth at 30 °C, six independent colonies were 
then restreaked onto triple dropout medium lacking histidine (TOO; top 
plates) and quadruple dropout medium also lacking adenine (QDO; 
bottom plates), to select for an interaction with two levels of stringency. 
These were then grown for a further 3 days at 30 °C, and then scanned to 
produce the image above. Yeast co-expressing Arf5Q71L are displayed 
on the right, while those expressing Arf5T31N are on the left. This 
experiment was performed three times with similar results.
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Fig. 3.3.4 Yeast two-hybrid Interaction assay between T12 and 
ArfS Q71L and T31N mutants.
Plasmid pACT2-T12 (encoding the C-terminal half of protein AB029343/a- 
helix coiled-coil rod homologue [HCR]) recovered from the two-hybrid 
screen, was co-transformed into yeast strain PJ69-2A with pGBT9- 
Arf5Q71L or pGBT9-Arf5T31N and plated onto synthetic media lacking 
leucine and tryptophan to select for the plasmids. After 3 days of growth at 
30 °C, six independent colonies were then restreaked onto triple dropout 
medium lacking histidine (TOO; top plates) and quadruple dropout 
medium also lacking adenine (QDO; bottom plates), to select for an 
interaction with two levels of stringency. These were then grown for a 
further 3 days at 30 °C, and then scanned to produce the image above. 
Yeast co-expressing Arf5Q71L are displayed on the right, while those 
expressing Arf5T31N are on the left. This experiment was performed 
three times with similar results.
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Fig. 3.3.5 Yeast two-hybrid interaction assay between B1 and ArfS 
Q71L and T31N mutants.
Plasmid pGAD10-B1 (encoding residues 557-756 of KIAA0665/Arfophilin) 
recovered from the two-hybrid screen, was co-transformed into yeast 
strain PJ69-2A with pGBT9-Arf5Q71L or pGBT9-Arf5T31 N and plated 
onto synthetic media lacking leucine and tryptophan to select for the 
plasmids. After 3 days of growth at 30 °C, six independent colonies were 
then restreaked onto triple dropout medium lacking histidine (TOO; top 
plates) and quadruple dropout medium also lacking adenine (QDO; 
bottom plates), to select for an interaction with two levels of stringency. 
These were then grown for a further 3 days at 30 °C, and then scanned to 
produce the image above. Yeast co-expressing Arf5Q71L are displayed 
on the right, while those expressing Arf5T31N are on the left. This 
experiment was performed three times with similar results.
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T3 T4 T12 T14 T20 T9
kDa
1 7 5 -
8 3 -
6 2 -
4 7 -
3 3 -
Fig. 3.3.6 Immunoblot analysis of yeast expressing putative 
ArfS-interacting GAL4 activation domain fusion 
proteins.
PJ69-2A yeast cells were transformed with the pACT2 plasmids 
indicated at the top and total protein extracts were prepared by 
trichloroacetic acid precipitation as described in section 3.2.4. 20 pi 
from each sample were subjected to SDS-PAGE on a 15% 
polyacrylamide gel, followed by immunoblotting with an anti- 
haemagluttinin antibody against an epitope situated between the 
GAL4 activation domain and any polypeptide fused to it. The Gal4 
activation domain has an apparent molecular weight of 20-25 kDa. T3 
encodes Arfaptin 2/PORI although no fusion protein was detected 
(see text), and plasmids T4, T9, T14 and T20 all encode arfophilin-2. 
T12 represents HCR (a-helix coiled-coil rod homologue). The 
positions of molecular weight markers (in kDa) are indicated on the 
left.
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S c o r e  = 150 b i t s  (3 8 0 ) , E x p e c t  = l e - 3 6
I d e n t i t i e s  = 9 2 /1 4 7  ( 6 3 % ) ,  P o s i t i v e s  = 1 1 6 /1 4 7  ( 7 9 % ) , G aps = 2 /1 4 7  (1%)
A r f o l :  612 QRDKEATQELIEDLRKQLEHLQLLKLEAEQ-RRGRSSSMGLQEYHSRARESELEQEVRRL 670  
Q+++EATQELIEDLRK+LEHLQ+ KL+ E+ RGRS+S GL E+++RARE ELE EV+RL 
A r f02 : 410  QKEREATQELIEDLRKELEHLQMYKLDCERPGRGRSASSGLGEFNARAREVELEHEVKRL 469
A r f o l :  671  KQDNRNLKEQNEELNGQIITLSIQGAKSLFST-AFSESLAAEISSVSRDELMEAIQKQEE 729  
KQ+N L++QN++LNGQI++LS+ AK+LF+ ++SLAAEI + SRDELMEA+++QEE 
A r f o 2 : 47 0 KQENYKLRDQNDDLNGQILSLSLYEAKMLFAAQTKAQSLAAEIDTASRDELMEALKEQEE 52 9
A r f o l :  730  INFRLQDYIDRIIVAIMETNPSILEVK- 756  
INFRL+ Y+D+II+AI++ NPSILE+K 
A r f02 : 530  INFRLRQYMDKIILAILDHNPSILEIKH 556
Fig. 3.3.7. BLAST alignm ent of Arfophîlin-1 and Arfophilin-2 C-termini.
The BLASTP output for the extreme C-terminal Arf-binding domains of 
Kiaa0665/Arfophilin (Arfol) and the novel Arfophilin-2 (Arfo2) is shown. They are 
63% identical with 79% homology. The region corresponds to the minimum Arf5 
binding domain of Arfophilin as determined by deletion analysis in (Shin et a/., 
1999). The N-termini are more divergent (see Chapter 4 for more detailed 
analyses).
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Given the high degree o f sequence similarity between the Arfs (see Fig 1.3.1 in Chapter 1), 
it was deemed important to test how specific the interactions were for Arf5. Therefore, 
murine Arf2 and human Arfs 3 and 4 were cloned from cDNA libraries, subjected to site- 
directed mutagenesis to produce Q71L and T31N point mutants, and subcloned into the 
pGBT9 yeast two-hybrid bait vector as described in section 3.2.9. Arfl and Arf6 mutants 
were similarly subcloned into the same vector from pre-existing plasmids. These were then 
tested for auto-activation and also against plasmids T3 (Arfaptin 2), B1 (Arfophilin), T20 
(Arfophilin-2) and T12 (unknown coiled-coil protein) in the yeast two-hybrid system as 
before. Slight auto-activation was observed with pGBT9-Arf6Q67L but not with any o f the 
other constructs (not shown). Fig. 3.3.8 shows the positives co-transformed with these 
constructs on triple and quadruple dropout media. No colonies grew in the presence o f any 
o f the dominant negative T-N mutants. Colonies expressing Arfaptin 2 grew very well with 
the activated class I Arfs, less well with Arfs 5 and 6, and hardly at all with Arf4. 
Conversely, Arfophilin did not allow growth with the class I Arfs on either selection 
medium, but did with the class II and III isoforms even on the high stringency quadruple 
dropout medium. It appeared to prefer Arf5, then Arf6 and Arf4 the least o f all (Fig. 3.3.8). 
Arfophilin-2 showed similar specificity although growth with Arf4 was even less 
pronounced and this construct did not allow growth on quadruple dropout selection. 
Arfophilin-2 also appeared to have a preference for Arf6 over Arf5 (Fig. 3.3.8). However, 
it should be noted that direct comparison between Arfophilin-1 and Arfophilin-2 in these 
experiments may not be entirely feasible since the fusion proteins are o f varying lengths 
and the vectors are not identical. The T12/HCR protein only allowed growth with the 
Q71L mutant o f Arf5.
Further investigation was prompted by the fact that T12 seemed specific for Arf5 and did 
not interact with Arf4, which is over 90% identical. Since the Arf N-teimini are known to 
be important sites o f  interaction with effectors, Arf4/Arf5 chimeras were generated to see 
whether the Arf5 N-terminus, which differs from that o f  Arf4 in only seven out o f  the first 
hundred amino acid residues, was responsible for the interaction. N4-Arf5 encoded Arf5 
with the N-terminus o f  Arf4, while N5-Arf4 encoded Arf4 with the N-terminus o f Arf5 
(see section 3.2.10 and Fig. 3.2.2). The corresponding Q71L and T31N mutants o f these 
chimeras were then tested, again in the yeast two-hybrid system, against the T12 protein 
and also against Arfaptin 2 (plasmid T3) and Arfophilin-2 (plasmid T20). Both N4- 
Arf5Q71L and N5-Arf4Q71L constructs allowed growth on selective media when 
cotransformed with Arfaptin 2 or Arfophilin-2 (Fig. 3.3.9). However, in the case o f the 
T12/HCR protein, growth was only observed with the N5-Arf4Q71L construct and not 
with the N4-Arf5Q71L construct. It was also apparent that N5-Arf4 mimicked Arf5 and
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N4-Arf5 mimicked Arf4 when cotransfonned with Arfophilin-2 (compare Figs. 3.3.8 and 
3.3.9).
115
ru
Class I
Class II
Class III [  Arf6
Class I
C ass
Class III [  Arf6
♦: o \
TOO
QDO
QLTN QLTN QL TN QL TN
Fig. 3.3.8 Specificity of interactions for different Arf isoforms 
using the yeast two-hybrid system.
GAL4 activation domain plasmids T3 (Arfaptin 2/PORI), B1 (Arfophilin), 
T20 (Arfophilin-2) and T12 in pACT2 recovered from the two-hybrid 
screen, were co-transformed into yeast strain PJ69-2A with Q-L and T-N 
mutants of all six mammalian Arfs in pGBT9. The yeast were plated onto 
synthetic media lacking leucine and tryptophan to select for the plasmids. 
After 3 days of growth at 30 °C, six independent colonies from each co­
transformation were then pooled in 1 ml of sterile water, diluted 100 fold 
and 10 pi from each were pipetted onto triple dropout medium lacking 
histidine (TOO; top panel) and quadruple dropout medium also lacking 
adenine (QDO; bottom panel), to select for interactions with two levels of 
stringency. These were then grown for a further 3 days at 30 °C, and 
scanned producing the images above. This experiment was performed 
three times with similar results.
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N4-Arf5Q71L N5-Arf4Q71L
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N4-Arf5Q71L N5-Arf4Q71L N4-Arf5Q71L N5-Arf4Q71L
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N4-Arf5T31N N5-Arf4T31N N4-Arf5T31N N5-Arf4T31N
Fig. 3.3.9 Yeast two-hybrid analysis of interactions between 
Arf4/ArF5 chimeras and the positives recovered from the 
Arf5 screen.
Arf4/Arf5 chimeras containing both Q71L and T31N mutations were 
produced and subcloned into pGBT9 as described in section 3.2.10. These 
were then co-transformed into yeast strain PJ69-2A with plasmids T3 (A, 
Arfaptin 2/PORI), B1 (B, Arfophilin), T20 (C, Arfophilin-2) and T12 (D). The 
cells were then grown on synthetic media lacking leucine and tryptophan to 
select for the plasmids, and after 3 days of growth at 30 °C, six independent 
colonies were then restreaked onto triple dropout medium lacking histidine 
to select for two-hybrid interactions. These were then grown for a further 3 
days at 30 °C, and scanned to produce the images above. These 
experiments were performed jointly with S. Yarwood and were repeated 
twice with comparable results.
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3.4 Discussion
This chapter describes the use o f the yeast two-hybrid system to screen for novel Arf5 
interacting proteins. The screening strategy was specifically geared towards identifying 
effector proteins that would only interact with Arf5 in a GTP-bound and not a GDP-bound 
conformation. This in-built control was a powerful way o f eliminating many false 
positives, as was the required activation o f two reporter genes. In some respects, it may 
have been preferable to perform the screen with Arf5Q71L fused to the N-terminus o f the 
GAL4 DNA-binding domain, as this would have provided a free Arf5 N-terminus, which 
is known to be an important site for some Arf/effector interactions. Nevertheless, the 
strategy used proved to be effective, perhaps aided by the sensitivity o f  the two-hybrid 
system. Even small pilot-scale screens yielded very interesting results including the 
discovery o f a completely novel protein, Arfophilin-2, and an uncharacterised one, HCR.
The fact that Arfaptin 2 was recovered was particularly encouraging as it indicated that the 
screen was functioning efficiently. This protein was originally identified by two groups 
and named Arfaptin 2 by one (Kanoh et al., 1997) and PORI by the other (van Aelst et al., 
1996), although the latter protein lacked the first 38 amino acids. The former group 
identified it in a yeast two-hybrid screen for Arf3 effectors along with Arfaptin 1 that is 
60% identical and 81% homologous. The other group reported it to bind Rad-G TP and 
therefore called it Partner o f R ad  (PORI). They then went on to show that PORI also 
interacted with Arf6 in a GTP-dependent manner and that Arf6 and R ad  work in opposing 
pathways through PORI in the regulation o f the cortical actin cytoskeleton (D'Souza- 
Schorey et ah, 1997). There appears to be some discrepancy as to the specificity o f  
Arfaptin 2/PORl for the different Arf iso forms. D ’Souza-Schorey and colleagues reported 
it to be an Arf6 effector and they confirmed the interaction using in vitro binding assays 
(D'Souza-Schorey et ah, 1997). Exton’s group, however, showed that the protein interacts 
much more strongly with the class I Arfs and only very weakly with Arf6 in the yeast two- 
hybrid system and in biochemical interaction assays (Shin et ah, 1999). A third group have 
since reported similar findings (Van Valkenburgh et ah, 2001), and the results presented 
here are also consistent with Arfaptin 2 being predominantly a class I Arf effector. The 
Rac-GTP interaction now seems questionable as a recent study involving yeast two-hybrid 
and GST pulldown methodologies showed negligible binding to this form o f Rac, but 
significant binding to Rac-GDP (Shin and Exton, 2001). The 40 bp insert present in the 
5’end o f the T3 Arfaptin 2 clone is interesting. Although it would not be predicted to give 
rise to a different protein product, since it is in the 5 ’UTR and lacks an ATG initiation
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codon, it may represent a transcript that is alternatively regulated. In any case it was not the 
result o f a cloning anomaly since Arfaptin 2 ESTs containing the extra sequence are 
present in the databases, and indeed this isoform has just been reported by others who 
cloned it from pancreatic cDNAs (Shin and Exton, 2001). The presence o f an in-frame stop 
codon very close to the GAL4/Arfaptin-2 fusion boundary was bewildering. The only 
explanation as to why an interaction was detected seems to be that suppressor tRNAs in the 
yeast must have allowed a small amount o f Arfaptin-2 to be translated. In theory, only two 
molecules need to be translated to allow activation o f the two reporter genes so a small 
amount o f  ‘read-through’ is all that would be required. Consistent with a very low level o f  
expression was the fact that no fusion protein was detected in immunoblot analysis (see 
Fig. 3.3.6). Another equally alarming phenomenon that has been reported in the literature 
is that out-of-frame fusions can produce functional proteins in yeast (Fromont-Racine et 
al., 1997). Collectively, these findings suggest that stop codon suppression and 
translational frameshifting are significant mechanisms o f protein expression in yeast and 
should be taken into account when analysing two-hybrid prey sequences.
It was also very encouraging to recover KIAA0665/Arfophilin in the screen, as this had 
just been published as a class Il-specific Arf effector (Shin et ah, 1999). However, the 
authors o f this paper had not tested whether Arfophilin interacted with Arf6, but had 
speculated that it probably did not, given that Arf6 is the most divergent isoform o f the 
family. More recently, they have published that it does indeed interact with Arf6 (Shin et 
ah, 2001). Intriguingly, the C-terminus o f  Arfophilin seems to bind different regions o f  
Arf5 and Arf6, implying that there may be two distinct binding sites within the Arfophilin 
C-terminus (Shin et ah, 2001). It would be interesting to see whether these interactions are 
mutually exclusive, and whether the same is true for Arfophilin-2. The results presented 
here are consistent with an Arf6 interaction with both Arfophilin-1 and Arfophilin-2, 
although the fact that slight auto-activation was observed with the pGBT9-Arf6Q67L 
construct, means that this cannot be heavily relied on. Neither Arfophilin-1 nor Arfophilin- 
2 has been tested for interactions with other members o f  the Arf family, such as the Arls or 
A RD l. Recent two-hybrid studies have shown that Aril does share some effectors with 
Arfs (Van Valkenburgh et al., 2001), but these were all proteins that showed no specificity 
within the true Arfs, such as MKLPl and Arfaptin 2. Given the Arf specificity observed 
with the Arfophilins it seems unlikely that they will interact with less conserved members 
o f the family, but this possibility should nonetheless be explored. The minimum Arf5 
binding site on Arfophilin was limited to the extreme C-terminal 144 amino acids by 
deletion analysis, and the ArfS N-terminus was shown to mediate the interaction (Shin et 
ah, 1999). Our findings are wholly consistent with these for both Arfophilin and
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Arfophilin-2. The shortest Arfophilin-2 cDNA recovered (clone T9) encoded 200 amino 
acids, and the Arfophilin clone (B l) encoded 199 amino acids. Furthermore, the Arf5 N- 
terminus also mediates the interaction with Arfophilin-2 since N5-Arf4 behaved like Arf5 
and N4-Arf5 behaved like Arf4 in the two-hybrid assay, with a stronger interaction being 
apparent in the former. The fact that so many Arfophilin-2 positives were recovered (5 
from only 60,000 transformants) was promising since it suggested that this was a ‘true’ 
positive likely to be o f  physiological importance, and also that testes must surely express 
the gene at very high levels.
The discovery o f  the T12/HCR coiled-coil protein as a putative Arf5 interacting protein 
was also intriguing. The fact that N5-Arf4 acquired the ability to interact while N4-Arf5 
lost it again suggests the N-terminus o f Arf5 is required for the interaction. AiT4 and 5 only 
differ in seven amino acids at their N-termini and some o f  these are highly conserved such 
as position 12 which is either leucine or isoleucine (see Fig 3.2.2). The most likely single 
residue conferring the Arf5 specificity is at position 7, which is serine in Arf4 and alanine 
in Arf5, since this is the least conserved difference. It would be relatively straightforward 
to mutate this residue and determine whether this is the case. It must be stressed that 
despite the controls built into the screening strategy, this T12/Arf5 interaction needs to be 
confirmed by some other, non-yeast-based, method such as by “pulldown” or co- 
immunoprecipitation experiments. The same is o f course true for Arfophilin-2, although in 
this case it is not so crucial given that it is highly homologous to Arfophilin, which has 
itself been confirmed as a bona fide  interacting protein (Shin et ah, 1999). If the T12/Arf5 
interaction is physiologically relevant, however, it could have very interesting implications 
suggestive not only o f unique class II Arf functions, but also o f  unique functions within the 
class itself. During the writing o f this thesis, it was drawn to my attention that this gene 
had in fact been studied in a molecular genetic context, as a candidate gene for psoriasis 
(Asumalahti et ah, 2000).
Owing to time constraints and the need to prioritise, it was decided that subsequent work 
would focus on the novel Arfophilin-2 protein rather than the T12 protein, given that no 
functional studies have been performed on the Arfophilins and that these are more likely to 
be true effectors. The next steps in this regard were to try to clone the full open reading 
frame o f  the Arfophilin-2 cDNA and to gather as much information as possible relating to 
the expression, distribution and function o f the gene and its product(s). The next two 
chapters seek to address such issues.
Chapter 4
The cloning and initial characterisation of 
Arfophiiin-2
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4.1 Introduction
As described in Chapter 3, a yeast two-hybrid screen for Arf5 effectors using a human 
testis library identified a novel gene homologous to Arfophilin-1, which we named 
Arfophilin-2. The aims o f this chapter were to clone the full Arfophilin-2 cDNA, to 
examine its tissue distribution, and to raise specific Arfophilin-2 antibodies to allow the 
subcellular distribution o f native protein to be examined.
4.1.1 Arfophilin-1 (KIAA0665)
Arfophilin-1, for which there has only been two publications to date, was identified by 
virtue o f its GTP-dependent interaction with Class II, but not Class I, Arfs in the yeast-two 
hybrid system (Shin et ah, 1999). This interaction was confirmed biochemically in GST- 
Arf5 pull-down assays o f  Arfophilin-1 overexpressed in CHO cells, and it was shown that 
the Arf N-termini and the Arfophilin-1 C-terminal 144 amino acids were responsible for 
this interaction. Furthermore, association o f overexpressed Arfophilin-1 with intracellular 
membranes was shown to increase upon incubation with Arf5 bound to GTPyS and to 
decrease in the presence o f Arf5 bound to GDPpS. Collectively, these data argue strongly 
that Arfophilin-1 is a bona flde  Class II Arf effector protein. However, no analysis o f  
endogenous Arfophilin-1 protein was performed and no information relating to its cellular 
function was put forward.
The gene encodes a polypeptide o f 756 amino acid residues with a calculated molecular 
mass o f 82.4 kDa. The sequence also corresponds to that o f KIAA0665 protein identified 
in large-scale cDNA sequencing projects (see http://www.kazusa.or.jp/huge/ 
gfpage/KIAA0665/). Notable features that were reported include the presence o f predicted 
coiled coils and leucine zipper motifs in the C-terminal Arf-binding domain (Shin et al., 
1999); see also Fig. 4.3.10 later in the chapter). Northern blot analysis revealed that the 
gene was expressed predominantly in heart and skeletal muscle, but lower levels were also 
reported in kidney, pancreas, brain, placenta and liver (Shin et al., 1999).
More recently, the same investigators have published a report indicating that Arf6 also 
binds to Arfophilin-1 in vitro, but that a different region o f  the Arf is required, suggesting 
the existence o f two Arf binding sites (Shin et al., 2001). Again, no functional data were 
presented.
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4.2 Materials & Methods
4.2.1 Cloning 5' ends of Arfophilin-2 by RACE PCR
A  5 ’ Rapid Amplification o f cDNA Ends (RACE) protocol was used to identify the 5’end 
o f the Arfophilin-2 cDNA. A schematic representation o f  the whole cloning strategy is 
given in Fig. 4.2.1. A  pair o f  nested primers was designed against the sequence o f  a human 
EST (accession number AI570483) known to represent part o f an Arfophilin-2 cDNA. The 
chosen sequences were 5 ' - c c t c g a c c c t t t c a t g g c g a a c a c c c - 3  ' (GSPl) and 5 ' - 
ccTTGAAGTTGATTCTCCccAGGTCGTTGG-3 ' (GSP2) and these Were analysed by BLAST 
against the non-redundant database (with an expected value o f  1000), to ensure that they 
were identical to the genomic sequence and also that they were specific for this sequence. 
Importantly, the melting temperature o f  GSPl was 71.0 °C, slightly higher than that o f the 
Clontech API primer, allowing ‘touchdown PCR’ to be performed to increase the chances 
o f specific amplification (Don et al., 1991). A 50 pi reaction was set up in a thin-walled 
PCR tube on ice as follows:
Expand buffer 2 (Roche) 5 pi
Nuclease free H2O (Promega) 37 pi
API primer (Clontech) 1 pi
GSPl (4 pmol/pl) 2.5 pi
Human testis Marathon-Ready cDNAs (Clontech) 2.5 pi
dNTP mix (10 mM each, Promega) 1 pi
This tube was then placed in a Techne Progene PCR machine set with the following 
cycling parameters:
94.0 °C 2 min
94.0 °C 15 sec
72.0 °C 4 min
94.0 “C 15 sec
70.0 °C 4 min
94.0 °C 15 sec
68.0 "C 4 min
68.0 "C 4 min
4.0 "C hold
5 cycles
5 cycles
30 cycles
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Step 1: 5’ end amplification
a p H B H atg TAA
<
Y
unknown
sequence
product(s) >
Step 2: Full ORF amplification
ATG TAA
<
/ /
product
Fig. 4.2.1 Overview of Arfophilin-2 cloning strategy.
5’RACE using adaptor (AP, in purple) primers (API and AP2) and 
nested gene-specific primers (GSPl and GSP2) was performed to 
specifically amplify the 5’ end of the arfophilin-2 cDNA from adaptor- 
ligated full-length cDNAs (top panel). The region in dark green 
represents the exons containing the EST AI570483 sequence.
A subsequent step using nested primers designed to the 5’UTR (D 
Fwd and D nested) and 3’UTR (All rev4 and All rev3) then amplified 
the full open reading frame (ORF, bottom panel).
In both steps, the outer primers (in red) were used in a first round PCR 
reaction, which was then used as the template for second round 
reactions using the nested inner primers (in blue), allowing specific 
amplification of the products indicated.
124
After the first minute at 94 °C, the program was paused, 1 pi o f  Expand enzymes (Roche) 
was added, and the cycling was resumed. Once finished, 25 pi o f  the reaction mixture was 
purified as described in section 2.2.1.2 and 5 pi o f this was used as a template in the 
second round PCR reaction using the nested AP2 and GSP2 primers. This was performed 
using the standard PCR protocol described in section 2.2.1.1. 25 pi o f  reaction mixture 
firom each round o f PCR were then electrophoresed on a 1% agarose gel, alongside a 1 kb 
ladder. Two bands (350 bp and 700 bp) were excised from the gel, purified, TA cloned into 
pCRII-TOPO and sequenced, all according to the methods described in section 2.2.1.
4.2.2 Cloning the full Arfophllln-2A open reading frame
Having obtained specific 5 ’ RACE products containing putative Arfophilin-2 start codons 
and 5’ UTRs, it was necessary to amplify the full ORFs from cDNAs (see Fig 4.2.1 for 
schematic overview o f the stategy). To do this, nested primers were designed against the 5 ’ 
and 3 ’ UTRs. The outer primers used were 5 ' - gtggtaccttatcgaagcccaggcag- s ' (D 
Fwd) and 5 ' - gaggcccggcttaggcctgcatccttgggc- 3 ' (A ll rev4) and again these had 
melting temperatures o f over 70 °C to allow several initial rounds o f high-temperature, 
specific amplification. The PCR conditions used were identical to those o f the 5 ’ RACE 
reactions section 4.2.1. A second round reaction was then performed using standard PCR 
conditions as described in section 2.2.1.1 and two inner nested primers 5 ' -  
CGCTCTCTCGGCATGCGACCTGTGCAG-3' (D nested) and 5 ' -gtcgacTTAGTGTTTGATCTCGAG 
gatggaggg-3  ' (A ll rev3; Sal I  site in small letters). 25 pi o f  reaction mixture from each 
round o f PCR were then electrophoresed on a 1% agarose gel, alongside a 1 kb ladder. A  
single band o f 2.1 kb was excised from the gel, purified, TA cloned into pCRII-TOPO and 
sequenced, all according to the methods in section 2.2.1.
4.2.3 Northern blot analysis of Arfophilln-1 a n d -2 expression
Human multiple tissue northern blots (M TNI and MTN II) were purchased from Clontech. 
These each had 2 pg/lane o f poly(A)+ RNA (i.e. mRNA) isolated from eight different 
tissues pooled from several individuals. The RNA had been electrophoresed on 
formaldehyde gels and transferred to nylon membranes by the manufacturers. Northern 
analysis o f  Arfophilin-2 was performed first. A  cDNA probe was produced by amplifying 
the 3 ’ 1 kb o f the Arfophilin-2 ORF by PCR using Taq polymerase, plasmid T20 pACT2 
(see the appendix) as template, and primers 5' - cagctcatgcacagcagcaacttcagc-3  ' (A ll 
north fwd) and 5 ' - cagccagccccgtgccttagtgtttg~ 3 '(A I I  north rev). The resulting
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product was run on an agarose gel and subsequently purified as described in section
2.2.1.4. Approximately 200 ng o f this was then incubated overnight at 37 with 3 pi 
(specific activity 3000 Ci/mmol) [a-^^P]-dCTP (NEN Dupont), 0.2 mM each unlabeled 
dATP, dGTP, dTTP plus 1 pi o f Klenow enzyme (Promega) in Klenow buffer to produce a 
radio labelled probe. The following day, the membranes were pre-hybridised in 25 ml 
ExpressHyb buffer (Clontech) at 68“C for 30 minutes in a Hybaid rotary hybridisation 
oven. Meanwhile the probe was purified to remove any unincorporated isotope using a G- 
20  column made from a 1 ml syringe barrel plugged with a small amount o f glass wool. 
The column was packed and spun twice in a benchtop centrihige at 2000 rpm for 2 minutes 
to remove all liquid. It was then placed in a clean 1.5 ml screw cap microcentrifuge tube, 
the labelled probe was added to the top and the column was spun once again. The purified 
labelled probe was then denatured by heating to 95”C for 5 min and placed on ice for 5 
min. It added directly to the ExpressHyb buffer (Clontech) and mixed before incubating 
with the membranes for 3 hours at 68“C. The blots were then washed twice for 20 min each 
in buffer 1 (300 mM NaCl, 30 mM sodium citrate, pH 7.0, 0.05% SDS) at room 
temperature and once in buffer 2 (15 mM NaCl, 1.5 mM sodium citrate, pH 7.0, 0.1% 
SDS) at 50°C for a further 20 min. The blots were then wrapped in saran wrap, sealed in 
polythene and exposed to autoradiography film at -70 °C for 3 days using a cassette with 
two intensifier screens. The film was then developed using a Kodak XO-MAT system. The 
blots were stripped by washing twice in stripping buffer (5 mM Tris.Cl, pH 8 ; 0.2 mM 
EDTA, 0.05% (w/v) Na pyrophosphate, 0.002% (w/v) polyvinyl-pyrolidone, 0.002% (w/v) 
bovine semm albumin, 0.002% (w/v) ficoll) at 70 ®C and for 20 min each and the efficacy 
of stripping was monitored by autoradiography. The blots were then exposed to film again 
for 3 days to verify that the probe had indeed been removed. Northern analysis was then 
repeated using an analogous probe amplified from KIAA0665 clone using primers 5 ' - 
ccTGACCATGGAGGCCCTGGAGGAC-3' (AI north Evd) and 5 ' - c t g c c t c t a c t t g a c c t c c a g g  
TTG-3 ' (AI north rev). These blots were exposed for 1 week at at -70 ”C using a cassette 
with two intensifier screens and developed as before.
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4.2.4 Construction of untagged Arfophiiin-2 expression piasmids
5’RACE PCR amplified two Arfophilin-2 5 ’ ends, product A  and product B (see Fig. 
4.3.3.2 for sequences), and these were TA cloned into pCRII as described in section 4.2.1. 
These plasmids were then used as templates for PCR reactions to specifically amplify the 
putative 5 ’ ends o f the putative ORFs. The primers used were 5 ' -ccgaattcATGCATAGAGC  
GCTCAGAACAGTGCCTGGC-3' and 5’-CCgaattcATGGCTGATACTGACCCCAGGGTGAGGG-3 '
(EcoRl sites in small letters) for product A  and product B, respectively. These were used 
in conjunction with the GSP2 primer originally used in the 2"^  ^ round RACE reaction and 
the PCR was performed using the EXPAND kit as described in section 2.2.1.1. The 
resulting products were then digested with EcoRl (incorporated in the primers) and 
BamHl (an internal site in both) and these were ligated into the same sites o f  pEGFPNl. 
The resulting plasmids were digested with BamHl and treated with calf intestinal alkaline 
phosphatase as described in section 2.2.1.7. They were then used to accept a BamHl 
fragment consisting o f  the entire Arfophilin-2A ORF (including the stop codon) obtained 
in section 4.2.2. Further restriction analysis was performed to verify the presence and 
correct orientation o f the inserts. A  plasmid containing product A  fused to the Arfophilin-2 
3’ sequence was designated Arfophilin-2 A and the one containing sequence derived from 
product B was designated Arfophilin-2B. A schematic overview o f the sub cloning 
procedure is given in Fig. 4.2.4. For an untagged Arfophilin-2A construct, the entire ORF 
was amplified (including the stop codon) from the plasmid obtained in section 4.2.2 using 
primers 5 ' -ccggatccccATGAAAGGGTGCGAGGAGCTGCTGAAGG-3 ' {BamHl site in small 
letters) and 5 ' -gtcgacTTAGTGTTTGATCTCGAGGATGGAGGG-3' {Sal I  site in small letters). 
The resulting product was gel purified, digested with BamHl and Sal 1, gel purified again 
and then ligated into the Bgl II and Sal I  sites o f pEGFPNl, although no fusion protein 
would be produced due to the presence o f  the TAA stop codon. All DNA manipulations 
were performed according to the molecular biology protocols described in section 2 .2 .1.
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Fig. 4.2.4 Construction of Arfophllin-2B and -20 untagged constructs.
The 5’ ends of the putative Arfophilin-2B and -20 splice variants (products A and 
B) were amplified by RACE PCR and cloned into pCRII as described in section
4.2.1. These were then used as templates for PCR using primers designed to 
include the ATG putative initiation codons and incorporating EcoRl restriction 
sites. These primers were used together with the GSP2 primer used in the 2"  ^
round RACE reaction (see section 4.2.1). The resulting products were digested 
with EcoRl and BamHl and ligated into the same sites of pEGFPNl (Clontech). 
The full Arfophilin-2A ORF and 5’UTR, cloned into pCRII as described in section
4.2.2, was then digested with BamHl, treated with alkaline phosphatase, and 
ligated into the BamHl sites of the pEGFPNl vectors previously obtained. The 
correct orientation of the insert was verified by further restriction digestion, and the 
amplified 5’ ends were sequenced to ensure no mutations had been introduced. 
Note that the GFP protein would not be translated due to the presence of the 
Arfophilin-2 stop codon. For simplicity, only one of the two constructs is shown.
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4.2.5 Production of polyclonal Arfophilin antisera
4.2.5.1 Production of recom binant Arfophiiin-2 antigen
A 1.2 kb B glll fragment was subcloned directly from the yeast two-hybrid T20 pACT2 
(see the appendix) vector into the BamHl site o f pQE32 (Qiagen) using the standard 
techniques described in chapter 2. This fragment corresponded to the 3 ’ 1 kb o f coding 
sequence together with the 3 ’UTR and was predicted to encode the C-terminal 330 amino 
acids o f  Arfophilin-2 that would be in frame with an N-terminal hexahistidine tag provided 
by the vector. The presence and correct orientation o f the insert was verified by further 
restriction digestion. The resulting AII330 pQE32 vector (see the appendix) was then 
transformed into chemically competent Escherichia coli strain BL21 DE3pLysS and 
selected for on LB-agar containing 100 pg/ml ampicillin. A  single colony was then used to 
produce and subsequently purify the recombinant His-Arfophilin-2AN from 1 L o f culture 
grown at 30°C according to the methods in section 2.2.4.7 and 2.2.4.8 . The resulting 
purified protein was analysed on a Coomassie-stained SDS-PAGE gel and also by 
immuno-blotting using monoclonal RGS-His antibody (Qiagen) as described in section
2.2.4.
4.2.5.2 Production of recom binant Arfophilin-1 antigen
A 900 bp B glll fragment was subcloned directly from yeast two-hybrid B l pGADlO 
vector (see the appendix) into the BamHl site o f  pQE31 (Qiagen) using standard 
techniques described in chapter 2. This fragment corresponded to the 3 ’ 600 bp o f coding 
sequence together with the 3 ’UTR and was predicted to encode an N-terminal 
hexahistidine tag fused to the C-terminal 200 amino acids o f Arfophilin-1. Production and 
purification o f the recombinant protein was performed exactly as for Arfophilin-2.
4.2.5.3 Inoculation of anim als and collection of se ra
All antibody production was performed by Diagnostics Scotland under the direction o f Dr. 
M. Chambers, Law Hospital, Carluke, Lanarkshire, Scotland.
Briefly, rabbit R1123 was inoculated twice at one month intervals, each time with 
approximately 150 p.g o f  recombinant Arfophilin-1 antigen in 150 pi o f  PBS and about 30 
ml o f serum was recovered after two months. This was followed by two booster injections
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o f antigen and two further bleeds in the subsequent two months, with the final bleed being 
an exsanguination.
For the production o f  Arfophilin-2 antibodies, sheep S638A was inoculated twice at one 
month intervals, each time with 250 pg o f recombinant Arfophilin-2 antigen and about 400 
ml serum was recovered after one month. This was followed by three booster injections o f  
antigen and two further bleeds in the subsequent two months.
In both cases, samples o f pre-immune serum were collected from the animals prior to the 
initial inoculation.
4.2.S.4 Production of His-Arfophilin-1 3 3 0  and His-Arfophilin-2 3 3 0  from 
pET28b vector
The 3 ’ 1 kb o f Arfophilin-1 ORF was amplified by PCR using Pfu polymerase (Promega), 
and oligonucleotide primers 5 ' -ggatccGCTCTCCAGCAAGAAGGTGGCAAGG-3 ' {BamHl site in 
small letters), and 5 ' -gtcgacGACCTTCCTGCCTCTACTTGACCTCCA-3' {Sail site in small 
letters, STOP codon in bold) from the KIAA0665 clone kindly provided by Dr Ohara 
(Kazusa sequencing project, Japan). The analogous region o f Arfophilin-2 was similarly 
amplified from T20 pACT2 plasmid using oligonucleotide primers 5 ' - 
ggatccCTCCAGCACGGCCTTTGGACGGCAGCTC-3 ' {BamHl sitc in small letters), and 5 ' -  
gtcgacTTAGTGTTTGATCTCGAGGATGGAGGG-3 ' {Sail site in small letters, STOP codon in 
bold). The resulting products were purified from agarose gel slices, treated with Taq 
polymerase for 20 minutes at 72 ”C to add ‘A ’ overhangs and TA-cloned using the pCRII- 
TOPO vector system (Invitrogen) as described in more detail in section 2.2.1.6. These 
were then sequenced using M l3 forward and reverse primers to ensure no PCR-induced 
mutations were present. These plasmids were then digested with BamHl and Sail and the 
released inserts were purified and subcloned into the same sites in pET28b (Novagen) 
giving rise to plasmids AI330 pET28b and AII330 pET28b (see the appendix).
These Arfophilin pET28b constructs were then each transformed into competent 
Escherichia coli strain BL21 DE3 and selected for on LB-agar containing 50 pg/ml 
kanamycin. Single colonies were then used to produce and subsequently purify by affinity 
chromatography the recombinant proteins from 1 L cultures grown at 37°C according to 
the methods in section 2.2.4. The resulting purified proteins were analysed on a 
Coomassie-stained SDS-PAGE gel.
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4.2.5.5 Preparation of Arfophilin-2 affinity column
1 g o f  activated CH-sepharose 4B (Pharmacia) was put into a 20 ml Econo-pak column 
(Bio-rad) and mixed with 15 ml 1 mM HCl. This was eluted and the column washed with a 
further 200 ml 1 mM HCl followed by 20 ml coupling buffer (0.1 M NaHCO], pH 8.0). 
Approximately 3 mg o f  purified His-Arfophilin-2330 produced from the pET28b vector was 
then added to 20 ml coupling buffer, the pH was adjusted to 8.0, and this was then added to 
the stoppered column. The column was left overnight rotating end over end at room 
temperature. It was then left to drain before being rotated for a further hour at room 
temperature in 20 ml blocking buffer (100 mM Tris/HCl, pH 8.0). This was then drained 
from the column, reapplied, and the column was then washed with 200 ml TBS containing 
0.1% v/v Tween-20 before proceeding directly to the antibody purification steps described 
below.
4.2.5.6 Affinity purification of Arfophilin-2 antibodies
20 ml o f  sheep S638A first bleed serum was diluted three-fold in TBS containing 0.1% v/v 
Tween-20 and loaded three times onto the Arfophilin-2 affinity column. The bound 
antibodies were then washed with 300 ml o f  TBS/Tween containing 400 mM NaCl to 
remove non-specifically bound proteins. The antibodies were then eluted from the column 
with 20 ml o f 50 mM glycine/HCl pH 2.5, and 1 ml fractions were collected in eppendorf 
tubes containing 50 pi o f  1.5 M Tris/HCl pH 8.0 to neutralise the pH. 13 pi from each 
fraction were then boiled in SDS-PAGE sample buffer, electrophoresed on a 15% 
polyacrylamide gel and the proteins stained with Coomassie brilliant blue. The peak 
fractions containing the antibodies were pooled, the protein concentration was estimated 
using the Bradford assay (see section 2.2.4.1), and the antibody was divided into 250 pi 
aliquots and stored at -80 °C until required. The column was recycled by washing with 100 
ml lOx TBS/Tween and stored at 4 °C in 15 ml TBS/Tween containing 0.02% sodium 
azide as a preservative.
131
4.2.6 Production of rat testis iysate for western biotting
A  testicle was removed from a 14 week old Wistar Kyoto strain rat following sacrifice. It 
was frozen in liquid nitrogen and then broken up and powdered in a small volume o f liquid 
nitrogen with a ceramic pestle and mortar that had been chilled on dry ice. Approximately 
1 g o f  powdered testicle was then transferred to 5 ml ice-cold lysis buffer (25 mM HEPES, 
pH 7.5; 50 mM NaCl; 5 mM EDTA; 10% (v/v) glycerol; 1% (v/v) Triton X-100) 
containing complete protease inhibitor cocktail (Roche). This was then subjected to 20 
strokes in a glass/Teflon homogeniser and incubated on ice for 10 minutes. The lysate was 
then clarified by centrifugation at full speed for 10 minutes in a microcentrifuge at 4”C. 
Supernatant containing 20 pg o f total protein as determined by the Bradford method (see 
section 2.2.4.1), was loaded onto SDS-PAGE gels for subsequent immuno-blot analysis 
according to the methods described in section 2.2.4. Human testis lysate (10 mg/ml) was 
purchased already in SDS-PAGE sample buffer from Clontech.
4.2.7 Subceiiular fractionation of HeLa celis
HeLa cells cultured in 10 cm dishes were grown to approximately 75% confluency. They 
were then rinsed twice with ice-cold HES buffer (255mM sucrose, 20mM HEPES, ImM 
EDTA, pH 7.4.) and all traces o f  the buffer were removed. The cells from each dish were 
then harvested in 750 pi HES containing complete protease inhibitor cocktail (Roche) 
using a rubber policeman. Cells from ten dishes were pooled and homogenised with 20 
strokes in a glass/teflon homogeniser, chilled on ice. The homogenate was then spun at
18,000 X g for 20 min in a refrigerated microcentrifuge, to give the low-speed pellet (PI). 
The supernatant was removed and transferred to a fresh tube and centrifuged at 100,000 x 
g in a Beckman TLA-100 rotor for 1 h at 4°C. This yielded the high-speed pellet (P2) and 
the supernatant (S) represented the cytosolic fraction. The PI and P2 pellets were 
resuspended in 200 pi o f  HES buffer with protease inhibitors. Equal amounts o f  total 
protein from each fraction were then subjected to SDS-PAGE followed by immunoblotting 
as described in section 2.2.4
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4.2.8 Separation of HeLa ceii membranes by sucrose density 
gradient centrifugation
A 1.8 M solution o f sucrose was made in HE buffer (20 mM HEPES, pH 7.4, 1 mM 
EDTA). This was then diluted with more HE buffer to give solutions o f 0.6 M, 0.8 M, 1.0 
M, 1.2 M, 1.4 M and 1.6 M sucrose. 1.7 ml o f the 0.6 M sucrose solution was added to the 
bottom o f a Beckman 13 ml Ultra-Clear™ 14x95 mm tube centrifuge tube. 1.7 ml o f each 
sucrose solution were then sequentially applied to the bottom o f  the tube by underlaying 
increasing concentrations o f sucrose under the previous layers. This was done using a 
pasteur pipette fitted to a 5 ml syringe and this was gently slid down the side o f the tube, 
taking care not to disturb the layers already present. This tube was then sealed with 
parafilm and kept upright at 4°C overnight to allow a linear gradient to form. Six 10 cm 
dishes o f dividing HeLa cells (about 75% confluent) were rinsed twice in ice-cold HES 
buffer (255mM sucrose, 20mM HEPES, ImM EDTA, pH 7.4.) and each plate was then 
scraped in 400 pi HES containing complete protease inhibitor cocktail (Roche) using a 
rubber policeman. The cells were pooled and spun at 2000 rpm for 2 min in a refrigerated 
microcentrifuge. The supernatant was discarded and the cells were resuspended in 600 pi 
HES containing complete protease inhibitor cocktail. They were then homogenised in a 1 
ml glass homogeniser and spun again at 200 rpm for 3 min at 4°C. The supernatant was 
removed and added to the top o f the sucrose gradient, and this was spun at 4°C for 6 h at
33,000 rpm in a Beckman SW-40 rotor. 1 ml fractions were then removed from the top o f  
the gradient and placed into chilled microcentrifuge tubes containing 20 pi 5 Ox protease 
inhibitor cocktail. Samples from each fraction were then diluted in SDS-PAGE sample 
buffer and subjected to SDS-PAGE and immunoblotting as described in section 2.2.4.
133
4.3 Results
4.3.1 Bioinformatic analysis of the Arfophilin~2 gene
As described briefly in Chapter 3, nucleotide BLAST analysis (Altschul et a l, 1990) 
against the non-redundant database revealed that the Arfophilin-2 cDNA sequences 
recovered from the yeast two-hybrid screen were identical to regions o f human 
chromosome 17qlL2. In particular, the sequences were found on two overlapping fully 
sequenced PAC and BAC clones, whose GenBank accession numbers are AC003101 and 
AC004526, respectively, and which constitute part o f  contig NT 010799.5. A  graphical 
overview o f the cytological position o f the gene is shown in Fig. 4.3.1.1. BLAST analysis 
against the human EST database also revealed that while there are many Arfophilin-2 
ESTs, nearly all are clustered at the 3 ’ end (in Unigene cluster Hs3454) and only one 
(accession number AI570483) extended our sequence in the 5 ’ direction. In addition, this 
EST was lacking the extreme 5 ’ exon o f the yeast two-hybrid T20 clone, suggesting 
alternative splicing (see Fig. 4.3.3.2). Primers were designed to this EST sequence and 
used to amplify the entire 3 ’ end o f the Arfophilin-2 open reading frame from testis 
cDNAs (not shown). Interestingly, the major product obtained lacked the 10^  ^ from last 
exon o f the cDNA recovered in the two-hybrid screen, indicating further alternative 
splicing. The EST sequence itself was found to span an intron o f approximately 100 kb 
making computer analysis o f the whole gene sequence problematic. A  158 kilobase portion 
(two thirds o f the gene and about the maximum size that can be analysed) was therefore 
assembled in silico from clones AC004526 (bases 180000-297878) and AC003101 (bases 
68953-109000) to include the entire 5 ’ end up to and including the eleventh from last exon 
(which appears to be present in all splice variants, see Fig. 4.3.3.2). This sequence was 
then analysed using Nix (at http://www.hgmp.mrc.ac.uk): a computer program that 
employs multiple bioinformatic packages and displays them in one easy-to-interpret 
interface. The programs it runs include Grail, Genemark, Genscan, Fgenes, HMMGene, 
Fex, MZEF and Hexon, which are exon prediction programs that use different algorithms, 
in addition to BLAST against multiple databases. The output from such analysis is shown 
in Figure 4.3.1.3. Several important observations are apparent. Firstly, the end o f  the 
neurofibromatosis type 1 gene {NFl) is at the start o f the sequence and this obviously sets 
a limit as to where the start o f the Arfophilin-2 gene must be. Secondly, the EST (accession 
number AI570483) corresponds to sequences around position 70000 bp (and 155000 bp) 
and nearly all the programs predict exons containing the same sequence. This means that 
the Arfophilin-2 gene must begin further back along the chromosome in the centromeric 
direction. Thirdly, there is an excellent candidate promoter complete with TATA box at
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about position 126000 o f the genomic sequence used as input. This is only a few kilobases 
upstream from the start o f the yeast two-hybrid clone T20 sequence and lies adjacent to a 
CpG island: a strong indication for the start o f a gene. For comparison, a similar Nix 
analysis was performed using a sequence assembled from the region o f 16pl3.3 containing
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Fig. 4.3.1.1 Schematic overview of the position of the Arfophilin-2 
gene on human chromosome 17.
Shown is a representation of human chromosome 17 (left-hand side) 
and a magnified view of the q11.2 region containing the NF1 and 
Arfophilin-2 genes which are indicated (right-hand side). Also indicated 
are the positions of a Unigene EST cluster (Hs3454) corresponding to 
Arfophilin-2 and the position of the sequence used for Nix analysis. A 
scale bar in Megabases is shown. The images were obtained from the 
genome resources available at http//:www.ncbi.nlm.nih.gov.
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ArfophiUn-2
II ESTAI570483
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clones
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V ____________________   V
Genomic sequence used 
for Nix analysis
Fig. 4.3.3.2 Overview of the chromosomal region (17q11.2) containing the 
Arfophiiin-2 5’ end.
A 200 kb portion of human chromosome 17q11.2 is shown (in green), with the 
approximate positions the 3' Arfophilin-2 exons deduced from the cDNA 
sequences recovered in the two-hybrid screen denoted by black bars. The 
position of sequences derived from ESTAI570483 are also shown (orange bars). 
Primers designed to the sequences denoted by the red arrows were used to 
amplify, from testis, the cDNA shown at the bottom. This lacked two exons that 
were recovered in the two-hybrid clones (dotted black bars). The 158 kb portion 
of genomic sequence used for Nix analysis is shown.
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Figure 4.3.1.3 Analysis of the human genomic sequence containing the 
5’ end of the Arfophilin-2 gene.
Shown is a graphical overview of a Nix output for the forward strand of a -158 
kb genomic sequence (see green bar at the bottom for scale) assembled from 
fully sequenced overlapping BAC/PAC clones AC004526 and AC003101 
corresponding to position 17q11.2 of the human genome. This sequence 
included the 10th from last exon (x-10) of the Arfophilin-2 gene, as determined 
by analysing the cDNA sequences recovered in the yeast two-hybrid screen. 
The different programs run by Nix are named on the left and regions predicted 
by the programs are denoted by bars and arrowheads at the appropriate 
positions along the sequence. Important features are indicated by arrows and 
include the end of the NFl gene, exons known to encode Arfophilin-2 from 
cDNA sequencing and EST data (that are also predicted by most of the 
programs), CpG islands and putative promoter. The region which must contain 
the true start of the gene is also indicated.
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Figure 4.3.1.4 Analysis of the human genomic sequence containing the 
KIAA0665/Arfophilin-1 gene.
Shown is a graphical overview of a Nix output for the forward strand of a -110 
kb genomic sequence from human chromosome 16p13.3. The different 
programs are named on the left and regions predicted by the programs are 
denoted by bars and arrowheads at the appropriate positions along the 
sequence. Note that the gene starts around a prominent CpG island and that 
many of the programs predict the same exons.
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the KIAA0665/Arfophilin-1 gene (bases 15000-260418 o f  clone AE006463). The output 
is shown in Fig. 4.3.1.4 and it reveals that the gene is smaller in size, that there is a large 
CpG island near the 5 ’ end, and that many o f the programs predict the exons with greater 
accuracy.
4.3.2 Molecular cloning of human Arfophilin-2
Numerous attempts at amplifying the 5 ’ end(s) o f  Arfophilin-2 by RACE PCR using 
different combinations o f  nested primers designed against the common 3 ’ sequence proved 
unsuccessful, as were several attempts at cloning an open reading frame predicted by 
Genscan starting around the CpG island. Therefore, it was decided to attempt 5’ RACE 
from human testis cDNAs using primers designed to the exons encoding EST AI570483, in 
the knowledge that this would not yield every 5’ end that exists (see Fig. 4.2.1 for an 
overview o f the strategy). This led to the amplification o f two distinct but specific products 
o f ~350 bp and -7 0 0  bp, designated Product A and Product B in Fig. 4.3.2.1 (panel A), 
respectively. Both aligned with the correct genomic sequence and their sequences are 
shown in Fig. 4.3.2.2. Both were predicted to encode distinct N-terminal splice variants 
when theoretically assembled with the known 3 ’ sequence. Furthermore, the presence o f  
upstream in-frame STOP codons suggested that the initiation codons were present. 
Forward primers designed against the predicted 5 ’ untranslated regions o f these were then 
designed and used in nested PCR to amplify the complete open reading frames. However, 
this was only successful for the amplification o f Arfophilin-2A (Fig 4.3.2.1, panel B) 
despite various annealing temperatures being employed with the other set o f  primers. The 
5’ end o f Arfophilin-2 A differed slightly from the initial RACE product in that it lacked 
the exon with the predicted initiating codon (see Figs. 4.3.2.2 and 4.2.2.3 for sequences 
and Fig. 4.3.2.4. for a diagrammatic representation). As there were still upstream stop 
codons, this meant that a different start site would be predicted in this isoform, resulting in 
a slightly smaller protein. The full sequence o f the Arfophilin-2A mRNA and its predicted 
protein product is given in Fig. 4.3.2.3.
As described in section 4.2.2, it was possible to assemble predicted Arfophilin-2B and -2C 
open reading frames by fusing the 5 ’ ends amplified by RACE to the 3 ’ Arfophilin-2A 
sequence via a BamHl site present in the overlapping sequence (see Figs. 4.3.2.2 & 4.3.2.3 
for the position). However, it is noted that caution is required when interpreting data 
obtained with these constructs since it is not certain that they exist in vivo as exon usage 
may differ with these variants. Thus the only open reading frame that we can be 
completely confident o f is that o f Arfophilin-2 A.
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Figure 4.3.2.1 Amplification of Arfophilin-2 from testis cDNAs.
Panel A: Two rounds (R1 and R2) of PCR were performed in 5’RACE reactions 
using nested adaptor and gene specific primers as described in section 4.2.1. 
This amplified the two specific products A and B as indicated. These were then 
cloned and sequenced (see Fig. 4.3.2.2).
Panel B: PCR reactions were performed using nested primers designed from 
the sequence obtained from 5’RACE product A along with primers designed to 
the 3’UTR of Arfophilin-2, resulting in the amplification of Arfophilin-2A as 
indicated. This was cloned and sequenced (see Fig. 4.3.2.3).
25 pi of 50 pi reactions were run on 1% agarose gels alongside 0.75 pg of 1 kb 
DNA ladder (L). The positions and sizes (in kb) of DNA markers are indicated.
1 4 U
P r o d u c t  A
1 CGCAGTGGTACCTTATCGAGCCAGCAGAGCCGCTCTCTCGCATGCGACTGTGCAGTCACTCAGGATTAGTG 7 87 9 CTCTGGGGTTGCCTTCTTGAATTCGTGGTAATGTTCCCCTTTGCCCTGGGCGCCACTAATTGCGGAGCTGGTCCTGG 15 6157 GCCGGGCTCCTGACTCCTCCAGGAGCTTTCCACAACCACATACCCCCTCTACCAGTGGCCTACCCAGGTGGTG 234235 CGAGATAACAATCATATGCATAGAGCGCTCAGAACAGTGCTGGCACAAGAGCTCGCTAGCATTGCT 312MHRALRTVPGTKEGSLSI CF
313  TTG A T'T"C "''" '::Tr:c?\nnnrTTf:Tr:nnz\TnTTTf;n:ùTrrlrnarf;A rrTr:f;f;r;A r;naTr& arTTr& & r;r; I 3 7 6DSRGKLVKYLDPNDLGRI NFK
Product B
1 GTAATATGATGACCACGGCAGAATGTGTACAGCACTACACGTGGTGTACACACAGCAGCATGA 7 8 7 9 AACTGTTTCTGTCCTACCTCCTGTTACACGGGAGAGAAACTCTCCAACCTCAGGGATGGCTGACTCTGCCAGGTGAA 15 6 157 ACTTACTTCCTTATTCATCTAACACTCTCATGAAGTGCAGTACAATAGACAGAAGTCATCAGCACAG 234 235 TGTCCATCTCAGTGAGTTTCCCCATCTAGCCAGCACCTGGAACAAGAATAGACAGAGAATGTGGATTCTG 312 313 GTCATTTACAATGAGTTTGTGTCTGTTTTGTGTGAAAGAAACCAATTTTAAAACATCGGCAGAGCCTCGGCTTTCATT 390 391 GTGCAGTCCTGGGAGAGCTCGCCTGAGCGTGTGCTCAGGAGGTGTGCTCAGGAGAGCGTGT 4 68 4 69 TGGCTCTGCTTTTCTTTGCCCGAGTTGTCTGTCACCATGGGGAGAATAAGTGGCCCATGGCTGATACTGACCAG 54 6M A D T D P R
547 GTGAGGTAGAGACTGGCGGGACACTGGTGTCCCTCCCTCCCTCCCAGCCTCCCCACCCAGCTCCCTGAGTCT 62 4 VRVRGLGGDTGVPPSLPASPPSSLSL
62 5 TCGGGAGATCCTTGGGTGTCTCACACCTGTCCCTGCTTCATTCCCACAGGTGGAAAAACTTGTGAAATATTTGGATCC 702 REI LGCLTPVPASFPQVEKLVKYLDP
7 0 3  I CftACGACCTGGGGAGflATCAACTTCAAGSi 731NDLGRINFK
Fig. 4.3.2.2 cDNA and predicted amino acid sequences of Arfophilin-2 
5’RACE products.
The cDNA and predicted amino acid sequences of the products A and B amplified 
by 5’ RACE from testis cDNAs are shown. In frame stop codons are underlined, 
the sequence of the nested (GSP2) primer used in the RACE reactions is boxed 
and the BamHl site used for assembling Arfophilin-2B and Arfophilin-2C is in red.
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1 CGCAGTGGTACCTTATCGAAGCCAGGCAGAGCCGCTCTCTCGGCATGCGACTGTGCAGTCACTCAGGATTAGTG 1 7 9 CTCTGGGGTTGCCTTCTTGAATTCGTGGTATGTTCCCCTTTGCCCTGGGCGCCACTAATTGCGGAGCTGGTCCTGG 15 6157 GCCGGCTCTGACTCCTCCAGGAGGCTTTCCACAACCACATACCCCCTCTACCAGTGGCCTACCCAGGGTGGAAA 234235 ACTGTGAATATTTGGATCCCAACGACCTGGGAGAATCACTTCAGGACTTTTGCCGGGGGTGTTCGCCATGA 312M K
313 AGGTGCGAGAGCTGCTGAGATGTGCTGTCGTGAGAGCGCGGACGCTGCGTGCGCGCAGAGATCCAG 390
g c e e l l k d v l s v e s a g t l p c a p e i p d
391 ACTGCGTGAGCAGGCAGCGAGTCACAGCCACTTGCTGATGGCGAGCTCATCCAGGACCGGCTT 4 68CVEQGSEVTGPTFADGELI PREPGFF
4 69 TCCGAGACGAGAGAGCTATGACGCTGCGCACTGAGGCCCAGAGTGTACACAGACAGCCATG 54 6PEDEEEAMTLAPPEGPQELYTDSPME
547 AGAGCACTCAGAGCTGAGGTCTGTCGGAGTCTGCGAGAGACGGGACTGGGCTGTTCTGCAG 62 4STQSLEGSVGSPAEKDGGLGGLFLPE
625 AAGACAAGTCCCTGGTCCACACTCCATCCATGACGACCTCAGACCTTTCTACACACTCCACCACCTCGCTCATCAGCA 702 DKSLVHTPSMTTSDLSTHSTTSLI SN
703 ATGAGAGCAGTTGAGACTATGGGAGGTGACGATGTGACTGTGCCCAGCAGCCTGCCGATGATGAGA 780 EEQFEDYGEGDDVDCAPSSPCPDDET
781 CAGACACGTCTACTCGACTGGTCTCGTGTCTCAGTGCGGGCAGACGCTAGGAAATGCGCACG 858 RTNVYSDLGSSVSSSAGQTPRKMRHV
859 TGTACACAGCGAATTGCTAGATGTTTACTGCTCTCATGCTGCAAGAAATCACCTGCTCAATGACTTGAAGCCC 936 YNSELLDVYCSQCCKKI NLLNDLEAR
937 GACTGAAACTGAGCACAGCCACGAAGATCTCAGCACGCTTGACGCAGCTCATGCACAGCA 1014 LKNLKANSPNRKI SSTAFGRQLMHSS
1015 GCACTCAGCAGCAGCATGCAGCACGAAGACTGTCGGACAGCATGACTCTGCGACATGACATCACAG 1092 NFSSSNGSTEDLFRDSI DSCDNDI TE
1093 AGAGTAGCTCTGAAGAGTGACAGAGCTGAGATGACAGCTGACATGGACTGAGAGCAGC 1170 KVSFLEKKVTELENDSLTNGDLKSKL
1171 TGAGCAGAGACACACAGCTGTGCACAGGTGCATGAGCTGAGAGATGTGAGATCAGAGACACGCG 124 8 KQENTQLVHRVHELEEMVKDQETTAE
124 9 AGCAGCTCTGAGAGAGCGCGCGCACGCGAGCTACGCAGCTGAGAGGAGAGCTACGAGTG 1326 QALEEEARRHREAYGKLEREKATEVE
1327 AGCTGCTCATGCAGGTGCAGCAGTGAGAGAATACAGAGCTAGACACAGTGACTCGCTCAGTCTC 14 04 LLNARVQQLEEENTELRTTVTRLKSQ
14 05 AACAGAGAACTGATGAGAGCGCAGCGCATGTCTGACGTCTGAGACACAGCTGCGCTCAAGATGAGA 14 82 TEKLDEERQRMSDRLEDTSLRLKDEM
14 8 3 TGACTGTACAGCGCATGATGACAGCTGCGACAGACGCTGAGTCAGAGAGCGGAGCGACGCAG 1560DLYKRMMDKLRQNRLEFQKEREATQE
15 61 AGCTCATCGAGACTGCGAGAGCTGAGCACTGCAGATGTACAGCTGACTGCGAGCGCAGCAGGC 1638LI EDLRKELEHLQMYKLDCERPGRGR
1639 GCAGTGCTCTCTGCTAGCGAGTCATGCAGGCCGCGAGTGAGCTCGAGCACGAGTCAGCGCTCA 1716 SASSGLGEFNARAREVELEHEVKRLK
1717 AGCAGAGATATAGCTGCGGATCAGACGACGACTGAATGGCAGATTGAGCTCAGCTCTACGAAGCAA 17 94 QENYKLRDQNDDLNGQI LSLSLYEAK
1795 AAAACCTCTTTGCTGCCAGACTAAGCCAGTCTCTGGCTGCGGAGATAGACACGCTCGCGCGATGAGCTATG 1872 NLFAAQTKAQSLAAEI  DTASRDELME
1873 AGCCTGAGAGCAGAGAGATCACTCGCTGAGCAGTACATGACAGATATCTCGCATCTGAC 1950 ALKEQEEI NFRLRQYMDKI  I LAI LDH
1951 ACATCCTCATCTCGAGATCAACACTAGCACGGCTGCTGCAGAGCAGCTAGACCTGGACAG 2028 NPSI LEI KH»
2029 GGCAGACCTGCCAAGGATGCAGGCTAAGCGGCTCACACTCACACTGTAATGTCTCTCTGCACATGAA 2106 2107 AAAAAAAA 2121
Fig 4.3.2 3 cDNA and predicted amino acid sequences of Arfophilin-2A.
The 2121 bp cDNA and predicted 557 amino acid protein are shown. The two in 
frame stop codons are underlined. The BamHl restriction site used for assembling 
Arfophilin-2B and -2C is in red.
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4.3.3 Bioinformatic anaiysis of Arfophiiin-2 protein sequence
Having successfully cloned one Arfophilin-2 splice variant and having predicted the 
sequences o f  two others with reasonable confidence, more rigorous bioinformatic analysis 
o f the deduced amino acid sequences was warranted. This was performed using Fix, which 
like Nix, provides a single output for multiple programs (see Fig. 4.3.3.1). This revealed 
that Arfophilin-2 is hydrophilic, is unlikely to have any signal sequences or transmembrane 
domains, but has a high probability o f forming coiled-coils in its C-terminus just like 
Arfophilin-1 (Fig. 4.3.3.1). Also, like Arfophilin-1, it has leucine zipper motifs in its C- 
terminus (Fig. 4.3.3.1). These consist o f five or more leucine residues spaced seven 
residues apart and are common modules in DNA-binding transcription factors. They are 
also present in numerous other proteins and often mediate dimérisation (reviewed in Busch 
and Sassone-Corsi, 1990). For a full sequence alignment o f Arfophilin-1 with Arfophilin- 
2A, see Fig. 4.3.3.2. It also became obvious that proteins homologous to both Arfophilins 
existed in Drosophila melanogaster and Caenorhabditis elegans. More specifically, the 
extreme C-termini o f the Arfophilins were homologous to the extreme C-terminus o f  a 
Drosophila protein called Nuclear Fallout (Nuf; see Fig 4.3.3.3). This is a very interesting 
protein (described later in section 5.1.1) that is also predicted to have coiled-coils. 
Similarly, the same region o f the Arfophilins showed homology to the central portion o f  
hypothetical C. elegans protein F55C12.1 (see Fig. 4.3.3.4), which also has a predicted 
leucine zipper motif near the Arfophilin-homology domain (not shown). Indeed all o f  these 
proteins contain a domain o f  ~70 residues catalogued in the protein domain (ProDom) 
database as PD031147. They also appeared to have the PD000002 domain typical o f  
muscle and non-muscle myosin heavy chain tails and tropomyosin. However, this is 
primarily a reflection o f the coiled-coil structures present in these domains, rather than any 
real sequence homology.
BLAST analysis o f the N-termini o f the Arfophilins did not uncover any interesting 
features. While Arfophilin-1 and -2 are quite divergent in their N-termini (see Fig. 4.3.3.2), 
there is a well conserved motif present (amino acid sequence EE[H/Q]FEDYGEG; see Fig. 
4.3.3.2). Intriguingly, this is encoded by the 10*^^^ from last exon o f  Arfophilin-2, the exon 
that can be spliced out in some variants (see Fig. 4.3.2.5).
Searching the non-human EST databases using the tBLASTn program revealed that there 
are Arfophilin homologues in Mus musculus, Rattus norvégiens. Sus scrofa. Bos taurus, 
Xenopus laevis, Danio rerio, and Oryzias latipes, in addition to Caenorhabditis elegans 
and Drosophila melanogaster as already mentioned. A subset o f  the results from such
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analysis is shown in Fig. 4.3.3.5. Also o f note is the fact that there are no apparent 
Arfophilin orthologues in the Saccharomyces cerevisiae genome.
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Figure 4.3.3.1 Analysis of human Arfophilin-2 predicted amino acid 
sequence.
Shown is the graphical overview of a Fix output for the 557 amino acid 
sequence of Arfophilin-2A. The different programs are indicated on the left. Of 
particular note are the predicted coiled-coil regions in the C-terminal half of the 
protein. The leucine zipper motifs are circled.
1 4 /
Hs Arfol MASAPPASPPGSEPPGPDPEPGGPDGPGAAQLAPGPAELRLGAPVGGPDPQSPGLDEPAP 60
Hs Arfol
Hs_Arfol Hs Arfo2A
GAAADGGARWSAGPAPGLEGGPRDPGPSAPPPRSGPRGQLASPDAPGPGPRSEAPLPELD 120
PLFSWTEEPEECGPASCPESAPFRLQGSSSSHRARGEVDVFSPFPAPTAGELALEQGPGS 180 -----------------------------------MKGCEELLKDVLSVESAGTLPCAPEIPDCVEQGS 34
HsArfol Hs Arfo2A PPQPSDLSQTHPLPSEPVGSQEDGPRLRAVFDALDGDGDGFVRIEDFIQFATVYGAEQVK 24 0EVTGPTFADGELIPREPGFFPEDE---------------------------EEAMTLAPPEGPQEL- 73• •• ★★ ★• • • ★ ★•••
HsArfol Hs Arfo2A DLTKYLDPSGLGVISFEDFYQGITAIRNGDPDGQCYGGVASAQDEEPLACPDEFDDFVTY 300  YTDSPMESTQSLEG-SVGSPAEKDGG LGGLFLPEDK-------------SLVHT 113
HsArfol Hs Arfo2A EANEVTDSAYMGSESTYSECETFTDEDTSTLVHPELQPEGDADSAGGSAVPSECLDAMEE 360PSMTTSDLSTHSTTSLISNEEQFEDYGEG-------------DDVDCAPSSPCPDDETRTNVY 163• .  *  *  » *  *  *  •
Hs_Arfol Hs Arfo2A PDHGALLLLPGRPHPHGQSVITVIGGEEHFEDYGEGSEAELSPETLCNGQLGCSDPAFLT 420 SDLGSSVSSSAGQTPR KMRHVYNSELLDVYCSQCCKKIN LLN-DLEARLKNLKA 216
HsArfol Hs Arfo2A PSPTKRLSSKKVARYLHQSG—ALTMEALEDPSPELMEGPEEDIADKWFLERRVLELEK 478 NSPNRKISSTAFGRQLMHSSNFSSSNGSTEDLFRDSIDSCDNDITEKVSFLEKKVTELEN 27 6 + ★ •••★★ ★ * # * » • • ★ • «• ★★★•
HsArfol Hs Arfo2A DTAATGEQHSRLRQENLQLVHRANALEEQLKEQELRACEMVLEETRRQKELLCKMEREKS 538 DSLTNGDLKSKLKQENTQLVHRVHELEEMVKDQETTAEQALEEEARRHREAYGKLEREKA 336 ★ • • #*«*»*** ★★★ • * * * ** *.****«
HsArfol Hs Arfo2A lEIENLQTRLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIESLTLRLSEEQENKR 598 TEVELLNARVQQLEEENTELRTTVTRLKSQTEKLDEERQRMSDRLEDTSLRLKDEMDLYK 396 ★ *# »*****»***»***» * * * * • •
Hs_Arfol Hs Arfo2A RMGDRLSHERHQFQRDKEATQELIEDLRKQLEHLQLLKLEAEQ-RRGRSSSMGLQEYHSR 657 RMDKLRQNRLEFQKEREATQELIEDLRKELEHLQMYKLDCERPGRGRSASSGLGEFNAR 456 ♦ ♦ * * * * * *  * * * • • • *
Hs_Arfol ARESELEQEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLFS-TAFSESLAAEISSVS 716Hs_Arfo2A AREVELEHEVKRLKQENYKLRDQNDDLNGQILSLSLYEAKNLFAAQTKAQSLAAEIDTAS 516
*  *  *  * * * * * * * * * * * * *  * * *  * * * *  * * * * * * *  * * * *  *  *  *  *  * * * * * * * * * *  * *
HsArfol Hs Arfo2A RDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK- 756 RDELMEALKEQEEINFRLRQYMDKIILAILDHNPSILEIKH 557 
* * * * * * * *  * « * * * * * * * * *  * * * * * * * * * * *  * * * * * * * * *
Figure 4.3.3.2 Sequence alignm ent of Arfophilins 1 and 2A.
A clustal alignment of Homo sapiens (Hs) Arfophilin-1 and Arfophilin-2A is shown. 
Identical residues are donated by asterisks, highly conserved residues by double 
dots and conserved residues by single dots. The leucine zipper motifs consisting 
of at least five leucine residues spaced seven residues apart are shown in blue, 
and the minimum Arf-binding domain (according to Shin et al., 1999) is underlined. 
Note also the conserved motif EE[H/Q]FEDYGEG (in red) in a region that is 
otherwise not well-conserved. This is encoded by an exon that can be spliced out 
in some Arfophilin-2 splice variants.
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H s A r f o l  
Hs_Arfo2 
Dm Nuf
PSPTKRLSSKKVARYLHQSG---------ALTMEALEDPSPELMEGPEEDIADKVVFLERRV 47 3
NSPNRKISSTAFGRQLMHSSNF------ SSSNGSTEDLFRDSIDSCDNDITEKVSFLEKKV 271
SSGRRQISSNALASQLYRSSSFNSSGRSSNCDTTEDMYSDISLENRHDYDYRLELLQRKV 221
Hs_Arfol 
Hs_Arfo2 
Dm Nuf
Hs_Arfol 
Hs_Arfo2 
Dm Nuf
LELEKDTAATGEQHSRLRQENLQLVHRANALEEQLKEQELRACEMVLEETRRQKELLCKM 533 
TELENDSLTNGDLKSKLKQENTQLVHRVHELEEMVKDQETTAEQALEEEARRHREAYGKL 331 
DDLSDTQNIAEDRTTRTKTEYAVLQARYHMLEEQYRESELRAEERLAEEQKRHREILARV 281
★ * * * * * * * * * * *
EREKSIEIENLQTRLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIESLTLRLSEE 593 
EREKATEVELLNARVQQLEEENTELRTTVTRLKSQTEKLDEERQRMSDRLEDTSLRLKDE 391 
EREASLQNENCQMKIRATEIEATALREEAARLRVLCDKQANDLHRTEEQLELARDQIGVL 341
Hs_Arfol 
Hs_Arfo2 
Dm Nuf
QENKRRMGDRLSHERHQFQRDKEATQELIEDLRKQLEHLQLLKLEAEQ-RRGRSSSMGLQ 652 
MDLYKRMMDKLRQNRLEFQKEREATQELIEDLRKELEHLQMYKLDCERPGRGRSASSGLG 4 51 
QQEHEEQAQALRRHEQEKKSTEELMLELGRELQRAREESGARAMPTTS PESIRLE 396
Hs_Arfol 
Hs_Arfo2 
Dm Nuf
Hs_Arfol 
Hs_Arfo2 
Dm Nuf
EYHSRARESELEQEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLFST-AFSESLAAE 711 
EFNARAREVELEHEVKRLKQENYKLRDQNDDLNGQILSLSLYEAKNLFAAQTKAQSLAAE 511 
ELHQEL— EEMRQKNRTLEEQNEELQATMLTNQATMLTNGVEQGRHLLNG— TLNSLAQE 452
ISSVSRDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK  756
IDTAS RDE LMEALKEQEEIN FRLRQYMDK11LAILDHNPSILEIKH 557
LEEMSQAQLQQAFQEKEDENVRLKHYIDTILLNIVENYPQLLEVKPMERK 502
Figure 4.3.3.3 Amino acid sequence alignment of Human Arfophilins and 
Drosophila Nuf.
Shown is a Clustal alignment of the extreme C-terminal -340 amino acid residues 
of human Arfophilin-1 (Hs_Arfo1), Arfophilin-2 (Hs_Arfo2) and Drosophila Nuf 
(Dm_Nuf). Asterisks (*) denote identical residues, double dots (:) denote highly 
conserved residues and single dots (.) denote conserved residues.
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Hs_Arfol KEATQELIEDLRKQLEHLQLLKLEAEQ-RRGRSSSMGLQEYHSRARESELEQEVRRLKQD 67 3
Hs_Arfo2 REATQELIEDLRKELEHLQMYKLDCERPGRGRSASSGLGEFNARAREVELEHEVKRLKQE 47 2
Dm_Nuf KKSTEELMLELGRELQRAREESGARAM PTTSPESIRLEELHQELEEMRQK 408
Ce F55C12.1 ----------------------------------------------------- KAKVAELMKEKEEMTDQ 264
Hs_Arfol NRNLKEQNEELNG QIITLSIQGAKSLFST-AFSESLAAEISSVSRDELMEAIQ 725
Hs_Arfo2 NYKLRDQNDDLNG QILSLSLYEAKNLFAAQTKAQSLAAEIDTASRDELMEALK 52 5
Dm_Nuf NRTLEEQNEELQATMLTNQATMLTNGVEQGRHLLNG— TLNSLAQELEEMSQAQLQQAFQ 4 66
Ce F55C12.1 ------------------------- LLATSVERGRSLIAD— TP-SLADELAGGDSSQLLDALR 300
Hs_Arfol KQEEINFRLQDYIDRIIVAIMETNPSILEVK------  756
Hs_Arfo2 EQEEINFRLRQYMDKIILAILDHNPSILEIKH  557
Dm_Nuf EKEDENVRLKHYIDTILLNIVENYPQLLEVKPMERK 502
Ce F55C12.1 EQEICNQKLRVYINGILMRVIERHPEILEI-------  330
Figure 4.3.3.4 Amino acid sequence alignment of Human Arfophilins, 
Drosophila Nuf and hypothetical C. elegans proteins.
Shown is a Clustal alignment of the extreme C-terminal -340 amino acid residues 
of human Arfophilin-1 (Hs_Arfo1), Arfophilin-2 (Hs_Arfo2), Drosophila Nuf 
(DmNuf) and residues 247-330 of hypothetical C. elegans protein 
(Ce_F55C12.1). Asterisks (*) denote identical residues, double dots (:) denote 
highly conserved residues and single dots (.) denote conserved residues. The last 
70 residues constitute domain PD031147 in the ProDom database.
150
>giI 5 910150 IgbjAW049621.11AW049621 Mus musculus cDNA clone Length = 363Score = 117 bits (294), Expect = 2e-26Identities = 57/70 (81%), Positives = 62/70 (88%) Frame = +2
Arfo2A: 1 MKGCEELLKDVLSVESAGTLPCAPEIPDCVEQGSEVTGPTFADGELIPREPGFFPEDEEE 60 MKGCEELLKDVLSVESAGTLPC+P+IPDCVEQGS+ +G T DGE +PREP FF EDEEE Sbjct; 158 MKGCEELLKDVLSVESAGTLPCSPDIPDCVEQGSDFSGST--DGEQLPREPDFFQEDEEE 331
Arfo2A: 61 AMTLAPPEGP 70 AMTLA PEGP Sbjct: 332 AMTLALPEGP 361
>gi111663880 IgbIBF554150.11BF554150 Rattus norvegicus cDNA clone Length = 4 60
Score = 174 bits (442), Expect = 2e-43Identities = 87/110 (79%), Positives = 95/110 (86%), Gaps = 1/110 (0%)Frame = -3
Arfo2A: 1 MKGCEELLKDVLSVESAGTLPCAPEIPDCVEQGSEVTGPTFADGELIPREPGFFPEDEEE 60 MKGCEELLKDVLSVESAGTLPC+P+IPDCVEQGS+ +G T+ADGEL+PREPGFF EDEEE Sbjct: 332 MKGCEELLKDVLSVESAGTLPCSPDIPDCVEQGSDFSGSTYADGELLPREPGFFQEDEEE 153
Arfo2A: 61 AMTLAPPEGPQELYTDSPMESTQSLEGSVGSPA-EKDGGLGGLFLPEDKS 109 AMTL PEGPQEL DSPMES+Q EGSV SP EK+ LGGLFLPED S Sbjct: 152 AMTLTLPEGPQELDMDSPMESSQGPEGSVRSPVEEKEPELGGLFLPEDTS 3
>gi111074 765|gb|BF1913 96.11BF1913 96 238972 Sus scrofa cDNA 5'.Length = 534Score = 166 bits (419), Expect = 8e-41Identities = 82/119 (68%), Positives = 90/119 (74%), Gaps = 2/119 (1%)Frame = +1
Arfo2A: 2 7 PDCVEQGSEVTGPTFADGELIPREPGFFPEDEEE--AMTLAPPEGPQELYTDSPMESTQS 84 P +QGSEV PTFADGEL+PREPGFFPEDE+E AMTLAPPEGPQEL + PMEST+S Sbjct: 109 PASGDQGSEVPDPTFADGELLPREPGFFPEDEDEDEAMTLAPPEGPQELDMEGPMESTRS 288
Arfo2A: 85 LEGSVGSPAEKDGGLGGLFLPEDKSLVHTPXXXXXXXXXXXXXXLISNEEQFEDYGEGD 143 L+GS+G PAEKD GLG LFLPEDKS VHTP L+SNEEQFEDYGE DSbjct: 289 LDGSLGMPAEKDAGLGSLFLPEDKSRVHTPPMTTSDLSTHSTTWLVSNEEQFEDYGEAD 465
Fig. 4.3.3.5 R esults of tBLASTn search es of Arfophilins 1 and 2 against 
non-hum an ESTs (continued overleaf).
Arfophilin-2A (Arfo2A, this page) and Arfophilin-1 (Arfol, next page) amino acid 
sequences were aligned against the non-human EST database translated in all 
reading frames (tBLASTn program). Shown are some of the high-scoring outputs 
shown aligned with the Arfophilin family member with which they exhibit the 
greatest homology.
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EM:BF606409 BF606409 273444 MARC 3BOV Bos taurus cDNA Length = 471Score = 247 bits (624), Expect = 6e-64Identities = 125/156 (80%), Positives = 134/156 (85%)Frame = +3
Arfol: 54 5 QTRLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIESLTLRLSEEQENKRRMGDRL 604 Q RLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIE L++RLS+EQEN+R++GDRL Sbjct: 3 QARLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIEELSVRLSDEQENRRKLGDRL 182
Arfol: 605 SHERHQFQRDKEATQELIEDXXXXXXXXXXXXXXXXXRRGRSSSMGLQEYHSRARESELE 664 SHERHQFQRDKEATQELIED RRGRSSS GLQEYHSR RESELESbjct: 183 SHERHQFQRDKEATQELIEDLRKQLEHLQLFKLEAEQRRGRSSSAGLQEYHSRTRESELE 362
Arfol: 665 QEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLF 700 QEVRRLKQDNR+LKEQN+ELNGQII LSIQGA+SLF Sbjct: 363 QEVRRLKQDNRSLKEQNDELNGQIINLSIQGARSLF 470
EM:AL585583 AL585583 Gallus gallus mRNA; expressed sequence tag Length = 402Score = 201 bits (506), Expect = 4e-50Identities = 103/115 (89%), Positives = 111/115 (95%)Frame = -2
Arfol: 642 RRGRSSSMGLQEYHSRARESELEQEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLFS 701 RRGRSSSMGLQEY+SR RE+ELEQE+ +LKQDNR+LKEQN+ELNGQII LSIQGAK+LFS Sbjct: 347 RRGRSSSMGLQEYNSRTRETELEQEINQLKQDNRSLKEQNDELNGQIINLSIQGAKNLFS 168
Arfol: 702 TAFSESLAAEISSVSRDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK 756 +FSESLAAEISSVSRDELMEAIQKQEEIMFRLQDYIDRIIVAIMETNPSILEVK Sbjct: 167 ASFSESLAAEISSVSRDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK 3
EM:BI064697 BI064697 normalized chicken fat cDNA library Gallus gallus cDNA Length = 548Score = 129 bits (320), Expect = 3e-28Identities = 78/161 (48%), Positives = 86/161 (52%)Frame = +3
Arfol: 110 PRSEAPLPELDPLFSWTEEPEECGPASCPESAPFRLQGSSSSHRARGEVDVFSPFPAPTA 169 P P P LDP WE E P PES G+ PA ASbjct : 144 PARPPPAPPLDPGPRWDEAGPEADPEPEPESELEAEPGAE PALWA 278
Arfol: 170 GELALEQGPGSPPQPSDLSQTHPLPSEPVGSQEDGPRLRAVFDALDGDGDGFVRIEDFIQ 229 E A P +PP G ED PRLR VFDALD DGDGFVR+E+F+QSbjct: 279 AEPAAGTPPWAPPGRG GCPEDEPRLRPVFDALDRDGDGFVRVEEFVQ 419
Arfol: 230 FATVYGAEQVKDLTKYLDPSGLGVISFEDFYQGITAIRNGD 270 FAT YGAEQVK+LTKYLDPSGL VISPEDF++GI AI GD Sbjct: 420 FATAYGAEQVKELTKYLDPSGLXVISFEDFHRGIXAIXXGD 542
EM:AU170919 AU170919 Oryzias latipes cDNA, clone:br6952.Score = 120 bits (299), Expect = 8e-26Identities = 65/89 (73%), Positives = 74/89 (83%), Gaps = 3/89 (3%)Frame = +3
Arfol: 668 RRLKQDNRNL KEQNEELNGQIITLSIQGAKSLFSTAFSESLAAEISSVSRDELMEAI 724RR NR + N+ELNGQII LSIQGAK+L S +FS+SLAAEI+SVSR ELME +Sbjct: 81 RRSNGSNRTTAL*RSFNDELNGQIINLSIQGAKTLMSASFSDSLAAEINSVSRVELMETV 260
Arfol; 72 5 QKQEEINFRLQDYIDRIIVAIMETNPSILEVK 756 KQEEIN+RLQDYID+IIVAIME NPSILEVK Sbjct: 261 HKQEEINYRLQDYIDKIIVAIMECNPSILEVK 356
EM :AW280381 AW280381 fj39c06.yl zebrafish adult brain Danio rerio Score = 61.3 bits (146), Expect = 7e-08Identities = 27/62 (43%), Positives = 41/62 (65%), Gaps = 1/62 (1%)Frame = +1
Arfol: 206 RLRAVFDALDGDGDGFVRIEDFIQFATVYG-AEQVKDLTKYLDPSGLGVISFEDFYQGIT 264 +L+ VFD D D DG++R+E F+ +G ++VK KYLDP+ G I+F+DF G+Sbjct: 58 KLKEVFDVCDEDADGYIRVEHFVDLGLQFGQGDEVKKFAKYLDPNAHGRINFKDFCHGVF 237
Arfol: 265 AIR 267 AI +Sbjct: 238 AIK 246
EM:AW636537 AW636537 bl47hl0.wl Xenopus laevis cDNA clone PBX0047H10 Score = 58.6 bits (139), Expect = 5e-07Identities = 34/95 (35%), Positives = 61/95 (63%), Gaps = 12/95 (12%)
Arfol: 662 ELEQEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLFSTAFSE----------------SLA 709E E+E +RL *fN*f+L+E NE+L ++ 4-Q F E S+ASbjct: 169 ECEREKQRLADENQSLREINEDLQDALL VQNGSVCFPYRTHEENSHSKPGSPVHSIA 339
Arfol: 710 AEISSVSRDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK 756 El 4.4- *f+ A+ +Q+EIN RL+ Y+DR+I+ ++E +P +LE+K Sbjct: 340 EEIDVCTQQQI-SALNEQKEINRRLRQYLDRVILTVLEKDPGLLEIK 477
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4.3.4 Tissue expression of human Arfophiiin mRNAs
Northern blot analyses o f  both Arfophilins-2 and -1 were performed to determine their 
expression profiles and also to see what size transcripts were present and whether these 
were in good agreement with the sizes o f cDNAs obtained from testis. Commercially 
bought, standardised, multiple-tissue blots containing 2 pg per lane o f polyA+ RNA  
recovered from 16 different tissues pooled from several individuals were used. The cDNA  
probes used corresponded to the extreme 3 ’ 1 kb o f the open reading frames and they were 
both expected to hybridise with all splice variants o f their respective genes, based on 
analysis o f the EST databases. The Arfophilin-2 blots were performed first, stripped o f  
probe, and then re-blotted for Arfophilin-1. Although an Arfophilin-1 northern blot has 
been previously published (Shin et al., 1999), it was deemed necessary to repeat this with 
more tissues including testis since we predicted that Arfophilin-2 would be highly 
expressed in this tissue given the high number o f  positives recovered from such a small- 
scale yeast two-hybrid screen. It was also necessary to check that the probes did not cross- 
hybridise.
As can be seen in Fig. 4.3.4 (panel A) Arfophilin-2 is indeed highly overexpressed in 
testes. Three transcripts are apparent with a major one -2 .4  kb in length, a less pronounced 
one o f -4 .4  kb, and a minor one o f -  5-6 kb. The -2 .4  kb band is in excellent agreement 
with the sizes o f Arfophilins-2 A, -2B and -2C, which are predicted to be between 2.1 and 
2.6 kb. A  much larger band running at about 7-10 kbp was also detected in skeletal muscle. 
Upon inspection o f longer exposures, a low level but ubiquitous expression o f the 4.4 kbp 
transcript was observed (Fig. 4.3. 4; panel B).
Arfophilin-1 is also highly expressed in testes with major 5-6 kb and minor -  4.4 kb 
transcripts being apparent (Fig. 4.3. 4; panel C). The larger o f  the two is also present at 
lower levels in ovary, skeletal muscle and kidney, while the smaller appears to be the 
predominant form in kidney. Skeletal muscle and heart also express large (7-10 kb) 
Arfophilin-1 mRNAs. These findings are not wholly consistent with the published data 
(Shin et al., 1999), which showed Arfophilin-1 expression almost exclusively in heart and 
skeletal muscle, despite the fact that the authors had identified the gene in a screen o f  
kidney cDNAs. The reason for this discrepancy is unclear especially as the blot they used 
was o f  the same type, from the same supplier and the probe was only marginally (200 bp) 
longer, and corresponded to the same region o f the open reading frame.
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Note that the major testis Arfophilin-2 band is absent in the Arfophilin-1 blot, and that the 
major kidney Arfophilin-1 band is absent in the Arfophilin-2 blot, showing that, under the 
conditions used, the probes were specific with no significant cross-hybridisation.
154
/
7.5
4.4
2.4
4.4
/
7.5
4.4
2.4 
1.35
Figure 4.3.4 Tissue expression profiies of human Arfophiiins 1 & 2.
Northern analysis of Arfophilin-2 (panels a and b) and Arfophilin-1 (panel c) 
using human multiple-tissue blots as indicated was performed using probes 
corresponding to the 3’ Ikb of the respective open reading frames. Both 
genes are highly expressed in testes. In addition, strong signals are 
apparent for Arfophilin-1 in skeletal muscle and kidney. Longer exposure 
revealed a 4.4kb Arfophilin-2 transcript present in nearly all the tissues 
(panel b). Note the lack of significant cross-hybridisation between probes. 
Approximate sizes of transcripts in kbp are indicated on the left-hand side.
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4-3.5 Production and initial characterisation of Arfophiiin antisera
We sought to produce specific antibodies to allow us to determine in which cells 
Arfophilins were expressed and then to try to uncover their subcellular distributions and 
possible roles within those cells. Recombinant proteins were produced in Escherichia coli, 
purified, and used to inoculate a rabbit and a sheep to produce Arfophiiin-1 and 
Arfophilin-2 polyclonal antibodies, respectively. The use o f  two different species was a 
conscious decision to allow for comparative analyses o f  products from the two different 
genes in future experiments.
Since the antisera we raised were from recombinant proteins comprising the regions o f  
Arfophiiin-1 and Arfophilin-2 with the greatest homology, it was necessary to test the 
specificity o f  each antibody and determine whether affinity purification against the other 
isoform would be required to obtain isoform-speciflc antibodies. To this end, 
hexahistidine-tagged Arfophiiin-1 and -2 recombinant proteins were produced 
corresponding to their respective C-terminal 330 amino acid residues - the same size as the 
original Arfophilin-2 antigen. It was found that the pET28b vector (Novagen) gave 
superior results compared to the pQE vectors (Qiagen) in that a single major band o f  the 
correct predicted molecular mass was produced for each protein as opposed to the multiple 
ladders o f bands previously observed with the pQE vector (not shown).
As can be seen in Fig. 4.3.5 (panel A), Arfophilin-2 immune serum, but not preimmune 
serum, only recognised the Arfophilin-2 recombinant protein and not the analogous 
Arfophiiin-1 protein in immuno-blot analysis. This shows that antibodies were successfully 
produced, that they are specific for Arfophilin-2 and that they do not recognise the His-tag 
present in both proteins. Equal protein was present in each lane, as determined by both 
Bradford assay and Ponceau staining (not shown).
Arfophilin-2 antibodies were then affinity purified using the same His-tagged Arfophilin-2 
produced from the pET vector in order to increase specific and decrease non-specific 
staining necessary for certain applications. Fig. 4.3.5 (panel B) is o f a polyacrylamide gel 
stained with Coomassie brilliant blue showing the purified IgG fractions eluted from the 
affinity column. Fractions 4-13 were pooled, separated into aliquots and stored at -80°C 
prior to use in the experiments described below. The protein concentration was 0.24 
mg/ml.
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Figure 4.3.5 Anti-Arfophilin-2 polyclonal antibodies.
Panel A: 1 pg of recombinant His-Arfophilin-1 (A1; C-terminal 330 
residues) and His-Arfophilin-2 (A2; C-terminal 330 residues) were run 
on a 10% SDS PAGE gel, transferred to nitrocellulose, and immuno- 
blotted with crude Arfophilin-2 immune serum according to the methods 
described in section 2.2.4. A duplicate blot was also performed using 
pre-immune serum (PI).
Panel B: Purified IgGs were eluted from an Arfophilin-2 affinity column 
and collected in 1 ml fractions. 13 pi of each fraction were boiled in 
sample buffer and loaded onto a 15% SDS-PAGE gel. Following 
electrophoresis, the gel was stained with Coomassie and then 
destained, to reveal the IgG light chains (lower bands) and heavy 
chains (intermediate bands). The positions and sizes (in kDa) of 
molecular weight markers are shown on the right). Fractions 4-13 were 
later pooled and the protein concentration was found to be 0.24 mg/ml.
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The rabbit polyclonal antibody to Arfophiiin-1 has not yet been characterised or affinity 
purified. The crude serum was, however, used in an immunoblot o f recombinant 
Arfophiiin proteins and also in immunofluorescence o f  cells transfected with an 
Arfophiiin-1 construct. Positive signals were observed compared to pre-immune serum 
indicating that the animal did indeed produce antibodies, but it remains to be seen how 
specific they are for Arfophiiin-1 (data not shown).
4.3.6 Endogenous Arfophilin-2 protein expression
The purified anti-Arfophilin-2-specific antibody was used to analyse the native protein by 
immunoblot analysis. Lysates from human and rat testes as well as cultured HeLa, HEK 
293 and CHO cells were run on SDS-PAGE gels, transferred to nitrocellulose and probed 
for Arfophilin-2 using the antibody at a concentration o f 50 ng/ml. This revealed a single 
major band with an apparent molecular mass o f ~83 kDa in all the cells o f  human origin 
examined: testis, HeLa and HEK 293 (Fig. 4.3.6; panel A), although the commercially 
obtained human testis preparation consistently produced a smear that may have masked 
less intense bands (Fig. 4.3.6, panel A, 2"^  lane). This suggests that despite the three 
distinct transcripts on the northern blot, only one protein seems to be made in testes. Rat 
testis and CHO cell lysates, on the other hand, showed no immunoreactivity with the 
Arfophilin-2 antibody (Fig. 4.3.6, panel A), suggesting that the epitopes do not reside in 
well-conserved regions o f Arfophilin-2.
Given the lack o f  immunoreactivity, CHO cells were used for the heterologous expression 
and subsequent western blotting o f  untagged Arfophilin-2 constructs, to allow direct 
comparison o f  the electrophoretic mobility o f each putative protein with the native ones in 
testis or HeLa cells. The results o f such analysis are also shown in Fig 4.3.6 (panel A), 
where it can be seen that untagged, heterologously expressed Arfophilin-2A migrates the 
same as the native proteins on an 8% polyacrylamide gel. It runs at 83 kDa despite having 
a calculated molecular mass o f 61 kDa. The constructs encoding putative Arfophilin-2B 
and -2C, however, each produced two bands that were spaced about 10 kDa apart. The 
reason for this is unclear but none o f  these bands migrated exactly as the endogenous 
proteins (Fig. 4.3.6; panel A). These data suggest that Arfophilin-2A is the major (or only) 
variant expressed in testes and HeLa cells.
Immunoprécipitation experiments were also carried out to further characterise the affinity- 
purified antibodies. One such experiment is shown in Fig. 4.3.6 (panel B) where it can be 
seen that the endogenous protein running at 83 kDa can be precipitated from a HeLa cell
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lysate using the antibody coupled to protein G-sepharose beads. Furthermore, this is a 
specific antibody/ antigen interaction since preimmune serum cannot reproduce the result.
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Fig. 4.3.6 Immunoblotting and immunoprécipitation using the 
affinity purified Arfophilin-2 -specific antibody.
Panel A: Lysates from rat testis, human testis, HeLa cells and HEK 
293 cells were run on an 8% SDS-PAGE gel alongside mock- 
transfected (mock) and untagged Arfophilin-2A/2B/2C-transfected 
(Arfo2) CHO cells (all 20 jjg per lane except transfected cells which 
had only 1 pg). The proteins were transferred to nitrocellulose and 
immunoblotted with the affinity-purified Arfophilin-2-specific antibody 
(50 ng/ml) according to the methods in section 2.2.4. The position of 
the 83 kDa molecular weight marker is indicated.
Panel B: HeLa cell lysates were subjected to immunoprécipitation 
using the Arfophilin-2 antibody (a Arfo 2; 10 pg/ml) coupled to protein 
G-sepharose, according to the method described in section 2.2.4.6. As 
a control, an equivalent amount of preimmune serum was used. 
Proteins associated with the beads (IP) and the supernatants (SP) 
were resolved on an 8% SDS-PAGE gel alongside 20 pg each of 
human testis and HeLa cell lysate. These were then transferred to 
nitrocelluose and immunoblotted with the same Arfophilin-2 antibody. 
The position of the 83 kDa molecular weight marker is indicated.
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4.3.7 Subcellular localisation of endogenous Arfophiiin-2 in 
interphase HeLa ceils
The data presented thus far have clearly established that Arfophilin-2 is expressed at the 
protein level in HeLa cells. Therefore, I used immunofluorescence and confocal 
microscopy to determine its subcellular localisation in this cell type; with a view to begin 
to understand what cellular function(s) it may be performing. As a first step to test its 
efficacy and specificity in such experiments, the affinity purified Arfophilin-2 antibody 
was used on its own to label fixed HeLa cells on coverslips. The results can be seen in Fig.
4.3.7.1, where diffuse cytosolic staining as well as perinuclear staining is apparent (upper 
panels). All the signals were abolished when the antibody was pre-incubated with antigen 
demonstrating that the staining patterns are specific for Arfophilin-2 (lower panel).
Double immunofluorescence labelling was then performed using the Arfophilin-2 antibody 
in conjunction with antibodies to a range o f other marker proteins. Representative confocal 
images from these experiments are shown in Fig. 4.3.7.2. Co-staining for filamentous actin 
(F-actin, panels a-c) clearly defines the outline o f the cells, as does staining for 
microtubules (MTs; panels d-f) using an a-tubulin antibody, and this allows good 
visualisation o f  the perinuclear Arfophilin-2 pool. Further analysis revealed that this 
staining was coincident with staining for the CI-MPR (Fig. 4.3.7.2, panels g-i) and to a 
lesser extent, the CD-MPR (Fig. 4.3.7.2, panels j-1) which both traffic between the TGN, 
late endosomes and the plasma membrane. It also partially colocalised with pCOP (Fig.
4.3.7.2, panels m-o), a constituent o f the COPI coatomer complex, and was adjacent to 
GRASP65 (Fig. 4.3.7.2, panels p-r), a Golgi cisternal stacking protein enriched in the 
medial Golgi (Barr et al., 1997). Colocalisation was not observed, however, with other 
proteins such as the AP-3 adaptor complex (Fig. 4.3.7.3, panels a-c) or GGAl (Fig. 4.3.7.3, 
panels d-f). Similarly, no obvious overlap was apparent with the endosomal transferrin 
receptor (TfR, Fig. 4.3.7.3, panels g-i) or RMEl (Fig. 4.3.7.3, panels j-1). Upon further 
investigation, it was noted that there was also a minor centrosomal pool o f Arfophilin-2 as 
evidenced by partial colocalisation with y-tubulin (Fig. 4.3.7.3, panels m-o) which is found 
at the hub o f the microtubule-nucleating centre. This pattern o f staining was so striking that 
centrosomes could easily be identified without the need for observing y-tubulin labelling, 
and it was specific as prior incubation o f the antibody with antigen abolished it (not 
shown). It was also noted that the Arfophilin-2 antibody stained peripheral structures 
resembling focal adhesions or filopodia (for example, see arrowheads in panel 1 o f Fig. 
4.3.7.2).
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Figure 4.3.7.1 Affinity purified Arfophilin-2 antibodies are specific 
for the antigen in immunofluorescence.
HeLa cells grown on coverslips were fixed and processed for 
immunofluorescence using the affinity purified Arfophilin-2 antibodies at a 
dilution of 1:100 (240 ng/ml), followed by an Alexa^®"^-conjugated anti­
sheep antibody, all according to the protocols described in section 2.2.3. 
The top two panels show representative confocal images of the stained 
cells. The bottom panel shows the effect of preincubating the antibody 
with 5 pg of recombinant His-Arfophilin-2 antigen for 30 min at room 
temperature. Scale bars, 10 pm.
Fig. 4.3.7.2 Subcellular localisation of endogenous Arfophilin-2 in 
HeLa cells.
HeLa cells grown on glass coverslips were washed in PBS and fixed in 
methanol at -20°C. They were then processed for immunofluorescence 
using the purified sheep anti-Arfophilin-2 antibody (Arfo 2; 1:200) in 
conjunction with a Cy3-conjugated anti-actin antibody (a-c), and 
antibodies to a  tubulin to label microtubules (MTs, d-f), CI-MPR (g-i), 
CD-MPR (j-1), pCOP (m-o) and GRASP65 (p-r). Alexa^^Aanti-sheep and 
Alexa'^^^-anti-rabbit/mouse secondary antibodies were then used as 
appropriate and the coverslips were mounted. Shown are 
representative confocal images. The arrowheads in panel I indicate 
peripheral Arfophilin-2 staining in focal adhesions. Scale bars, 10 pm.
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Fig. 4 3.7.3 Subcellular localisation of endogenous Arfophilin-2 in 
HeLa cells (continued).
HeLa cells grown on glass coverslips were washed in PBS and fixed in 
methanol at -20°C. They were then processed for immunofluorescence using 
the purified sheep anti-Arfophilin-2 antibody (Arfo 2; 1:200) in conjunction with 
antibodies against AP-3 (a-c), GGAl (d-f), TfR (g-i), RMEl (j-1) and y tubulin (m-
o) that were all used at a 1:200 dilution. Alexa®®^  anti-sheep and Alexa^ ®® anti­
rabbit/mouse secondary antibodies were then used and the coverslips were 
mounted. Shown are representative confocal images. The inset in panel o is an 
enlargement of the boxed region where partial colocalisation between 
Arfophilin-2 and y tubulin staining is apparent. Scale bar, 10 pm.
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4.3.8 Subcellular localisation of endogenous Arfophiiin-2 in 
dividing HeLa ceils
The centrosomal localisation o f Arfophilin-2 was particularly intriguing given the fact that 
the homologous N uf protein cycles on and off this organelle and is believed to function 
there at various stages o f the Drosophila syncytial cell cycle (Rothwell et al., 1998). Given 
this information, a preliminary experiment was performed looking at the distribution o f  
Arfophilin-2 in mitotic cells. An asynchronous population o f HeLa cells on glass 
coverslips was fixed and processed for immuno fluorescence using a-tubulin and 
Arfophilin-2 antibodies and care was taken not to wash o ff the mitotic cells. Dividing cells 
were then located and confocal images were taken. Although diffuse staining throughout 
the cytosol was apparent, Arfophilin-2 appeared concentrated at the spindle poles during 
metaphase (Fig. 4.3.8 panels a-c) and anaphase (panels d-f) and some cells exhibited 
Arfophilin-2 staining at the midbody during late telophase/cytokinesis (panels g-i).
4.3.9 The effects of drug treatment on endogenous Arfophiiin-2 
localisation
Further studies were performed to investigate the effects o f  the drugs nocodazole and 
brefeldin A (BFA) on Arfophilin-2 distribution. The former is a microtubule-disrupting 
agent known to result in shortened Golgi stacks (reviewed in Thyberg and Moskalewski, 
1985), while the latter causes a collapse o f the Golgi into the endoplasmic reticulum by 
inhibiting Arf activation by BFA-sensitive GEFs (see section 1.1.1.3). In control cells, as 
previously mentioned, Arfophilin-2 colocalises with the CI-MPR in the TGN region (Fig. 
4.3.9, panels a-c). Upon BFA treatment (20 pg/ml for 10 min), both proteins are dispersed, 
with Arfophilin-2 staining appearing very diffuse (Fig. 4.3.9, panels d-f). Nocodazole 
treatment (50 ng/ml for 1 h) also disrupted the localisations o f both proteins (Fig. 4.3.9, 
panels g-i), although Arfophilin-2 remained in punctate structures. While some 
colocalisation between the two proteins persisted following microtubule disruption, it was 
noticeably reduced (see inset in panel i, Fig. 4.3.9). Conversely, neither BFA nor 
nocodazole treatment appeared to have any effect on the distribution o f the centrosomal 
Arfophilin-2 staining (Fig. 4.3.9, panels j-o). In nocadazole-treated cells, Arfophilin-2 
immunoreactivity at the cell periphery was also apparent, as previously seen (see 
arrowheads panels i and o, Fig. 4.3.9). Cells were also treated for 1 h with 100 nM 
wortmannin but this had no discernible effect on Arfophilin-2 localisation suggesting that 
this is not dependent on phosphatidyl inositol 3 kinase activity (data not shown).
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Figure 4.3.8 Distribution of Arfophilin-2 in mitotic HeLa cells.
Asynchronous Mela cells (30-50% confluent) grown on coverslips were fixed 
and processed for immunofluorescence using the affinity purified Arfophilin-2 
antibodies (Arfo 2; centre panels and RED in the merged images) in conjunction 
with an a-tubulin antibody to stain microtubules (MTs; left hand panels and 
GREEN in the merged images). Representative images of cells in metaphase 
(panels a-c), anaphase (panels d-f) and late telophase/cytokinesis (panels g-i) 
are shown. Scale bar, 10 pm.
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Fig. 4.3.9 The effects of drug treatment on endogenous Arfophilin-2 
localisation
HeLa cells grown on glass coverslips were incubated in serum free media for 2 
h and then treated with DMSO (control, 1 h, panels a-c), brefeldin A (BFA; 20 
pg/ml for 10 min, panels d-f and j-1) or nocodazole (noco; 50 ng/ml for 1 h, 
panels g-i and m-o). The cells were washed in PBS, fixed in methanol and 
processed for immunofluorescence using the purified sheep anti-Arfophilin-2 
antibody (Arfo 2; 1:200) in conjunction with antibodies against CI-MPR (a-i), or y 
tubulin (j-o). Alexa^^^-anti-sheep and Alexa^®®-anti-rabbit/mouse secondary 
antibodies were then used. Shown are representative confocal images 
obtained. The inset in I represents a magnification of the boxed region. The 
arrowheads in panels i and o point to peripheral Arfophilin-2 staining. Scale 
bars, 1 0  pm.
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4.3.10 Biochemical analysis of Arfophiiin-2 in HeLa ceils.
The distribution o f  endogenous Arfophilin-2 in HeLa cells was also determined using 
biochemical fractionation approaches. In one approach, crude subcellular fractionations 
were performed to isolate low -(Pl) and high-(P2) speed pellets and soluble proteins (S) 
and these were then subjected to immunoblot analysis using a variety o f  antibodies to 
cellular markers as well as the Arfophilin-2 antibody. The results o f  these experiments can 
be seen in Fig. 4.3.10.1. The PI fraction contains the majority o f  Arf6 and the Na/K 
ATPase, suggesting that the plasma membrane is enriched in this fraction. The majority o f  
GRASP65 and GGAl were also present in the low speed pellet suggesting that a large 
proportion o f the Golgi may also be in this fraction. B y contrast, Arfophilin-2 was 
predominantly found in the high-speed P2 pellet with lower amounts in the cytosolic S 
fraction and a small amount in the PI pellet. Syntaxin 6, a t-SNARE implicated in 
TGN/endosomal traffic; RME-1, a regulator o f the recycling endosomes; 
cellubrevin/VAMP3, an endosomal v-SNARE; and y-tubulin, were all similarly more 
abundant in this Arfophilin-2-enriched high-speed fraction. The transferrin receptor was 
present in roughly equal amounts in both membrane fractions consistent with its recycling 
through the endosomal system to and from the plasma membrane. Collectively these data 
show that Arfophilin-2 exists in both cytosolic and membrane-associated pools, and 
suggest that the latter predominantly resides in a compartment distinct from the plasma 
membrane and Golgi, but enriched in endosomal markers. Furthermore, since the early 
endosomal markers EEAl and Rab5 appeared more abundant in the PI fraction, it is likely 
that the majority o f  membrane-associated Arfophilin-2 is in a later subcompartment(s) o f  
the endocytic system. These experiments were repeated using cells that had been treated 
with wortmannin and with cells that had been permeabilised and incubated with GTPyS, 
but neither o f these conditions appeared to affect the subcellular distribution o f Arfophilin- 
2 (data not shown).
Another approach was to take a post-nuclear HeLa cell homogenate and to separate it on a 
0.6 M to 1.8 M linear sucrose density gradient. Fractions recovered from such separation 
were then analysed by immuno-blotting for different cellular markers and for Arfophilin-2, 
This also revealed a cytosolic pool o f Arfophilin-2 present in fraction 1 at the top o f the 
gradient (Fig 4.3.10.2), and the membrane-associated pool was also found near the top o f  
the gradient in fractions 2 and 3 consistent with the previous experiments. The Na/K 
ATPase plasma membrane marker was enriched in fractions 5 and 6 as these membranes 
are denser. EEA l, RME-1, y-tubulin, (3COP, CI-MPR and syntaxin 12 all seemed fairly
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enriched in the lower density membranes nearer the top o f the gradient. Of these, only 
syntaxin 12 appeared to have a similar distribution to Arfophilin-2.
Interestingly, there are 2 distinct proteins cross-reacting with the GGAl antibody and these 
can be separated on the sucrose gradient with one peak at the top and the other in denser 
fractions more like those o f the plasma membrane. The two species also migrate differently 
on gels. It would be interesting to know what they represent as no real differences between 
the GGAs have thus far been reported. They could potentially be products o f different 
GGA genes, or they could be distinct GGAl splice variants or they could have undergone 
different post-translational modification.
Considering the immunofluorescence data and the biochemical fractionation data as a 
whole, Arfophilin-2 in HeLa cells resides in cytosolic and membrane-associated pools in 
the vicinity o f the trans-Golgi network and also at the centrosome.
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Fig.4.3.10.1 Immunoblot analysis of HeLa subceliular fractions.
HeLa cells grown in 10 cm dishes were scraped into HES buffer and 
homogenised as described in section 4.2.7. The cell homogenate was 
then subjected to centrifugation at 18,000 g for 20 min to produce the PI 
pellet. The supernatant was further centrifuged at 100,000 x g for 1 h to 
yield a P2 pellet and a cytosolic (S) fraction. The PI and P2 pellets were 
resuspended in buffer and 20 pg protein per lane of each fraction were 
resolved on 8-15% SDS-PAGE gels, as appropriate. The proteins were 
transferred to nitrocellulose and immunoblotted with the antibodies 
indicated on the left, according to the methods outlined in section 2.2.4.
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Fig.4.3.10.1 Immunoblot analysis of HeLa proteins separated on a 
linear sucrose density gradient.
HeLa cells grown in 10 cm dishes were scraped into HES buffer and 
homogenised as described in section 4.2.8. The cell homogenate was 
then applied to a 0.6 M to 1.8 M linear sucrose density gradient and spun 
at 33,000 rpm for 6 h in a Beckman SW-40 rotor. 1 ml fractions were 
taken from the top of the gradient (starting with fraction 1) and equal 
volumes of the fractions (20 pi) were subjected to SDS-PAGE on 8-15% 
polyacrylamide gels, as appropriate. The proteins were transferred to 
nitrocellulose and immunoblotted with antibodies against the proteins 
indicated on the left, all according to the methods outlined in section 
2.2.4.
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4.4 Discussion
The results presented in this chapter have described the molecular cloning and initial 
characterisation o f human Arfophilin-2, following its identification in the previous chapter.
By analysing and comparing the sequences o f  the genomic region, ESTs and the cDNAs 
recovered in the Arf5 yeast two-hybrid screen, it has become apparent that the Arfophilin-2 
gene is moderately large (about 200 kilobases) and encodes multiple splice variants. 
Whether the predicted Arfophilin-2A, -2B and -2C mRNAs actually produce distinct 
proteins is yet to be determined. Potentially, they could differ only in their 5 ’ UTRs, or 
they could result in distinct protein products. It is important to remember that only 
Arfophilin-2A was amplified in its entirety and that the assembled Arfophilin-2B and -2C 
constructs may not exist in vivo. For example, these 5’ ends may only exist if  the 10^  ^ from 
last exon is spliced out. On the other hand, the two exons found in the T20 yeast two- 
hybrid clone that were absent in other amplified cDNAs clearly indicate that alternative 
splicing resulting in distinct protein products does indeed occur. One o f these exons 
encodes the amino acid sequence EE[H/Q]FEDYGEG present in both Arfophilins 1 and 2, 
and this could be an interesting regulatory motif. From the Nix analysis, it seems likely 
that there is a promoter around the CpG island (in addition to one further upstream), 
although numerous attempts at RACE cloning the 5 ’ UTR o f  such a species have so far 
failed. If there are two promoters driving the expression o f the Arfophilin-2 gene, it would 
be interesting to see whether they are differentially regulated, for example in different 
tissues or at different stages o f the cell cycle.
The BLAST searches against the non-human EST databases revealed that there are many 
ESTs that are almost identical to the 3 ’ end o f Arfophiiin-1 but not Arfophilin-2, and that 
there are also some that are virtually identical to the 5 ’ end o f Arfophilin-2A, but not 
Arfophiiin-1. This either suggests that both genes may be present in some o f  these species, 
or that there are single genes having 5’ ends more like Arfophilin-2 and 3’ ends more like 
Arfophiiin-1. BLAST analysis also revealed that there are no significantly homologous 
genes in the Saccharomyces cerevisiae genome. This implies that the Arfophilins have 
evolved more recently and hence are more likely to participate in specialised cellular 
events in metazoans, unless o f course there are functional homologues that cannot be 
identified on the basis o f sequence analysis alone. It is o f note that yeast lack Class II Arf 
isoforms, and indeed homologues o f  several other proteins important in membrane 
trafficking in metazoans such as RME-1. The 70 amino acid conserved protein domain
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(PD031147) at the C-termini o f the Arfophilins and N uf presumably serves an important 
function for it to have been conserved through evolution. Interestingly, it contains a motif 
SLAxEL (where x is any amino acid) that is present in all species examined that could 
perhaps be a serine phosphorylation site. All o f  the proteins also appear to have coiled-coil 
structures in and around this region. Coiled-coils are often present at sites o f protein- 
protein interaction, for example in the formation o f SNARE complexes during membrane 
fusion (see section 1.1.7).
The proximity o f  the Arfophilin-2 gene to the neurofibromatosis type 1 (NFl) gene is 
interesting. N Fl encodes a putative Ras GEF and has an unusually high mutation rate (3 x 
10'  ^ to 1 X 1 0 '\ Vogel and Motulsky, 1997), which is why neurofibromatosis type 1 is one 
o f the most common autosomal dominant conditions. A subset o f  patients actually have a 
complete gene deletion resulting in a very severe phenotype including dysmorphism, 
mental retardation and the early onset o f a large number o f neurofibromas (see Riva et al., 
2000 and references therein). Fluorescent in situ hybridisation analysis o f some such 
patients has revealed that, centromerically from the N Fl gene, there is a common deletion 
breakpoint but that telomerically, the position o f the break is variable (Riva et al., 2000). 
These latter breaks would affect, to varying degrees, the Arfophilin-2 gene, whose 
existence is unknown to researchers in the neurofibromatosis field and which may aid in 
explaining the lack o f a genotype-phenotype correlation in the condition. It could be 
potentially useful to study these patients with respect to Arfophilin-2, although interpreting 
which effects are due to the disruption o f which o f the two genes may be problematic.
During the latter stages o f the work presented in this thesis, two mRNA sequences 
corresponding to that o f  Arfophilin-2 appeared in the GenBank and HUGE databases. 
They had come from large-scale cDNA sequencing projects and encoded the protein 
designated as KIAA1821 (accession numbers AB058724 and XM_050101). This protein is 
identical to the predicted Arfophilins-2B and -2C except in the first 27 amino acids. The 
extreme 5’ end o f  the KIAA1821 cDNA sequence encoding these amino acids does not 
appear to align with the genomic sequence in BLAST analysis and is, therefore, 
questionable. In addition, it is unlikely that the full ORF is present as there is no apparent 
5’UTR containing in-frame stop codons. If the complete ORF is present, however, it would 
encode a protein identical to that o f Arfophilin-2 A. The sequences also differ in that they 
have a 3 ’UTR o f ~5 kb, much larger than the ones present in testis. Semi-quantitative RT- 
PCR performed at the kazusa sequencing project using primers within the 3 ’UTR revealed 
the highest expression in brain, the tissue from which it was cloned with no expression 
apparent in testis (see http://www.kazusa.or.jp/huge/g^age/KIAAl 821/). The northern
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analysis performed here is more informative as it uses a probe to the coding sequence and 
not to the variable UTR. It seems likely that the large transcripts apparent on the northern 
blot in brain, heart and skeletal muscle are due to similarly large 3 ’ UTRs. These have been 
linked to decreased mRNA stability particularly if  AU-rich elements are present and this 
may influence the protein levels accordingly in these tissues (reviewed in Guhaniyogi and 
Brewer, 2001).
The significance o f  the apparent overexpression o f Arfophilin-2 mRNAs (and Arfophilin-
1) in testes is not presently known. It will be interesting to determine whether this is due to 
a unique testis-specific function or whether this is a reflection o f  the high degree o f  mitotic 
and meiotic cell division occurring in testes compared to the other tissues examined which 
are terminally differentiated. The notion o f a role in cell division is attractive given the 
homology with N uf and also given the localisation o f Arfophilin-2 at the spindle poles and 
the midbody in dividing cells. This, however, will be discussed in greater depth in the next 
chapter. Whether Arfophiiin protein levels are actually different between tissues has not 
been addressed. From immunoblot analysis, similar levels o f  Arfophilin-2 appear to be 
present in testis and in HeLa cells with markedly lower amounts in HEK 293 cells. HeLa 
cells are derived from a carcinoma, and consistent with elevated expression, an Arfophilin- 
1 EST (xsl 76) has been reported to be overexpressed during the development o f  pancreatic 
cancer (Gress et al., 1996).
The Arfophilin-2 polyclonal antibody characterised in this chapter is a powerful tool for 
future studies o f Arfophilin-2. It has proved to be a good reagent for immuno-blotting and 
immunofluorescence and also to be capable o f immunoprecipitating the native protein 
from cell lysates. Importantly, it has shown that heterologously expressed Arfophilin-2A 
migrates exactly as the native protein in testis, HeLa, HEK 293 cells indicting that the full 
open reading frame has been cloned. By separating HeLa cell homogenates by 
centrifugation, it has also been possible to see that native Arfophilin-2 is both cytosolic and 
associated with intracellular membranes devoid o f  plasma membrane markers.
Indirect immunofluorescence microscopy has also provided much information regarding 
the subcellular distribution o f Arfophilin-2. In particular, a major brefeldin A-sensitive 
pool has been localised to the TGN region o f the cell. This localisation would be consistent 
with a role for Arfophilin-2 in Arf5-mediated events. However, minor but specific staining 
was also observed at the centrosome and in peripheral structures such as focal adhesions or 
actin-rich protrusions. Plasma membrane localisation would be more in keeping with a role 
in Arf6 signalling, since this is where the activated Arf6 resides (D ’Souza-Schorey et al..
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1995; Cavenagh et al., 1996; see also section 1.3.5). Given that Exton’s group has shown 
Arfophiiin-1 binding to both o f these Arf isoforms (Shin et al., 1999, 2001), it is tempting 
to speculate that, depending on the cellular context, the Arfophilins could be dual class II 
and class III effectors. Arf5 appears to require the N-terminal alpha helix for the 
interaction with Arfophiiin-1 (Shin et al., 1999) while Arf6 seems to bind independently o f 
the N-terminus via a more central region (Shin et al., 2001). This implies that there are two 
distinct binding sites in the Arfophiiin-1 C-terminal 144 residues, and it is conceivable that 
each interaction could mediate distinct downstream events. Indeed, the Arfophilins may 
function as linkers between Arf5 and Arf6, rather like the proposed role for Arfaptin 
2/PORl in Arf6 and Rac signalling (refer to sections 1.3.4.5 and 1.3.7). It would be 
interesting to see whether Arf5 and Arf6 binding is mutually exclusive, and also whether 
the two Arfophilins exhibit any preferences for the two Arf isoforms.
The centrosomal pool o f Arfophilin-2 needs further characterisation. There are well- 
documented methods for purifying centrosomes (Blomberg-Wirschell and Doxsey, 1998; 
Mitchison and Kirschner, 1986) and these should be employed to confirm that Arfophilin-2 
is indeed associated with these organelles.
It will be extremely interesting in future work to discover whether Arfophiiin-1 exhibits 
any similarities or differences compared to Arfophilin-2. Once the antiserum is affinity 
purified, similar experiments can be performed to see in which cells it is produced, where 
it is localised, and also to test whether the predicted open-reading frame encodes a protein 
that migrates the same as native protein(s) on SDS-PAGE gels. Furthermore, since we 
raised antibodies in different species, it should be possible to examine the distributions o f  
both Arfophilins relative to each other in the same cells by immunofluorescence. 
Hopefully both reagents will be useful for other applications such as microinjection, 
immuno go Id electron microscopy and immunocytochemistry. Antibody injection is a 
potential way o f perturbing Arfophiiin function in live cells and is one avenue worth 
exploring. Similarly, immunogold electron microscopy would allow much higher 
resolution images to be taken and this could help further pinpoint Arfophiiin localisation.
Although, Arfophilin-2 was identified by virtue o f  its selective interaction with Arf5Q71L 
in the yeast-two hybrid system, this interaction has not yet been confirmed biochemically. 
Initial attempts were hampered by the fact that E. coli would not produce GST-Arfophilin- 
2 from a pGEX-5X vector or His-tagged Arfophilin-2 from a pQE vector. In both cases 
translation appeared to stop prematurely resulting in a ladder o f  protein when run on SDS- 
PAGE gels. Many different growth conditions and E. coli strains were tried to no avail.
175
Several approaches were attempted unsuccessfully, including GST pulldowns and co- 
immunoprecipitations (see Table 4.4.1 below).
beads protein
produced
in?
interacting
protein?
produced in? detected using?
GSH-GST- E. coli HA-Arfophilin-2 HeLa or CHO anti-HA
Arf5Q71 L cells
GSH-GST-Arfo2 E. coli Arf5Q71LHA CHO cells anti-HA
(330)
GSH-GST-Ario2 E. coli Arf5Q71 LHA CHO cells anti-HA
(152)
GSH-GST- E. coli His-Arfo2(330) E. coli anti-His
Arf5Q71L
His-Arfo2(330) E. coli GSH-GST-
Arf5071L
E. coli anti-GST
Protein G- HeLa cells Arfo2 HeLa cells anti-Arfo2
sepharose-anti-
HA-Arf5Q71LHA
(endogenous)
Protein G- HeLa cells Arf5Q71 LHA HeLa cells anti-HA
sepharose-anti-
Arfo2-Arfo2
(endogeno
us)
Protein G- CHO cells Arf6 CHO cells anti-Arf6
sepharose-anti-
Arfo2-Arfo2
(endogenous)
Table 4.4.1 Sum m ary of Arf/Arfophilin-2 biochem ical interaction a ssay s 
attem pted.
Various pulldown/co-immunoprecipitation approaches were employed 
unsuccessfully to try to confirm the Arf5/Arf6 Interaction with Arfophilin-2, using 
both native and recombinant proteins. Numbers in brackets refer to the number of 
C-terminal amino acids used in truncated forms of Arfophilin-2. * GTPyS was 
included in these experiments to try to ‘lock’ the endogenous Arf in the active 
GTP-bound conformation. Following 1 h Incubations at 4°C, the beads were 
washed and associated proteins were removed by boiling in SDS-PAGE sample 
buffer. Samples were then processed for immunoblotting using the antibodies 
indicated in the right hand column.
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Bacterially expressed Arfophilin-2 may be lacking important post-translational 
modifications necessary for the interaction, or the proteins may be incoiTectly folded. It 
would be useful to repeat the Exton lab procedure, whereby GST-tagged Arfophiiin was 
produced in CHO cells (Shin et al., 1999). Otherwise, other eukaryotic systems such as 
baculovirus expression or in vitro translation using a reticulocyte lysate system could prove 
fruitful. Also potentially problematic is the fact that the Arfophilin-2 antiserum was raised 
against the portion containing the Arf-binding domain. This may hamper co- 
immunoprecipitation experiments. Similarly, while a GAL4 DNA-binding domain fusion 
at the N-terminus of Arf5 may permit an interaction in the yeast two-hybrid system, an N- 
terminal GST-tag may not allow the interaction in pulldown assays. Despite the lack of 
data from these important experiments, it seems highly likely that Arfophilin-2 is a true 
Arf binding protein given that Arfophiiin-1 has been shown to be (Shin et al., 1999, 2001) 
and given that they are 63% identical (and 79% conserved) in their C-terminal Aif-binding 
domains.
In summary, chapter 4 has shown that Arfophilin-2 is an endogenous cytosolic and 
membrane-associated protein in HeLa cells. It exhibits the same electrophoretic mobility as 
the cloned Arfophilin-2A and, by immunofluorescence microscopy, it localises around the 
trans-Golgi network and the centrosome in this cell line. HeLa cells represent a good 
model system to study, as they are likely to express the appropriate cellular machinery 
required for Arfophilin-2 function.
The next step is to try to elucidate what the function of Arfophilin-2 might be. One 
approach to address this is to construct chimeric proteins whereby full-length and truncated 
foiTns of Arfophilin-2 are fused to GFP, and to express them in cells and monitor their 
behaviour. This type of experiment is described in the following chapter.
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Chapter 5
Functional characterisation of Arfophilin-2
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5.1 Introduction
As described in chapter 3, a yeast-two hybrid screen for Arf5 effectors identified a novel 
protein that we named Arfophilin-2. The cloning and initial characterisation o f Arfophilin- 
2 was then presented in chapter 4, where the native protein was examined in HeLa cells 
and shown to reside in cytosolic and membrane-associated pools, and to localise around 
the trans~Go\gi network and the centrosome. The main aim o f  this chapter is to expand on 
these findings and to provide insight into the cellular function(s) o f Arfophilin-2. One 
specific aim includes the generation, expression and analysis o f  GFP-Arfophilin-2 fusion 
proteins. Another aim is to pursue the finding that Arfophilins share sequence homology 
with nuclear fallout, a well-characterised Drosophila protein, and to examine whether any 
functional homology can be uncovered. A  third aim is to investigate the relationship 
between Arfophilins and Arfs in a cellular context by making use o f mutant forms o f Arf.
5.1.1 Nuclear fallout
In addition to the observed homology with KIAA0665/Arfophiiin, it was apparent that 
Arfophilin-2 also shared significant homology with a hypothetical Caenorhabditis elegans 
protein and Drosophila melanogaster nuclear fallout (Sullivan et al., 1993).
Nuclear fallout is an essential matemal-effect gene, whose product is required for 
cellularisation (Rothwell et al., 1998; Rothwell and Sullivan, 2000). This process is a 
dramatic variation o f animal cell cytokinesis (Schejter and Wieschaus, 1993; Miller and 
Kiehart, 1995) that transforms a one-cell syncytium into a multicellular embryo by the 
synchronous encapsulation o f approximately 6000 cortical nuclei with one continuous 
plasma membrane furrow. The furrow invaginates between adjacent nuclei and at right 
angles to the cell surface before widening along its base to seal each nucleus o ff from the 
inner cytoplasm. Furrow progression is dependent on an actomyosin-based contractile 
mechanism that also requires other elements such as anillin, septins and formin homology 
proteins (Glotzer, 2001). Golgi derived membrane secretion and syntaxin-mediated fusion 
with the plasma membrane are also key events, as in cytokinesis (Glotzer, 2001).
Nuclear fallout encodes a highly phosphorylated coiled-coil protein o f 502 amino acids, 
whose subcellular localisation changes in a cell-cycle-regulated fashion (Rothwell et a l ,  
1998). During the late syncytial divisions, it is generally cytoplasmic but concentrates at 
the centrosomes during prophase. It is also found at the centrosomes throughout 
cellularisation where it is believed to load vesicles onto microtubules for transport to the
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furrows (Rothwell et a l, 1999). In «M/-mutant embryos, the recruitment o f cortical actin is 
disrupted as is the localisation and phosphorylation o f another protein required for cortical 
furrow formation, discontinuous actin hexagon (Dah) (Rothwell et al., 1999; Zhang et al., 
2000). Interestingly, the sequence o f  Dah is homologous to the dystrobrevin family o f  
proteins and the carboxyl terminal portion o f  the dystrophin molecule. A  working model 
for N uf and Dah function, as proposed by Sullivan and colleagues, the principal 
investigators o f these proteins, is given in Fig. 5.1.1.
Later in the chapter, evidence will be provided suggesting that Arfophilins and nuclear 
fallout are functionally related, and the implications for membrane trafficking and 
cytokinesis w ill be discussed.
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Fig. 5.1.1 Working model proposed by Sullivan and colleagues 
for Nuf function in the Drosophila embryo.
A model proposing that Nuf acts at the centosome to load vesicles for 
transport to the cortex. Side by side particles of actin and Dah are shown 
being transported together, as a unit. Furrow invagination may occur 
through vesicle fusion in a process requiring the Dah membrane- 
associated protein. Reproduced from Rothwell et al., 1999.
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5.2 Materials and Methods
Arf5T31N-HA and Arf5Q71L-HA mammalian expression constructs were generous gifts 
from Jeremy Tavare (University o f  Bristol) and the Arf6T27N-HA construct was kindly 
provided by Julie Donaldson (NIH, Bethesda, USA). The wild-type ArfS-FLAG 
mammalian expression plasmid was previously generated in this laboratory and has been 
described elsewhere (Campbell, 1999).
5.2. f Generation of Arfophilin constructs for over-expression
Several Arfophilin-1 and Arfophilin-2 mammalian expression constructs were generated 
(see Fig. 5.2.1 for a diagrammatic overview, and the appendix for plasmid maps). The 
plasmid T20 pACT2 (see the appendix) recovered in the yeast two hybrid screen had three 
Bgl II restriction sites, one just between the GAL4 activation domain and the HA tag, an 
internal one in the Arfophilin-2 ORF 990 bases from the stop codon, and one immediately 
after the Arfophilin-2 3 ’UTR. This plasmid was, therefore, partially digested for 20 min 
with Bgl II and the DNA fragments were separated by agarose gel electrophoresis as 
described in section 2.2.1. This allowed the isolation o f a partially digested fragment in 
which the internal Bgl II  site was uncut. This was gel extracted and ligated into the BamHl 
site o f pCDNA3.1mycHis (Invitrogen) and the Bgl II site o f pEGFPC2 (Clontech), giving 
rise to construct A  (Arfo-2T2o pCDNA3) and construct B (Arfo-2T2o pEGFPC2), 
respectively. The cut vectors were treated with calf intestinal alkaline phosphatase 
(Promega) and gel purified prior to ligation and all procedures were according to the 
general molecular biology protocols described in section 2.2.1. The presence and correct 
orientation o f the inserts were verified by further restriction digestion (not shown). The 
HA epitope excised from the pACT2 vector contained an ATG initiation codon and 
immunoblot analysis using an antibody to the HA tag revealed that both proteins were 
efficiently translated in transfected HeLa cells (not shown). For the production o f construct 
C in Fig. 5.2.1 (Arfo-2330 pEGFPC2), plasmid T20 pACT2 was digested to completion 
with Bgl II and the resulting ~1 ,3 kb band (representing the 3 ’ kilobase o f the ORF and the 
3 ’UTR o f  Arfophilin-2) was gel purified and also ligated into the Bgl II site o f pEGFPC2. 
Again the presence and correct orientation o f the insert was verified by further restriction 
digestion. The analogous Arfophilin-1 construct (D in Fig. 5.2.1; Arfo-Uso pEGFPC2) was 
obtained by PCR and subsequent subcloning into pEGFPC2. Briefly, the 3 ’ 1 kb o f the 
Arfophilin-1 ORF was amplified using Pfu polymerase and primers 5 ' -  
ggatccGGCTCTCCAGCAAGAAGGTGGCAAGG-3 ' {BamHl site in Small) and 5 ' -gtcgacGACCTT
182
ccTGCCTCTACTTGACCTCCA-3 ' {Sal I  site in small, stop codon in bold) from KIAA0665 
clone (in pBluescript SK^, obtained from Dr. Ohara, Kazusa sequencing project, Japan). 
This was then treated with Taq polymerase to add A  base overhangs, TA cloned into 
pCRII-TOPO as described in sections 2.2.1.5 and 2.2.1.6, and sequenced to ensure no 
mutations were present. This plasmid was then digested with BamH l and Sal I  and the 
released fragment was gel purified and ligated into the Bgl II and Sal I  sites o f pEGFPC2.
Constructs I, J and K in Fig. 5.2.1 (untagged Arfophilin-2 A, -2B and -2C, respectively) 
were described in section 4.2.4. To generate constructs E, G and H in Fig. 5.2.1 (encoding 
eGFP fused to the N-termini o f Arfophilin-2A, -2B and -2C, respectively), the Arfophilin- 
2 (putative) ORFs were excised from constructs I, J and K by digestion with EcoRl and 
Sal I. These were then gel purified and ligated into the EcoRl and Sal I  sites o f pEGFPC2
5.2,2 Generation of GFP-Nuf mammalian expression construct
A N uf cDNA (kindly provided by Dr. W. Sullivan, UCSC, Santa Cruz, USA) was used as 
template in a PCR reaction using the EXPAND kit (see section 2.2.1.1) and primers 5 ' - 
ggatccGCATGGCACCAATGCCCCGAATTCAGTTAC-3 ' {BamHl sitc in Small letters, ATG in 
bold) and 5 ' -gtcgacCTACTTTCGCTCCATGGGCTTGACTTCCAG-3 ' {Sal I  site in small letters, 
stop codon in bold). The resulting ~1.5 kb product was TA cloned into pCRII-TOPO 
according to the methods described in section 2.2.1.6 and sequenced to ensure no 
mutations had been introduced during amplification. The N uf ORF was then excised from 
the pCRII vector by restriction digestion with BamHl and Sal I  and then subcloned into the 
Bgl II and Sal I  sites o f pEGFPC2 (see appendix).
183
HA epitope Exon x-10i i
pCDNA3 1 1 Arfo-2T2o TAA
Arfo-2T2o TAA
i
Arfo-2ggQ TAA
Arfo-ljao TAA
antigen
minimum Arf-BD
A
B
C
D
Arfo-2A TAA
Arfo-2A TAA
Arfo-2B TAA G
Arfo-2C TAA H
ATG Arfo-2A TAA 1
ATG Arfo-2B TAA J
ATG 1 Arfo-2C TAA
Fig. 5.2.1 Diagrammatic overview of Arfophilin mammalian expression 
constructs
Shown are  protein products encoded by constructs A-K. Construct A w as in vector pCDNAS.I while 
constructs B-K w ere in pEGFP-N or -0  vectors (see  text for more details). eG FP in dark green 
corresponds to enhanced green fluorescent protein. Arfo-2j2o (constructs A and B) represen ts the 
longest clone recovered in the yeast two-hybrid screen, directly subcloned including HA epitope tag 
(in red). C and D represent the C-terminal 330 amino acids of Arfophilin-2 and Arfophilin-1, 
respectively, fused to the C-terminus of eGFP. Construct F represen ts Arfophilin-2A lacking the 10*^  
from last exon. E, G & H represent full-length Arfophilins-2A/-2B/-2C, respectively, fused to the C- 
terminus of eG FP (described in section 4.2.4). I, J & K are  full-length untagged Arfophilin-2A/-2B & - 
2C constructs, respectively. The approximate positions and sizes of the minimal Arf-binding domain 
(Arf-BD) and the portion of Arfophilin-2 used for antibody production are  given at the top of the 
diagram.
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5.2.3 Generation of GFP-Arfophilin-2 stabie ceil lines
Sparsely populated (~10-15% confluency) HeLa, HEK 293 and CHO cells growing in 10 
cm dishes (three each) were transfected with Arfo-2330 pEGFPC2 (encoding the C- 
terminal 330 amino acids o f Arfophilin-2 fused to the C-terminus o f  enhanced GFP; 
construct C in Fig. 5.2.1) according to the Lipofectamine method described in section
2.2.2.4. Nineteen hours post-transfection the media were replaced with the appropriate 
complete growth media (containing 10% foetal calf serum, see section 2.2.2.1 for precise 
compositions) to which sterile-filtered G418 sulphate (Sigma) had been added to a final 
concentration o f  600 pg/ml. These G 418-containing complete growth media were used for 
all subsequent culture o f  these cells and the media were replaced every 2-3 days. Cells 
were grown at 37°C in a humidified atmosphere containing 5% CO2, as with the wild type 
cells. After 1 to 2 weeks, the G418-resistant cells from each cell type were trypsinised (see 
section 2.2.2.2), pooled, spun at 2000 x g for 3 min at room temperature, and resuspended 
in 20 ml complete growth media containing 600 pg/ml G418 sulphate. The cells were then 
serially diluted in the same media in sterile 96 well plates (Iwaki, 100 pl/well) using a 
multi-channel pipette. The cells were returned to the incubator and grown for a further 3-4 
weeks. During this time, the cells were monitored for the presence o f single colonies in the 
wells and for GFP fluorescence associated with those colonies using a Zeiss Axiovert 
fluorescence microscope. None o f the HeLa transfectants exhibited any GFP fluorescence, 
while many CHO and HEK 293 colonies did. These were allowed to reach confluency, at 
which point they were trypsinised using 100 pl/well trypsin/EDTA (Gibco, Life 
Technologies, Paisley, UK) and transferred to 25 cm2 flasks. Once these reached near 
confluency, the cells were further passaged into several 75 cm2 flasks (see section 2.2.2.2). 
When sufficient cells had grown, several flasks o f the different G418-resistant, GFP- 
Arfophilin-2-expressing clones were frozen down (see section 2.2.2.3), while others were 
maintained for subsequent experiments.
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5.3 Results
5.3.1 Subcellular localisation of overexpressed GFP-Arfophiiin-2 
chimeras
In an attempt to shed light on the cellular role o f Arfophilin-2, constructs were engineered 
to encode chimeric proteins fused to enhanced green fluorescent protein (GFP). Initially 
these were made by fusing the 3 ’ ends o f Arfophilin-2 recovered in the yeast two-hybrid 
screen to the 3 ’ end o f  GFP in pEGFP-C vectors, but this was then extended to include 
full-length sequences. All o f the constructs are described in section 5.2.1 and graphically 
represented in Fig. 5.2.1. These were then transiently transfected into HeLa and CHO cells 
and the resulting overexpressed proteins were monitored by laser scanning confocal 
microscopy. In addition to the GFP fluorescence, known cellular compartments were 
labelled using a panel o f  antibodies to different marker proteins in indirect 
immunofluorescence experiments similar to the ones described in chapter 5. These 
analyses revealed that, in both cell types, GFP-Arfophilin-2 localised to a tight peri-nuclear 
compartment that surrounded the centrosome marker protein y-tubulin (HeLa cells Fig.
5.3.1.1 A, panels a-c; CHO cells not shown). More strikingly, transfected cells displayed a 
dramatic accumulation o f transferrin receptors (TfRs) and the recycling endosomal marker 
Rab 11 in the same peri-centriolar region, while adjacent untransfected cells exhibited 
much more diffuse staining for these proteins (Fig. 5.3.1.1 A, panels d-i). A similar change 
in distribution was also observed for GGAI (Fig. 5.3.1.1 A, panels j-1). By contrast, the 
distributions o f  a variety o f other proteins were unaffected by GFP-Arfophilin-2 
expression. These included Golgi proteins such as GRASP 55 (Fig. 5.3.1.1 A, panels m-o) 
and GRASP 65 (not shown), p COP coatomer protein (Fig. 5.3.1.IB, panels a-c), adaptor 
proteins AP-1 (y adaptin subunit, Fig. 5.3.1.IB, panels d-f) and AP3 (5 subunit. Fig. 
5.3.1.IB, panels g-i), and both isoforms o f the mannose-6-phosphate receptors (Fig. 
5.3.1.IB, panels j-o). Similarly early endosomal marker proteins such as Rab 4, EEAl and 
the glucose transporter GLUTl showed no apparent alterations in distribution (Fig. 
5.3.1.1C, panels a-i), and nor did clathrin (Fig. 5.3.1.1C, panels j-1) or the small GTPase 
Rac (Fig. 5.3.1.1C, panels m-o). Other proteins involved in membrane trafficking events, 
such as RM El, TGN38, sortilin, PACS-1, PLDl, dynamin II, Rab5 and Rho also appeared 
to be unaffected, although the antibodies to some o f  these were poor for 
immunofluorescence (data not shown). Nevertheless, these data as a whole suggested that 
GFP-Arfophilin-2 overexpression was specifically interfering with some aspect o f the 
recycling endosomes. All the experiments shown in Figs. 5.3.1.1 A-C were performed
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using constructs B or F from Fig. 5.2.1, but similar results were seen for all constructs 
containing the C-terminal 330 amino acids or more.
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Fig. 5.3.1.1A Localisation of GFP-Arfophilin-2 in HeLa ceiis.
HeLa cells transiently expressing GFP-Arfophilin-2 (Arfo2; shown in the 
centre panels and GREEN in right-hand panels) were fixed in methanol 
18 h after transfection and processed for immunofluorescence using 
primary antibodies against y tubulin (a-c), TfR (d-f), R ab ll (g-i), GGAI 
(j-1) and GRASP 55 (m-o). Confocal images were taken and the marker 
proteins are shown on the left-hand panels and RED in the merged 
images. Scale bars, 10 pm.
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Fig. 5.3.1.1B Localisation of GFP-Arfophiiin-2 in HeLa ceiis.
HeLa cells transiently expressing GFP-Arfophilin-2 (Arfo2; shown in the 
centre panels and GREEN in right-hand panels) were fixed in methanol 18 h 
after transfection and processed for immunofluorescence using primary 
antibodies against p  COP (a-c), API ( y  adaptin; d-f), AP3 ( 5  subunit; g-i), 
CI-MPR (j-1) and CD-MPR (m-o). Confocal images were taken and the 
marker proteins are shown on the left-hand panels and RED in the merged 
images. Scale bars, 10 pm.
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Fig. 5.3.1.10 Localisation of GFP-Arfophiiin-2 in HeLa ceils.
HeLa cells transiently expressing GFP-Arfophilin-2 (Arfo2; shown in the 
centre panels and GREEN in right-hand panels) were fixed in methanol 
18 h after transfection and processed for immunofluorescence using 
primary antibodies against Rab4 (a-c), EEAl (d-f), GLUTl (g-i), clathrin 
(j-1) and R a d  (m-o). Confocal images were taken and the marker 
proteins are shown on the left-hand panels and RED in the merged 
images. Scale bars, 10 pm.
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Fig. 5.3.1.2 Localisation of GFP-Arfophiiin-1 in HeLa ceiis.
HeLa cells transiently expressing GFP-Arfophilin-1 (GFP-Arfol; construct 
D in Fig. 5.2.1; shown in the centre panels and in GREEN in right-hand 
panels) were fixed in methanol 18 h after transfection and processed for 
immunofluorescence using primary antibodies against y tubulin (a-c) and 
the transferrin receptor (TfR; d-f). Confocal images were taken and the 
marker proteins are shown on the left-hand panels and RED in the 
merged images. Scale bars, 10 pm.
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Similar experiments were also performed using the construct encoding GFP fused to the C- 
terminal 330 amino acid residues o f Arfophilin-1 (construct D in Fig. 5.2.1). Although this 
fusion protein was less extensively studied, it also localised around the centrosome (Fig. 
5.3.1.2, panels a-c) and specifically caused an accumulation o f  TfRs in the same region 
(Fig. 5.3.1.2, panels d-f).
5.3.2 Analysis o f TfR trafficking in GFP-Arfophiiin-2 expressing 
ceiis
In light o f these findings, experiments were performed to determine whether the profound 
morphological effects on TfR distribution were due to a specific block in its exit from 
recycling endosomes or whether the compartment had simply become concentrated in a 
smaller physical space whilst still able to function. To this end, it was determined whether 
the GFP-Arfophilin-2 and TfR-positive compartment was accessible to fluorescently 
labelled transferrin added to the culture medium, and if  so, whether this could be chased 
out o f the compartment with unlabelled transferrin. Within 5 min o f uptake at 37”C, 
substantial colocalisation between the GFP chimeras and Texas-red transferrin was 
observed (Fig. 5.3.2.1, panels a-c), demonstrating that TfRs from the cell surface were able 
to traffic efficiently to the compartment. After a 30 min uptake, the GFP-Arfophilin-2 
compartment was brightly stained with Texas-red transferrin (Fig. 5.3.2.1, panels a-c) and 
a steady decrease in transferrin fluorescence was observed over the chase time in both 
transfected and untransfected cells (Fig. 5.3.2.1, panels g-r). By 90 min nearly all the 
labelled transferrin had disappeared (Fig. 5.3.2.1, panels d-r).
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Fig. 5.3.2.1 Effects of GFP-Arfophilin-2 overexpression on fluorescent 
transferrin trafficking in HeLa cells.
HeLa cells transiently expressing GFP-Arfophilin-2 (Arfo2; shown in the centre 
panels and GREEN in right-hand panels) were serum starved for 1 h then 
incubated with 1 pg/ml Texas Red-transferrin either for 5 min (a,b and c) or for 30 
min (d-r). Those incubated for only 5 min were washed and fixed immediately 
while those incubated for 30 min were washed and further incubated in complete 
medium containing serum and 1 0 0  pg/ml unlabelled transferrin for the times 
indicated (in minutes). These cells were then washed in ice-cold PBS, fixed in 
methanol and confocal images were taken. Transferrin fluorescence is shown in 
panels a,d,g,j,m & p and in RED in the merged images. Scale bars, 10 pm.
193
5.3.3 Sensitivity of GFP-Arfophilin-2 to drug treatment
The effects o f the fungal metabolite brefeldin A, the actin monomer-stabilising agent 
latrunculin A and the microtubule disrupting drug nocodazole on the distribution o f GFP- 
Arfophilin-2 were assessed. In contrast to the effect on the endogenous protein (see Fig.
4.3.7.4, panels a-f), a 10 min brefeldin A treatment (20 p-g/ml) had no obvious effect on the 
localisation o f  GFP-Arfophilin-2 despite markedly scattering GRASP 55 immunoreactivity 
(Fig. 5.3.3.1, panels a-f). Moreover, GGAI colocalisation persisted under these conditions 
(Fig. 5.3.3.1, panels g-i), as did colocalisation with the transferrin receptor and R abll (not 
shown). Similarly, 200 pM latrunculin A  did not alter GFP-Arfophilin-2 distribution but 
did lead to gross changes o f the actin cytoskeleton as evidenced by diffuse staining and the 
lack o f  discernible actin filaments (Fig. 5.3.3.2, panels a-f). Conversely, a 1 h 50 ng/ml 
nocodazole treatment did disperse GFP-Arfophilin-2 from its peri-centrosomal location, 
resulting in large punctae present throughout the cytoplasm (Fig 5.3.3.3, panels d-f), 
demonstrating that the integrity o f the microtubule cytoskeleton is required for its 
localisation. This dispersal was reversible since the fusion protein returned to the 
microtubule organising centre within 1 h following a washout o f  the drug (Fig. 5.3.3.3, 
inset in panel f). Furthermore, analysis o f TfR and GGAI immunofluorescence following 
nocodazole treatment showed that colocalisation with GFP-Arfophilin-2 was maintained 
under these conditions (Fig. 5.3.3.3, panels g-1), suggesting that all three molecules were 
intimately associated with one another. Rab 11, however, could not be detected in the 
dispersed punctae (data not shown), although the Santa Cruz R abll antibody is not 
particularly sensitive.
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Fig. 5.3.3.1 Effect of Brefeldin A treatment on GFP-Arfophiiin-2 
locaiisation.
HeLa cells on coverslips were transiently transfected with GFP-Arfophilin-2 
(GFP-Arfo2). 18 h post-transfection, the cells were incubated in serum free 
medium for 2 h and then with 20 pg/ml Brefeldin A (BFA, d-i) or vehicle control 
(a-c) for 10 min. Cells were then fixed in ice-cold methanol and processed for 
immunofluorescence using aGRASP55 (a,d, RED in c,f) and aGGAI (g, RED in 
i) primary antibodies. GFP fluorescence is in GREEN in the merged images. 
Scale bars, 10 pm.
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Fig. 5.3.3 2 Effect of disruption of the actin cytoskeieton on GFP- 
Arfophiiin-2 iocalisation.
HeLa cells on coverslips were transiently transfected with GFP-Arfophilin-2 
(Arfo2). 18 h post-transfection, the cells were incubated in serum free medium 
for 2 h and then with 200 pM latrunculin A (Lat A, d-f) or vehicle control (a-c) for 
10 min. Cells were then fixed in ice-cold methanol and incubated with a Cy3- 
conjugated monoclonal anti-actin antibody (left hand panels, RED in merged 
images). Confocal images are shown with GFP fluorescence is GREEN in the 
merged images. Scale bar, 10 pm.
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Fig. S.3.3.3 The effect of microtubule disruption on GFP-Arfophiiin-2 
locaiisation.
HeLa cells on coverslips were transiently transfected with GFP-Arfophilin-2 
(Arfo2). 18hrs post-transfection, the cells were incubated in serum free medium 
for 2 h and then with 50 ng/ml nocodazole (noco, d-i) or vehicle control (a-c) for 1 
h. Cells were then fixed in ice-cold methanol and processed for 
immunofluorescence using anti-a tubulin (a,d, RED in c,f), aTfR (g, RED in i), or 
aGGAI (j, RED in i) primary antibodies as indicated. The inset in f shows a 
typical GFP-arfophilin-2 expressing cell 1 hr following a washout of the drug. GFP 
fluorescence is in GREEN in the merged images. Scale bars, 10 pm.
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5.3.4 Analysis of GFP-Nuf expression in HeLa ceiis
Given the fact that Arfophilin-2 is homologous to Drosophila nuclear fallout and that both 
proteins partly localise to the centrosome, I sought to determine whether they exhibited any 
functional similarities. Since the homology is in the carboxyl terminal where Arfs bind 
Arfophilin-2, one o f the most obvious experiments was to investigate whether N uf was 
itself an Arf-binding protein. To this end, a N uf cDNA was obtained from W. Sullivan 
(Santa Cruz, CA, USA) and cDNAs o f the Drosophila Class I, II and III Arfs were 
obtained from the Berkeley Drosophila Genome project (http://www.fruitfly.org/). These 
were then subcloned and tested for interactions in the yeast-two hybrid system in much the 
same way as described in chapter 3. Both full-length N uf and the C-terminal 300 amino 
acids (the Arfophilin-homology domain) o f N uf fused to the GAL4-transactivation domain 
in pACT2 were tested against Q-L and T-N mutants o f  Drosophila and mammalian Arfs 
fused to the GAL4 DNA-binding domain in pGBT9. No interactions were detected with 
any combination suggesting that N uf is not a direct Arf effector (data not shown).
In spite o f  these findings, it was decided to examine whether overexpression o f  N uf in 
mammalian cells would lead to similar phenotypes as those observed for the Arfophilins 
and hence potentially shed some light on the requirement for Arfs with respect to these 
phenotypes. Therefore, N uf was subcloned into a GFP vector as described in section 5.2.2 
and transiently expressed in HeLa cells. The results were striking. As with the Arfophilins, 
GFP-Nuf localisation in the majority o f cells was tightly around the y-tubulin-positive 
centrosome (Fig. 5.3.4.1, panels a-c), and transferrin receptors and R abll were also 
concentrated in the same region (Fig. 5.3.4.1, panels d-i). In addition, endogenous 
Arfophilin-2 was itself enriched in the Nuf-positive peri-centriolar region (Fig. 5.3.4.1, 
panels j-1). However, GGAI was not detected in the Nuf-positive compartment (not 
shown). It was also observed that a small proportion o f GFP-Nuf-expressing cells (about 
10%) exhibited a markedly different phenotype whereby GFP-Nuf was found packaged 
into a small ‘bud’ protruding from the cell surface (see Fig. 5.3.4.1, panels m-o). These 
buds also appeared to contain transferrin receptors (Fig. 5.3.4.1, panels m-o).
Transferrin pulse-chase experiments were also performed on cells expressing GFP-Nuf to 
see whether TfR recycling through the compartment was still functional, as it had been in 
GFP-Arfophilin-2-expressing cells. Fig. 5.3.4.2 shows the results o f  such an experiment 
where it can be seen that after a 30 min pulse, fluorescent transferrin accumulates in and 
around the Nuf-positive compartment (panels a-c). This fluorescence can subsequently be
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Fig. 5.3.4.1 Localisation of GFP-Nuf in HeLa cells.
Shown are confocal images of HeLa cells transiently expressing GFP-Nuf (centre 
panels and GREEN in right hand panels) counterstained for y tubulin (a, RED in c), 
TfR (d m RED in f,o), Rabll (g, RED in i) and endogenous Arfophilin-2 (j, red in I). 
Merged images appear in the right-hand panels. Also shown are cells displaying GFP- 
Nuf-containing ‘buds’ that also contain TfRs (m-o). Note that low level expression of 
Nuf results in marked alterations in TfR and Rabi 1 distribution similar to that observed 
with Arfophilin-2 overexpression. Also note the colocalisation of Nuf with endogenous 
Arfophilin-2 encircling the Arfophilin-2 positive centrosome (inset in I). Scale bars, 10 
pm.
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Fig. 5.3.4.2 Effects of GFP-Nuf overexpression on fluorescent 
transferrin trafficking in HeLa cells.
HeLa cells transiently expressing GFP-Nuf (centre panels and GREEN 
in right-hand panels) were serum starved for 1 hr then incubated for 30 
minutes with 1 pg/ml Texas Red-transferrin (Tf). Cells were then 
washed and incubated in complete medium containing 1 0 0  pg/ml 
unlabelled transferrin for the indicated times (in min). Cells were then 
washed in ice-cold PBS, fixed in methanol and confocal images were 
taken. Transferrin fluorescence is shown in panels a,d,g,j and in RED in 
the merged images. Scale bars, 10 pm.
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chased out over a similar time course to that observed with GFP-Arfophilin-2, with very 
little fluorescent transferrin remaining after 90 min (Fig. 5.3.4.2, panels j-1), again 
suggesting that there is no qualitative block on TfR recycling in these cells.
5.3.5 Analysis of untagged Arfophiiin-2 expression in HeLa ceils
Since GFP- and epitope-tags can interfere with the function o f proteins, and since the 
Arfophilin-2-specific antibody was available, the constructs encoding untagged full-length 
Arfophilins-2A, -2B and -2C described in chapter 4 were also expressed in HeLa cells and 
visualised by indirect immunofluorescence. In particular, their localisations were 
monitored in relation to the markers o f  interest: transferrin receptors, R abll and GGAI. 
These are shown in Figs. 5.3.5.1 A, 5.3.5.2, and 5.3.5.3. Untagged Arfophilin-2A lost most 
o f its peri-centrosomal localisation, only marginally colocalised with the transferrin 
receptor (Fig. 5.3.5.1 A, panels a-c) and did not appear to colocalise at all with R abll 
(panels d-f) or GGAI (panels g-i). It seemed to be mainly scattered throughout the 
cytoplasm in small punctate vesicular structures with diffuse cytosolic staining also 
apparent (Fig. 5.3.5.1). By contrast, Arfophilins-2B and -2C (Figs. 5.3.5.2 and 5.3.5.3, 
respectively) retained their tight peri-centrosomal distributions, maintained strong 
colocalisation with the TfR (panels a-c) and showed less diffuse staining. R abll was only 
detected in the Arfophilin-2C-positive compartment (Fig. 5.3.5.3, panels d-f) and, to a 
lesser exten,t in the Arfophilin-2B compartment (Fig. 5.3.5.2, panels d-f). GGAI did not 
appear coincident with either o f  these proteins (panels g-i), as it had been with the GFP 
chimeras. These results are summarised and compared to the GFP-Arfophilin-2 and the 
GFP-Nuf chimeras in Table 5.3.5.1.
Arfophilin-2A, which was shown in the last chapter to have the same electrophoretic 
mobility as the endogenous HeLa protein, was examined in more detail. Fig. 5.3.5.IB 
shows that its overexpression had little effect on the distributions o f the pCOP (panels a-c), 
CI-MPR (panels d-f), or RMEl (panels g-i).
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Fig. 5.3.5.1A Localisation of untagged Arfophilin-2A in HeLa cells.
HeLa cells transiently expressing Arfophilin-2A (shown in the centre 
panels and RED in the right-hand panels) were fixed in methanol 18 h 
after transfection and processed for immunofluorescence using the 
anti-Arfophilin-2 antibody (1:1000 dilution) in conjunction with primary 
antibodies against TfR (a-c), R ab ll (d-f), and GGAI (g-i). 
Representative confocal images were taken and the marker proteins 
are shown in the left-hand panels and in GREEN in the merged 
images. Scale bar, 10 pm.
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Fig. 5.3.5.1B Localisation of untagged Arfophilin-2A in HeLa cells.
HeLa cells transiently expressing Arfophilin-2A (shown in the centre 
panels and RED in the right-hand panels) were fixed in methanol 18 h 
after transfection and processed for immunofluorescence using the 
anti-Arfophilin-2 antibody (1:1000 dilution) in conjunction with primary 
antibodies against (3GGP (a-c), CI-MPR (d-f), and RMEl (g-i). 
Representative confocal images were taken and the marker proteins 
are shown in the left-hand panels and in GREEN in the merged 
images. Scale bars, 10 pm.
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Fig. 5.3.5.2 Localisation of untagged Arfophilin-2B in HeLa cells.
HeLa cells transiently expressing Arfophilin-2B (shown in the centre panels and 
RED in the right-hand panels) were fixed in methanol 18 h after transfection and 
processed for immunofluorescence using the anti-Arfophilin-2 antibody (1:1000 
dilution) in conjunction with primary antibodies against TfR (a-c), R abll (d-f), 
and GGAI (g-i). Representative confocal images were taken and the marker 
proteins are shown in the left-hand panels and in GREEN in the merged images. 
Scale bars, 10 pm.
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Fig. 5.3.5.3 Localisation of untagged Arfophilin-2C in HeLa cells.
HeLa cells transiently expressing Arfophilin-2C (shown in the centre panels and 
RED in the right-hand panels) were fixed in methanol 18 h after transfection and 
processed for immunofluorescence using the anti-Arfophilin-2 antibody (1:1000 
dilution) in conjunction with primary antibodies against TfR (a-c), R abll (d-f), 
and GGAI (g-i). Representative confocal images were taken and the marker 
proteins are shown in the left-hand panels and in GREEN in the merged images. 
Scale bar, 10 pm.
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Table 5.3.5.1 Summary of phenotypes observed upon expression  of 
different Arfophilin-2/Nuf constructs in HeLa cells.
Untagged and tagged constructs are scored according to whether the 
resulting proteins exhibit pericentrosomal localisation and whether they 
colocalise with the transferrin receptor (TfR), Rab11 and GGA1. Three 
ticks represent strong colocalisation, one tick represents weak 
colocalisation, while a cross indicates the lack of discernible 
colocalisation. The constructs used are referred to by letter according to 
Fig. 5.2.1. *GFP-Arfo2 represents any of the Arfophilin-2 constructs 
containing the minimum Arf-binding domain (constructs B/C/E/F/G/H). 
GFP-Nuf represents full-length Nuf fused to the C-terminus of GFP.
206
5.3.6 The effect of over-expression of A rf mutants on Arfophilin-2 
distribution
The Arfophilins were identified by virtue o f their GTP-dependent interactions with Arf5. 
Therefore, I wished to examine the effects o f over-expression o f wild-type, constitutively 
active and dominant negative forms o f  Arf5 on Arfophilin-2 distribution. C-terminally 
epitope-tagged Arf5 constructs were, therefore, expressed in HeLa cells and the resulting 
proteins were monitored by immunofluorescence using antibodies to the epitope tags all 
according to the methods described in sections 2.2.2.4 and 2.2,3. Whereas wild-type Arf5- 
FLAG and activated Arf5Q71L-HA did not seem to affect endogenous Arfophilin-2 
distribution to any great extent in these cells (Fig. 5.3.6, panels a-d), the expression o f  the 
dominant negative GTP-binding deficient Arf5T31N-HA mutant completely dispersed it 
into the cytoplasm even in relatively low-expressing cells (Fig. 5.3.6, panels e-f). The 
analogous Arf6 mutant, Arf6T27N-HA, was similarly analysed but it was not capable o f  
disrupting Arfophilin-2 staining (Fig. 5.3.6, panel g-h).
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Fig. 5.3.6 The effect of expression of Arf m utants on endogenous 
Arfophilin-2 distribution in HeLa cells
HeLa cells on coverslips were transfected with mammalian expression 
vectors encoding Arf5-FLAG (a-b), Arf5Q71L-HA (c-d), Arf5T31 N-HA (e-f) 
and Arf6T27N-HA (g-h) as indicated. After 18-20 h, the cells were fixed 
and processed for immunofluorescence using monoclonal anti-FLAG 
(Sigma) or anti-HA (Santa Cruz) antibodies (1:200 dilution, right-hand 
panels) and a polyclonal anti-Arfophilin-2 antibody (1:200, left hand 
panels), followed by Alexa^®®-anti-mouse and Alexa®®^-anti-sheep 
secondary antibodies. Shown are representative confocal images of cells 
expressing the Arf proteins. This experiment was performed twice with 
similar results. Scale bar, 10 pm.
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5.3.7 The production of ceii iines stabiy expressing a GFP- 
Arfophiiin-2 chimera
It was decided to produce stable cell lines expressing GFP-Arfophilin-2 (C-terminal 330 
amino acids) to facilitate future study. One particular application would be for electron 
microscopic analysis o f  the pericentrosomal TfR-positive compartment, as high resolution 
images o f the structures may shed more light onto the function o f Arfophilin-2. Other 
experiments in mind for stable cell lines included the analysis o f  the kinetics o f  
radiolabelled ^^^I-transferrin trafficking, and their use as a source o f protein for 
biochemical Arf binding assays.
G418 resistant HEK 293 and CHO cell lines were produced as described in section 5.2.3, 
and clonal populations were then examined by confocal microscopy and immunoblotting, 
to check for GFP-Arfophilin-2 expression. As can be seen in the immunoblot in Fig 5.3.7.1 
(panel B), several expressing lines were produced. Furthermore, immunofluorescence 
microscopy analysis o f the HEK 293 clones revealed that the GFP-Arfophilin-2 protein 
was similarly concentrated in a TfR-positive (Fig 5.3.7.2, panels a-c), Rab 11-positive 
(panels d-f) and GGAl-positive (panels g-i) pericentrosomal compartment. It was noted 
that these cells grew markedly slower that wild-type HEK 293 eells, with a doubling time 
roughly three to four times longer (data not shown). Endogenous Arfophilin-2 protein 
levels also seemed to be elevated in these cells given the increased intensity o f  the bands 
present in the immunoblot (see Fig. 5.3.7.1, panel B), when equal amounts o f total protein 
were loaded (see the Ponceau-stained blot in panel A). This may have been a reflection o f  
an adaptive mechanism trying to overcome a block induced by the overexpressed protein. 
The generation o f stably expressing HeLa cells was also attempted, but while many G418- 
resistant clones were isolated, none exhibited any detectable GFP fluorescence (data not 
shown).
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Fig. 5.3.7.1 Analysis of GFP-Arfophilin-2 stable ceii lines.
HEK 293 and CHO cells were transfected with GFP-Arfophilin-2 (0- 
terminal 330 amino acids; construct 0  in Fig. 5.2.1) and clonal, 
G418-resistant cell lines were selected and cultured. Whole cell 
lysates were prepared from the different cells indicated and 20 \ig 
protein per lane were separated on a 10% SDS-PAGE gel. The 
proteins were then transferred to nitrocellulose, stained with 
Ponceau-S (Panel A), and immunoblotted with anti-Arfophilin-2 
antibodies (Panel B), all according to the methods in section 2.2.4. 
The positions of the endogenous and heterologously-expressed 
proteins are indicated on the right, and the sizes of molecular weight 
standards (in kDa) are given on the left. Wild-type HeLa and HEK 
293 cells are present in the first two lanes for comparison. Note that 
all three HEK stable cell lines have markedly elevated endogenous 
Arfophilin-2 signals compared to the wild-type cells.
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Fig. 5.3.7.2 Confocal analysis of a HEK 293 cell line stably 
expressing GFP-Arfophilin-2.
HEK 293 cells were transfected with GFP-Arfophilin-2 (C-terminal 330 
amino acids; construct C in Fig. 5.2.1) and clonal, G418-resistant cell lines 
were selected. One such clone (clone A) was then cultured on glass 
coverslips, fixed in methanol and processed for immunofluorescence using 
primary antibodies against TfR (a-c), R ab ll (d-f), and GGAl (g-i), and 
TRITC-conjugated secondary antibodies. Confocal images were taken and 
the marker proteins are shown in the left-hand panels and in RED in the 
merged images, while GFP fluorescence is shown in the centre panels and 
in green in the merged images.
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5.4 Discussion
In this chapter, experiments have been described whereby the overexpression o f various 
Arfophilin-2 constructs in HeLa cells results in very interesting phenotypes. The specific 
and drastic change in transferrin receptor distribution automatically implicates Arfophilin- 
2 in the regulation o f the endosomal system since this receptor is the archetypal marker o f  
this trafficking pathway (see section 1.1.2.1). Furthermore, the fact that Rab 11 was 
similarly affected strongly argues that Arfophilin-2 specifically affects the peri-centriolar 
recycling compartment (Ullrich et al., 1996) and (see sections 1.1.2.2 and 1.1.2.3). The 
specificity for this compartment is perhaps best demonstrated by the inability o f  
Arfophilin-2 to alter the distributions o f Rab 4 and EEA l, since these are found in the 
other subdomains o f the endosomal system, although the former can be seen to partially 
overlap with Rab 11 (Sormichsen et al., 2000).
The fact that fluorescent transferrin can still enter and leave the compartment relatively 
efficiently argues that the changes in TfR distribution are not due to a qualitative 
trafficking block. This is perhaps not particularly surprising given that nocodazole 
treatment does not interfere with transferrin receptor recycling (Jin and Snider, 1993), 
whereas the Arfophilin-2-mediated effects are sensitive to the drug. A  TfR recycling block 
was however recently described upon overexpression o f  GFP-myosin Vb tail, which 
caused internalised transferrin to accumulate in a similar Rab 11-positive compartment 
around the centrosome, but in this case it could not be chased out even after 6 hours 
(Lapierre et al., 2001). While this is clearly not happening with Arfophilin-2 
overexpression, subtle changes in the kinetics o f entry/exit from the recycling endosomes 
may still be occurring and these could account for the observed effects. For instance, a 
slight decrease in the rate o f  exit or a slight increase in the rate o f  entry may produce the 
endosome morphology described here. Hopefully, future experiments monitoring ^^ I^- 
transferrin trafficking in the stable cell lines will uncover if  this is the case.
A similar phenotype was also recently reported for overexpression o f mammalian and 
worm RMEl (Grant et al., 2001; Lin et al., 2001), an EH domain-containing protein 
discovered in a C. elegans screen for mutants defective in receptor mediated endocytosis. 
Expression o f  a dominant negative RMEl point mutant in CHO cells lead to a slowing o f  
transferrin receptor recycling and a slowing o f the delivery o f  a TGN38 chimera to the 
TGN (Lin et al., 2001). In the case o f Arfophilin-2, the effect seems to be on the 
distribution, but not necessarily the function, o f the recycling endosomal compartment.
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Exactly how Arfophilin-2 could regulate the distribution o f this compartment is unclear. 
Potentially it could be involved in motor protein recruitment or the regulation o f  
microtubule associated proteins.
The recycling endosomes exhibit heterogeneity, differences having been noted based on 
the analysis o f  cellubrevin versus transferrin receptor trafficking (Teter et al., 1998). They 
are also continually exchanging membrane with the plasma membrane, the late endocytic 
compartments and the TGN (Ghosh et al., 1998). It would therefore be very interesting to 
see whether GFP-Arfophilin-2 has a global effect on the recycling endosomes, or whether 
only a subset are affected, and if  so, whether these are on a specific transport route to/from 
particular compartment.
The brefeldin A insensitivity o f GFP-Arfophilin-2 localisation also supports the notion that 
it is the recycling endosomes that are being affected, since these organelles in particular are 
well documented as being remarkably resistant to the drug (Lippincott-Schwartz et al., 
1991; Sormichsen et al., 2000). It is conceivable that endogenous Arfophilin-2 traffics 
between a major BFA-sensitive pool in the TGN area and a BFA resistant recycling 
endosome pool and that it gets tiapped in the latter upon expression o f the various 
constructs described. This idea is supported by the observation that the endogenous 
Arfophilin-2 colocalises with GFP-Arfbphilin-1 and GFP-Nuf in the pericentrosomal 
location. The addition o f a GFP moiety or even the N-termini o f putative Arfophilins-2B or 
-2C to Arfophilin-2A causes the clustered endosome morphology, whereas untagged 
Arfophilin-2A disperses throughout the cell and only marginally alters endosome 
morphology in some cells. This suggests that a free amino-terminus is probably required 
for Arfbphilin-2 function, and can also be interpreted to imply that Arfophilin-2A is the 
endogenous isoform.
The nocodazole-sensitivity clearly demonstrates the microtubule-dependency o f the 
compartment; also a well-documented characteristic o f the recycling endosomes (Cole and 
Lippincott-Schwartz, 1995). The fact that it is reversible implies that minus-end-directed 
motor protein activity is still functional. It may be that plus-end directed motor recruitment 
or function is being inhibited upon GFP-Arfophilin-2/Nuf overexpression, and this would 
correlate nicely with the model proposed for N uf function described in the introduction to 
this chapter (section 5.1.1). The TfR/Rabll positive compartment induced by GFP-myosin 
Vb tail was also dispersed by nocodazole and the authors postulated that both actin-based 
and microtubule-based motor proteins were involved in trafficking through the 
compartment, and that they were interfering with a myosin/kinesin interaction (Lapierre et
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al., 2001). It would be interesting to see where myosin V resides in cells overexpressing 
Arfophilin-2 and vice versa and to work out whether the two proteins function in parallel, 
or indeed in the same, pathways.
The change in GGAl localisation is very interesting, not least because it too is an Arf- 
binding protein (Boman et al., 2000). The GGAs are less well described having only been 
discovered in the last year or two. Nevertheless, there is good evidence showing that they 
are clathrin-binding adaptors that also directly bind MPR cytoplasmic tails and are 
involved in their trafficking out o f  the TGN (Puertollano et al., 2001a; Puertollano et al., 
2001b). The fact that MPRs themselves were unaffected by expression o f any o f the 
Arfbphilin constructs implies that the GGA sequestration occurs at steps either before or 
after their involvement in MPR trafficking. It also strengthens the likelihood that 
Arfophilin-2 and the CI-MPR are not associated with one another despite the marked 
colocalisation o f the endogenous proteins seen in chapter 5. A  similar situation seems 
likely for sortilin, which was again unaffected by Arfophilin-2 expression despite a recent 
report that it interacts with the VHS domain o f GGA2 (Nielsen et al., 2001).
The observation that N uf overexpression results in largely the same phenotype is a 
particularly exciting finding. It is a strong indication that N uf is functionally related to the 
Arfophilins and this has several important implications. Firstly it suggests a potential role 
for the Arfophilins in cell division and particularly cytokinesis, since N uf exhibits cell- 
cycle-dependent behaviour and is required for the formation o f cellularisation furrows in 
the Drosophila embryo. The findings also implicate the recycling endosomes in 
cytokinesis. This would be consistent with recent studies o f  cytokinesis in the early 
Caenorhabditis elegans embryo, where RNAi-induced suppression o f Rab 11 was shown 
to lead to a very specific regression o f  the cleavage furrow at the final stage o f abscission 
(Skop et al., 2001). There is a large body o f evidence from diverse organisms that 
intracellularly-derived membrane delivery and syntaxin-mediated fusion is required for 
cytokinesis in addition to the well-characterised acto-myosin contractile mechanism 
(Sisson et al., 2000; Burgess et al., 1997; Conner and Wessel, 1999; Lauber et al., 1997; 
Jantsch-Plunger and Glotzer, 1999). It is conceivable that this membrane is delivered 
from/via the recycling endosomes in a Nuf/Arfophilin-regulated manner, from the 
centrosomal region to the cleavage site along the microtubule spindle. Since testis is a 
tissue undergoing a high degree o f mitotic and meiotic cell division, such a role may help 
to explain the high level o f expression observed in this tissue in the last chapter. It may 
also help to explain why HEK 293 cells stably expressing GFP-Arfophilin2 grow much 
slower than their wild-type counterparts.
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Albeit indirectly, Arfs themselves have also been implicated in cell division since brefeldin 
A, which inhibits membrane trafficking and secretion by blocking Arf activation 
(Donaldson et ah, 1992; Helms and Rothman, 1992; see section 1.3.2.3), also inhibits 
cellularisation in Drosophila (Sisson et ah, 2000) and cytokinesis in the Caenorhabditis 
elegans embryo (Skop et ah, 2001). Further circumstantial evidence is provided by the fact 
that Arfs also interact with the mitotic kinesin MKLPl in a GTP-dependent manner 
(Boman et ah, 1999), and that this motor protein is a micro tubule bundling protein 
involved in cleavage furrow formation (Glotzer, 2001). It is found in the nucleus in 
interphase cells, at the spindle poles during metaphase and concentrates at the midbody and 
on the midzone microtubules during anaphase (Nislow et ah, 1992; Sellitto and Kuriyama, 
1988). Mutants o f  the Drosophila and Caenorhabditis elegans homologues o f  MKLPl, 
pavarotti and Zen-4, respectively, show cytokinetic defects (Adams et ah, 1998; Powers et 
ah, 1998; Raich et ah, 1998). Collectively, these data could argue for a role for Arfs and 
Arfophilins in cytokinesis.
The fact that Arfophilins appear to be homologues o f nuclear fallout and given that there 
are strong genetic interactions between nuf and discontinuous actin hexagon in Drosophila, 
prompts the investigation into a potential role for members o f the related dystrobrevin 
family in Arfophilin-mediated events. Dystrophins and dystrobrevins form the core o f  
large membrane- and actin-bound complexes in metazoans (reviewed in Roberts, 2001) 
Such an involvement might help explain the observation that some Arfophilin-2 
immunoreactivity was detected at the plasma membrane. Attention should also be paid to 
the fact that N uf is highly phosphorylated and exhibits cell-cycle-dependent behaviour 
(Rothwell et al., 1999; Rothwell et al., 1998). The Arfophilins are likely to be similarly 
regulated. Furthermore, their constitutive overexpression could lead to effects that 
normally only occur at precise points in the cell cycle, such as the accumulation o f  
endosomes around the microtubule-organising centre (see section 1.2.3).
The differences in the distributions o f  TfRs/Rab 11 /GGA 1 observed with different 
constructs suggest that the effects on each o f these proteins are separable and, therefore, 
not induced by the same protein-protein interaction(s). O f the three proteins, the transferrin 
receptor was the commonest affected and GGAl was the least affected. Perhaps different 
Arfophilins are involved in directing TfR-positive vesicles to different destinations. For 
example, one Arfbphilin variant may sort it back to the TGN with GG Al, whereas another 
might sort it to the plasma membrane. It would be interesting to see whether the TfR- 
positive, Rab 11-negative compartments induced by some constructs were positive for other 
Rab proteins such as Rab7, Rab9, Rab 17, Rab 18 and Rab20, all known to reside in sub­
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compartments o f  the endosomal system (see Fig. 1.1.9). It would also be o f interest to 
assess whether the absence o f  R abll results in defects in TfR trafficking, since this Rab 
has been implicated in its exit from recycling endosomes (Ren et ah, 1998; Ullrich et ah, 
1996). However, this is probably not the case since the GFP-Nuf compartment did not 
contain Rab 11 and the TfRs seemed to traffic normally through it.
From the experiments performed to date, it is hard to draw many conclusions about the role 
of Arfs in Arfbphilin function. The fact that similar effects were observed for GFP- 
Arfophilin-2 and GFP-Nuf overexpression, and given that N uf does not seem to bind Arfs 
in the yeast two-hybrid system, suggests that Arf binding is secondary in the observed 
phenotype. On the other hand, expression o f Arf5T31N in HeLa cells completely dispersed 
the endogenous Arfophilin-2 TGN staining implying that Arf5 regulates its membrane 
association. This is wholly consistent with the data presented by Shin et al. (1999), who 
showed that the C-terminal domain o f Arfbphilin-1 associates with intracellular CHO cell 
membranes in the presence o f ArfS-GTPyS and dissociates in the presence o f Arf5- 
GDPpS. The fact that the analogous Arf6 mutant did not disrupt the intracellular 
Arfophilin-2 localisation in this study argues that Arf6 does not regulate this Arfophilin-2 
pool in vivo. Perhaps the Class II Arfs regulate Arfbphilin recruitment/function at the 
TGN, while effects on the distribution o f the recycling compartment are separate Arf- 
independent events. Then again, Arf6-GDP has been localised to the pericentriolar 
recycling endosomes by sensitive electron microscopy (D'Souza-Schorey et al., 1998), and 
it could potentially then interact with Arfophilins upon nucleotide exchange. Clearly a 
detailed analysis o f  the localisation o f different Arfs and indeed the effects o f different Arf 
mutations on endogenous/overexpressed Arfophilin-2 and the recycling endosomes in 
general is warranted. Isoform-specific Arf antibodies have been described (Cavenagh et al., 
1996; West et al., 1997), and these would be highly useful reagents to help dissect the 
precise roles o f  the Arfs in these events.
The identification o f  further common and specific Arfbphilin- l/Arfbphilin-2/Nuf binding 
partners will be key in the elucidation o f the precise cellular roles o f this protein family. 
Yeast two-hybrid screening offers one potential and attractive method in this respect. Since 
similar phenotypes were observed upon overexpression o f the different family members in 
HeLa cells, it would be predicted that they would all interact with common binding 
partners through their conserved C-terminal coiled-coil domains. Putative positives 
recovered from two-hybrid screens, could therefore be tested against all three proteins to 
classify them into common or specific interacting partners, the former being potentially 
more interesting in terms o f explaining the phenotype observed in HeLa cells.
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Furthermore, given that both Arfophilins are highly expressed in testis, this tissue is likely 
to express interacting partners at similarly high levels and therefore represents the best 
tissue to screen. Bait constructs encoding the C-terminal 330 amino acids o f Arfbphilin-1, 
Arfophilin-2 and N uf have been constructed, shown not to allow trans-activation when 
cotransformed with an empty prey vector, and are awaiting use in such experiments.
2 1 7
Chapter 6
Conclusions and future directions
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Arf proteins are important regulators o f membrane trafficking and cytoskeletal remodelling 
in eukaryotic cells. It is not clear why mammalian cells possess three classes o f these 
proteins consisting o f  six distinct isoforms. Most attention has been paid to the class I and 
III Arfs, while the class II members have been largely neglected. Recently, a class IRIII 
Arf-interacting protein, Arfbphilin, was identified but its function is unknown (Shin et al., 
1999, 2001).
The work presented in this thesis has described the use o f  the yeast two-hybrid sytsem to 
identify two potential Arf effector proteins, HCR and Arfophilin-2 and the latter has been 
characterised in greater detail. Assuming that the Arfophilins are bona fide  Arf effectors, 
this work together with that o f the Exton laboratory, provides compelling evidence for the 
existence o f  specific class II Arf-regulated pathways. This in itself is a major step forward 
as many researchers in the field have assumed these Arfs to have merely redundant roles. 
Taking the situation one step further, the data presented here strongly suggest a role for the 
Arfophilins in regulating membrane dynamics in the trans-Golgi network (TGN) and/or 
endosomal recycling systems. This is based on the findings that endogenous Arfophilin-2 
predominantly localises to a TGN compartment in HeLa cells and that expression o f an N- 
terminally GFP-tagged or truncated mutant causes the R ab ll and transferrin receptor- 
positive endosomes to redistribute around the centrosome. Satisfyingly, previous studies in 
this laboratory using myristoylated synthetic Arf peptides suggested a role for Arf5 in 
regulating endosomal recycling in 3T3 LI adipocytes (Millar et al., 1999). Hopefully, 
future studies will uncover the molecular basis o f this regulation.
It will be important to dissect the precise roles o f Arf5 and Arf6 in Arfbphilin function. It 
has been suggested that these Arfs bind distinct sites on Arfbphilin-1 (Shin et al., 2001), so 
it may be possible to generate mutants defective in one or both o f these thus allowing the 
contributions o f each Arf to be assessed individually. It may also be worthwhile disrupting 
the leucine zippers by site-directed mutagenesis and observing the effects on Arf binding 
and cellular phenotype.
It is particularly regrettable that a biochemical interaction between Arfophilin-2 and 
Arf5/Arf6 has not yet been demonstrated, and this is something that needs to be 
reproducibly shown despite the ~70% identity with Arfbphilin-1 in the Arf-binding 
domain. It has been attempted unsuccessfully using several approaches including pulldown 
assays using bacterially produced GST-Arf proteins (mutants and wild-type, with and 
without GTPyS) and cell lysates overexpressing the Arfophilin-2 C-terminus. 
Coimmunoprecipitation o f endogenous Arfophilin-2 from HeLa cells transfected with HA-
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tagged Arf mutants has also failed to demonstrate binding. A  direct interaction using 
purified His-tagged Arfophilin-2 and GST-Arfs has been problematic, primarily due to 
problems arising from the fact that Arfophilin-2 produced by E. coli often appeared as a 
ladder o f (His-tag-positive) bands when resolved by SDS-PAGE. However, this appears to 
have been rectified by changing from a pQE (Qiagen) to a pET (Novagen) vector, although 
binding assays have not yet been attempted with this protein. It would probably be 
worthwhile repeating the exact method used by the Exton lab for Arfbphilin-1 (Shin et al., 
1999, 2001). By using Arfbphilin-1 as a positive control, it should be possible to 
conclusively show whether Arfophilin-2 is a bona fide  Arf binding partner. I believe that 
the interaction is genuine, but that the assay conditions tried so far have not been optimal. 
One problem may have arisen from too little protein being used to detect the interaction. 
Also, while an N-terminal fusion o f  the GAL4-binding domain with Arf in the yeast two- 
hybrid system supports an interaction, GST fused to the Arf N-terminus may not in 
pulldown experiments. In fact, it might be better if  myristoylated untagged Arf proteins 
were used in binding experiments.
Other important challenges for future studies o f Arfbphilin function include the elucidation 
of additional Arfophilin-interacting proteins. In this respect, yeast-two hybrid screening 
and affinity chromatography could be fruitful approaches to take. Considering the high 
level o f expression in testis, this would seem the logical tissue to screen. Given that highly 
homologous proteins are predicted from EST data in other species such as cattle, obtaining 
enough material for chromatography should not be problematic.
It w ill also be very interesting to uncover what the different roles are for the different 
Arfophilins. What functions do the distinct N-termini serve and where are these variants 
expressed? Similarly, why is the EE[H/Q]FEDYGEG m otif conserved in both Arfbphilin-1 
and Arfophilin-2 and why is it spliced out in some variants? Why does the addition o f the 
GFP moiety to the amino terminus o f Arfophilin-2 A result in a markedly different cellular 
phenotype? All o f these questions need to be answered to obtain a more complete picture 
o f the roles o f these proteins.
The work presented here also uncovered similarities between the Arfophilins and 
Drosophila Nuclear Fallout. These include sequence homology and comparable 
phenotypes upon overexpression o f GFP fusion proteins in HeLa cells. These data raise a 
whole new set o f interesting questions since Nuclear Fallout is a cell-cycle regulated, 
highly phosphorylated protein required for cellularisation (Sullivan et al., 1993; Rothwell 
et al., 1998), a process akin to cytokinesis. The proposed model for the action o f N uf in
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Drosophila involves it cycling between the cytosol and the centrosome, where it may 
regulate the association o f  vesicles with microtubules (see Fig. 5.1.1). This fits in nicely 
with the observed microtubule-dependent clustering o f membranes around the centrosome 
described here upon GFP-Arfbphilin expression. If the homology between the Arfophilins 
and N uf can be extended to include the control o f cytokinesis/cellularisation, and that Arfs 
were somehow involved in this regulation, this would be a major breakthrough in the field. 
As a first step, it should be relatively straightforward to monitor endogenous Arfophilins 
through the cell-cycle and see, for example, whether their expression, localisation and 
phosphorylation states are altered in different phases. Along the same lines, it would also 
be exciting to see whether the mammalian Arfophilins can rescue the lethal N uf phenotype 
in Drosophila.
A  role in cell division could explain the fact that high mRNA levels in testis were detected 
in a northern blot. Alternatively, this may reflect a role specific to this tissue. It would be 
very interesting to locate, by immunocytochemistry or in situ hybridisation, which cells are 
responsible for the high levels o f expression as this could be very informative. During 
spermatogenesis, spermatids change from round to elongate cells in a process that involves 
them being translocated into apical invaginations o f Sertoli cells (Beach and Vogl, 1999 
and references therein). Furthermore, this translocation appears to involve microtubule- 
based motility (Beach and Vogl, 1999). Given the observed effects o f GFP-Arfophilin-2 
expression on the distribution o f microtubule-associated membranes, it would be tempting 
to speculate that Arfophilin-2 might regulate spermatid translocation if  it were found to be 
highly expressed in Sertoli cells.
To summarise, this thesis has uncovered and cloned a new class II/III Arf-binding protein 
and member o f the Arfbphilin family, Arfophilin-2. It has identified homologues in 
Drosophila and C. elegans and a high quality Arfophilin-2-specifîc antibody has been 
produced and characterised. Analysis o f  cultured cells has revealed that the endogenous 
protein is both membrane-associated and cytosolic, and is primarily localised in and 
around the TGN in interphase cells. Expression o f GFP chimeras resulted in a dramatic and 
specific redistribution o f the perinuclear recycling compartment to a tight pericentrosomal 
localisation. This phenomenon was dependent on the integrity o f the microtubule 
cytoskeleton and did not result in gross changes in transferrin receptor recycling.
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GBT9 generates a hybrid protein that contains the sequence o f  the GAL4 DNA-Binding domain 
(DNA-BD; a.a. 1-147). The fusion protein is expressed in yeast host cells from the constitutive 
A D H l promoter; transcription is terminated at the A D H l transcription signal. The hybrid protein is 
targeted to the yeast nucleus by nuclear localisation sequences that are an intrinsic part o f  the 
GAL4 D N A-BD. pGBT9 replicates autonomously in both E. coli and S. cerevisiae. It carries the 
bla gene (for ampicillin resistance in E. coli) and the TRPl nutritional marker that allow yeast 
auxotrophs carrying pGBT9 to grow on limiting synthetic medium lacking Trp.
The Q71/67L and T27/31N mutants o f Arfl, Arf2, ArO, Arf4, Arf5 and Arf6 were 
cloned in frame into the BamHI and Sail sites. Arf5 and Arf6 cDNAs were cloned 
in using Bglll and Xhol, so both BamHI/Sall restriction sites are abolished. Arfl, 
Arf2, Arf3 and Arf4 were cloned in using BamHI and Xhol, so the Sail restriction 
site is abolished.
N4Arf5 (BamHI and Xhol cut) and N5Arf4 (Bglll and Xhol cut) constructs were 
also ligated into the BamHI and Sail sites o f pGBT9.
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The hybrid protein is expressed at high levels in yeast host cells from the constitutive A D H l 
promoter ( P); transcription is terminated at the A D H l transcription termination signal ( T). 
The protein is targeted to the yeast nucleus by the nuclear localization sequence from SV40 T- 
antigen which has been cloned into the 5’ end o f the GAL4 AD sequence. pACT2 replicates 
autonomously in both E. coli and S. cerevisiae. It carries the bla gene, which confers ampicillin 
resistance in E. coli and the LEU2 nutritional gene that allows yeast auxotrophs to grow on 
limiting synthetic media.
The cDNAs o f the putative Arf5 interacting proteins (T3, T4, T9, T12, T14 
and T20) are located between the EcoRl and Xho I sites o f  pACT2 (Clontech).
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pGAD 10 (Clontech) is similar to pACT2 but does not have a HA tag. The 
insert in plasmid B1 pGAD 10 (600 bp o f 3 ’ ORF and 3 ’UTR o f Arfophilin-1) 
is located between the EcoRI site and the 2nd Bglll site.
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The 3’ 990 bp o f  the Arfophilin-2 ORF (including 3 ’UTR directly cut using Bglll 
from T20 pACT2) was subcloned into the BamHI site o f  pQE32 (Qiagen), in frame 
with the N-terminal RGS-His tag.
The 3 ’ 600 bp o f the Arfophilin-1 ORF together with the 3 ’UTR (the entire insert 
cut from B1 pGADlO using B glll) was inserted into the BamHI site o f  pQE31 
(Qiagen), in frame with the N-terminal RGS-His tag.
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The 3 ’ 990 bp o f  the Arfophilin-l and Arfophilin-2 ORFs were subcloned into the 
BamHI and Sail sites o f pET28b (Novagen), in frame with the N-terminal 
hexahistidine tag.
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SV40 polyadenylation signals downstream o f  the EGFP gene direct proper processing o f the 3' end 
o f  the EGFP mRNA. The vector backbone also contains an SV40 origin for replication in 
mammalian cells expressing the SV40 T-antigen. A neomycin-resistance cassette (neor), consisting 
o f  the SV40 early promoter, the neomycin/kanamycin resistance gene o f  Tn5, and polyadenylation 
signals from the Herpes simplex thymidine kinase gene, allows stably transfected eukaryotic cells to 
be selected using G418. A bacterial promoter upstream o f  this cassette (Pamp) expresses kanamycin 
resistance in E. coli. The pEGFP backbone also provides a pUC19 origin o f replication for 
propagation in E. coli and an f l origin for single-stranded DNA production.
The 3 ’ 990 bp o f the Arfophilin-2 ORF (including 3 ’UTR directly cut from T20 
pACT2) was subcloned into the Bglll site. Similarly a partially Bglll digested 
Arfophilin-2 fragment containing the entire T20 pACT2 insert (including HA tag 
and 3’UTR) was also cloned into the Bglll site o f pEGFP-C2 (Clontech).
The full-length Arfophilin-2A ORF (digested with BamHI and Sail) was subcloned 
in frame into the Bgl II and Sail sites o f this vector.
Full-length Arfophilin-2B and -2C ORFs were excised from pEGFP-Nl vectors 
using EcoRl and Sail and were subcloned in frame into the same sites o f pEGFP- 
C2.
The 3 ’ 990 bp o f the Arfophilin-1 ORF (digested with BamHI and Sail) was 
subcloned into the Bglll and Sail sites o f pEGFP-C2.
The full-length ORF o f Drosophila nuclear fallout (Nuf; containing 5 ’ BamHI and 
3 ’ Sal I sites) was also cloned into the Bglll and Sail sites o f pEGFP-C2.
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The pEGFP-Nl (Clontech) vector has the same features as pEGFP-C2 except that the multiple 
cloning site (MCS) precedes the EGFP sequence.
The full-length Arfophilin-2A ORF (digested with BamHI and Sail) was subcloned 
into the Bgl II and Sail sites o f this vector (note that stop codon is present so no 
EGFP fusion is made).
Full-length Arfophilin-2B and -2C ORFs were assembled in this vector and are 
found between the EcoRI and Sal I sites (note that stop codons are present so no 
EGFP fusions are made).
